{"entity":"cvs-health","id":"ent_cvs-health","name":"CVS Health","wikidata":"Q624375","page":"https://asof.is/record/cvs-health","summary":"CVS Health is a company, headquartered in Woonsocket. It reported revenue of $402.07B for the period ended December 31, 2025.","title":"CVS Health: revenue $402.07B","key_facts":[{"label":"Chair","value":"J. David Joyner","claim":"clm_CD3F5A892A25"},{"label":"CFO","value":"Brian O. Newman","claim":"clm_D8BDE5FBAB36"},{"label":"Headquarters","value":"Woonsocket","claim":"clm_51282B82469D"},{"label":"Revenue","value":"$402.07B","recorded":"402,067,000,000 United States dollar","note":"to 2025-12-31","claim":"clm_B99511607945"},{"label":"Ticker","value":"CVS · NYSE","claim":"clm_8E541519C12F"}],"faq":[{"question":"Where is CVS Health headquartered?","answer":"Woonsocket."},{"question":"What is CVS Health's revenue?","answer":"$402.07B for the period ended December 31, 2025."}],"as_of":null,"known_by":null,"since":null,"fact_pages":[{"predicate":"chair","page":"https://asof.is/record/cvs-health/chair","md":"https://asof.is/record/cvs-health/chair.md","json":"https://asof.is/v1/entities/cvs-health/chair"},{"predicate":"cfo","page":"https://asof.is/record/cvs-health/cfo","md":"https://asof.is/record/cvs-health/cfo.md","json":"https://asof.is/v1/entities/cvs-health/cfo"},{"predicate":"headquarters","page":"https://asof.is/record/cvs-health/headquarters","md":"https://asof.is/record/cvs-health/headquarters.md","json":"https://asof.is/v1/entities/cvs-health/headquarters"},{"predicate":"revenue","page":"https://asof.is/record/cvs-health/revenue","md":"https://asof.is/record/cvs-health/revenue.md","json":"https://asof.is/v1/entities/cvs-health/revenue"},{"predicate":"net_income","page":"https://asof.is/record/cvs-health/net_income","md":"https://asof.is/record/cvs-health/net_income.md","json":"https://asof.is/v1/entities/cvs-health/net_income"},{"predicate":"operating_income","page":"https://asof.is/record/cvs-health/operating_income","md":"https://asof.is/record/cvs-health/operating_income.md","json":"https://asof.is/v1/entities/cvs-health/operating_income"},{"predicate":"quarterly_revenue","page":"https://asof.is/record/cvs-health/quarterly_revenue","md":"https://asof.is/record/cvs-health/quarterly_revenue.md","json":"https://asof.is/v1/entities/cvs-health/quarterly_revenue"}],"products":[],"coverage":{"entity":"cvs-health","name":"CVS Health","kind":"organization","sources":[{"source":"wikidata","item":"Q624375","covers":"dated statements whose reference URL is the source: leadership, ownership, names, founding, headquarters; never financial figures"},{"source":"wikidata-products","covers":"products it makes, develops or publishes, as released claims, when the release date cites a reference URL; a rotating scan, a few dozen entities a run"},{"source":"sec","cik":64803,"ticker":"CVS","covers":"annual and quarterly figures from XBRL, registrant name, tickers and fiscal year end; officer and director changes (8-K Item 5.02) and material events (other 8-K items)"}],"holds":{"claims":515,"open":22,"retracted":0,"first":"1963-01-01","predicates":{"cash_and_equivalents":{"claims":76,"open":1,"kind":"fact"},"shares_outstanding":{"claims":70,"open":1,"kind":"fact"},"quarterly_net_income":{"claims":43,"open":1,"kind":"fact"},"quarterly_operating_income":{"claims":56,"open":1,"kind":"fact"},"total_equity":{"claims":72,"open":1,"kind":"fact"},"sic_industry":{"claims":1,"open":1,"kind":"identifier"},"quarterly_revenue":{"claims":56,"open":1,"kind":"fact"},"total_assets":{"claims":72,"open":1,"kind":"fact"},"operating_income":{"claims":19,"open":1,"kind":"fact"},"revenue":{"claims":19,"open":1,"kind":"fact"},"registrant_name":{"claims":5,"open":1,"kind":"fact"},"net_income":{"claims":16,"open":1,"kind":"fact"},"state_of_incorporation":{"claims":1,"open":1,"kind":"identifier"},"headquarters":{"claims":1,"open":1,"kind":"fact"},"fiscal_year_end":{"claims":1,"open":1,"kind":"identifier"},"x_username":{"claims":1,"open":1,"kind":"identifier"},"ticker":{"claims":1,"open":1,"kind":"identifier"},"listed_on":{"claims":1,"open":1,"kind":"fact"},"chair":{"claims":1,"open":1,"kind":"fact"},"cik":{"claims":1,"open":1,"kind":"identifier"},"website":{"claims":1,"open":1,"kind":"identifier"},"cfo":{"claims":1,"open":1,"kind":"fact"}}},"freshness":[{"origin":"sec","label":"SEC EDGAR filings: XBRL figures, registry fields, 8-K officer changes and events (sec_ingest.py, sec_officers.py, sec_events.py)","claims":513,"last_added":"2026-11-08","last_checked":"2026-11-09","last_verified":null},{"origin":"wikidata","label":"Wikidata statements that cite a reference URL (wikidata_ingest.py)","claims":2,"last_added":"2026-11-08","last_checked":"2026-11-08","last_verified":null}],"gaps":["ceo: none public; unknown, not absent: a claim is published only once checked against its source","posts: no official feed speaks for it (pipeline/feeds.json primary_for); what it holds comes from Wikidata, filings and other publishers' feeds"],"group":[],"group_complete":true,"rule":"sources: what the pipeline reads for this entity, from its config (pipeline/entities.json, feeds.json, sec_companies.json, huggingface_authors.json). holds: its public claims by predicate; open is held today; kind fact is what entity_state answers by default, event is for timeline. freshness, per ingest (origin): last_added is the day it last put a new claim here (first_seen_at), last_checked the day one was last checked against its source (checked_on), last_verified the day reverify.py last confirmed one against Wikidata (value_json.verified_at). Only checked claims are public, so a fact missing here is unknown, not absent. gaps: what the record does not cover for this entity, so an empty answer is not read as news."},"claims":[{"id":"clm_687FA44BD471","predicate":"shares_outstanding","value":"1,279,474,188 shares","valid_from":"2026-10-28","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,279,474,188 shares\", as of 2026-10-28. Claim clm_687FA44BD471, https://asof.is/claim/clm_687FA44BD471, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_687FA44BD471","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_81B0FD010E0C","predicate":"total_equity","value":"80,497,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 80,497,000,000 United States dollar\", as of 2026-09-30. Claim clm_81B0FD010E0C, https://asof.is/claim/clm_81B0FD010E0C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_81B0FD010E0C","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_8E2C754E23C9","predicate":"quarterly_operating_income","value":"3,566,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,566,000,000 United States dollar\", as of 2026-09-30. Claim clm_8E2C754E23C9, https://asof.is/claim/clm_8E2C754E23C9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_8E2C754E23C9","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_9CC0835CD0B3","predicate":"quarterly_revenue","value":"108,399,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 108,399,000,000 United States dollar\", as of 2026-09-30. Claim clm_9CC0835CD0B3, https://asof.is/claim/clm_9CC0835CD0B3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_9CC0835CD0B3","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_B06B50BDA5DB","predicate":"total_assets","value":"258,075,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 258,075,000,000 United States dollar\", as of 2026-09-30. Claim clm_B06B50BDA5DB, https://asof.is/claim/clm_B06B50BDA5DB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_B06B50BDA5DB","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_B17E3CAA413D","predicate":"quarterly_net_income","value":"2,172,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,172,000,000 United States dollar\", as of 2026-09-30. Claim clm_B17E3CAA413D, https://asof.is/claim/clm_B17E3CAA413D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_B17E3CAA413D","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_C5BD452E3A6B","predicate":"cash_and_equivalents","value":"11,738,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 11,738,000,000 United States dollar\", as of 2026-09-30. Claim clm_C5BD452E3A6B, https://asof.is/claim/clm_C5BD452E3A6B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_C5BD452E3A6B","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_7092F128E7C5","predicate":"shares_outstanding","value":"1,278,970,369 shares","valid_from":"2026-07-29","valid_to":"2026-10-28","published":"2026-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,278,970,369 shares\", as of 2026-07-29 (until 2026-10-28). Claim clm_7092F128E7C5, https://asof.is/claim/clm_7092F128E7C5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm.","url":"https://asof.is/claim/clm_7092F128E7C5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_687FA44BD471","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2026, filed 2026-08-05"}},{"id":"clm_1F978A1D79E0","predicate":"quarterly_operating_income","value":"4,703,000,000 United States dollar","valid_from":"2026-06-30","valid_to":"2026-09-30","published":"2026-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 4,703,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_1F978A1D79E0, https://asof.is/claim/clm_1F978A1D79E0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm.","url":"https://asof.is/claim/clm_1F978A1D79E0","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8E2C754E23C9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2026, filed 2026-08-05"}},{"id":"clm_881E8EF664F0","predicate":"total_equity","value":"79,702,000,000 United States dollar","valid_from":"2026-06-30","valid_to":"2026-09-30","published":"2026-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 79,702,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_881E8EF664F0, https://asof.is/claim/clm_881E8EF664F0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm.","url":"https://asof.is/claim/clm_881E8EF664F0","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_81B0FD010E0C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2026, filed 2026-08-05"}},{"id":"clm_95DC59014CE8","predicate":"total_assets","value":"253,768,000,000 United States dollar","valid_from":"2026-06-30","valid_to":"2026-09-30","published":"2026-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 253,768,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_95DC59014CE8, https://asof.is/claim/clm_95DC59014CE8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm.","url":"https://asof.is/claim/clm_95DC59014CE8","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B06B50BDA5DB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2026, filed 2026-08-05"}},{"id":"clm_AF1958FE690F","predicate":"quarterly_net_income","value":"2,979,000,000 United States dollar","valid_from":"2026-06-30","valid_to":"2026-09-30","published":"2026-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,979,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_AF1958FE690F, https://asof.is/claim/clm_AF1958FE690F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm.","url":"https://asof.is/claim/clm_AF1958FE690F","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B17E3CAA413D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2026, filed 2026-08-05"}},{"id":"clm_D65C8B4171D6","predicate":"quarterly_revenue","value":"106,096,000,000 United States dollar","valid_from":"2026-06-30","valid_to":"2026-09-30","published":"2026-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 106,096,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_D65C8B4171D6, https://asof.is/claim/clm_D65C8B4171D6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm.","url":"https://asof.is/claim/clm_D65C8B4171D6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9CC0835CD0B3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2026, filed 2026-08-05"}},{"id":"clm_D8B75ADB2373","predicate":"cash_and_equivalents","value":"11,329,000,000 United States dollar","valid_from":"2026-06-30","valid_to":"2026-09-30","published":"2026-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 11,329,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_D8B75ADB2373, https://asof.is/claim/clm_D8B75ADB2373, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm.","url":"https://asof.is/claim/clm_D8B75ADB2373","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C5BD452E3A6B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2026","published_at":"2026-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2026, filed 2026-08-05"}},{"id":"clm_80A64BAFA131","predicate":"shares_outstanding","value":"1,275,927,307 shares","valid_from":"2026-04-29","valid_to":"2026-07-29","published":"2026-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,275,927,307 shares\", as of 2026-04-29 (until 2026-07-29). Claim clm_80A64BAFA131, https://asof.is/claim/clm_80A64BAFA131, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm.","url":"https://asof.is/claim/clm_80A64BAFA131","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7092F128E7C5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2026, filed 2026-05-06"}},{"id":"clm_08828AE65EA2","predicate":"quarterly_revenue","value":"100,426,000,000 United States dollar","valid_from":"2026-03-31","valid_to":"2026-06-30","published":"2026-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 100,426,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_08828AE65EA2, https://asof.is/claim/clm_08828AE65EA2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm.","url":"https://asof.is/claim/clm_08828AE65EA2","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D65C8B4171D6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2026, filed 2026-05-06"}},{"id":"clm_5FADE5727052","predicate":"total_assets","value":"252,974,000,000 United States dollar","valid_from":"2026-03-31","valid_to":"2026-06-30","published":"2026-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 252,974,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_5FADE5727052, https://asof.is/claim/clm_5FADE5727052, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm.","url":"https://asof.is/claim/clm_5FADE5727052","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_95DC59014CE8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2026, filed 2026-05-06"}},{"id":"clm_9CC86217BBF1","predicate":"quarterly_operating_income","value":"4,680,000,000 United States dollar","valid_from":"2026-03-31","valid_to":"2026-06-30","published":"2026-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 4,680,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_9CC86217BBF1, https://asof.is/claim/clm_9CC86217BBF1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm.","url":"https://asof.is/claim/clm_9CC86217BBF1","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1F978A1D79E0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2026, filed 2026-05-06"}},{"id":"clm_D6B98B7D05C5","predicate":"cash_and_equivalents","value":"9,542,000,000 United States dollar","valid_from":"2026-03-31","valid_to":"2026-06-30","published":"2026-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 9,542,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_D6B98B7D05C5, https://asof.is/claim/clm_D6B98B7D05C5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm.","url":"https://asof.is/claim/clm_D6B98B7D05C5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D8B75ADB2373","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2026, filed 2026-05-06"}},{"id":"clm_E164CF245987","predicate":"total_equity","value":"77,456,000,000 United States dollar","valid_from":"2026-03-31","valid_to":"2026-06-30","published":"2026-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 77,456,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_E164CF245987, https://asof.is/claim/clm_E164CF245987, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm.","url":"https://asof.is/claim/clm_E164CF245987","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_881E8EF664F0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2026, filed 2026-05-06"}},{"id":"clm_FF31176E7782","predicate":"quarterly_net_income","value":"2,943,000,000 United States dollar","valid_from":"2026-03-31","valid_to":"2026-06-30","published":"2026-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,943,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_FF31176E7782, https://asof.is/claim/clm_FF31176E7782, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm.","url":"https://asof.is/claim/clm_FF31176E7782","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AF1958FE690F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2026","published_at":"2026-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2026, filed 2026-05-06"}},{"id":"clm_CD167661C6C4","predicate":"shares_outstanding","value":"1,272,211,063 shares","valid_from":"2026-02-04","valid_to":"2026-04-29","published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,272,211,063 shares\", as of 2026-02-04 (until 2026-04-29). Claim clm_CD167661C6C4, https://asof.is/claim/clm_CD167661C6C4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm.","url":"https://asof.is/claim/clm_CD167661C6C4","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_80A64BAFA131","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2025, filed 2026-02-10"}},{"id":"clm_CD3F5A892A25","predicate":"chair","value":"J. David Joyner","valid_from":"2026-01-01","valid_to":null,"published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health chair: J. David Joyner\", as of 2026-01-01. Claim clm_CD3F5A892A25, https://asof.is/claim/clm_CD3F5A892A25, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/cvs-20251231.htm.","url":"https://asof.is/claim/clm_CD3F5A892A25","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/cvs-20251231.htm","tier":"primary","publisher":"SEC EDGAR 10-K","published_at":"2026-02-10T00:00:00+00:00"}],"evidence":{"by":"page-read","on":"2026-11-09","quote":"J. David Joyner , age 61, has been the President and Chief Executive Officer of CVS Health Corporation since October 2024, and Chair of the Board of Directors of CVS Health Corporation since January 2026.","url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/cvs-20251231.htm"}},{"id":"clm_40C242560A21","predicate":"total_equity","value":"75,214,000,000 United States dollar","valid_from":"2025-12-31","valid_to":"2026-03-31","published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 75,214,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_40C242560A21, https://asof.is/claim/clm_40C242560A21, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm.","url":"https://asof.is/claim/clm_40C242560A21","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E164CF245987","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2025, filed 2026-02-10"}},{"id":"clm_96EA4714F001","predicate":"net_income","value":"1,768,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 1,768,000,000 United States dollar\", as of 2025-12-31. Claim clm_96EA4714F001, https://asof.is/claim/clm_96EA4714F001, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm.","url":"https://asof.is/claim/clm_96EA4714F001","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2025, filed 2026-02-10"}},{"id":"clm_A25A25B58E67","predicate":"cash_and_equivalents","value":"8,453,000,000 United States dollar","valid_from":"2025-12-31","valid_to":"2026-03-31","published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 8,453,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_A25A25B58E67, https://asof.is/claim/clm_A25A25B58E67, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm.","url":"https://asof.is/claim/clm_A25A25B58E67","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D6B98B7D05C5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2025, filed 2026-02-10"}},{"id":"clm_A89384995235","predicate":"operating_income","value":"4,660,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 4,660,000,000 United States dollar\", as of 2025-12-31. Claim clm_A89384995235, https://asof.is/claim/clm_A89384995235, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm.","url":"https://asof.is/claim/clm_A89384995235","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2025, filed 2026-02-10"}},{"id":"clm_B99511607945","predicate":"revenue","value":"402,067,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 402,067,000,000 United States dollar\", as of 2025-12-31. Claim clm_B99511607945, https://asof.is/claim/clm_B99511607945, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm.","url":"https://asof.is/claim/clm_B99511607945","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2025, filed 2026-02-10"}},{"id":"clm_D4BC175A88B3","predicate":"total_assets","value":"253,538,000,000 United States dollar","valid_from":"2025-12-31","valid_to":"2026-03-31","published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 253,538,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_D4BC175A88B3, https://asof.is/claim/clm_D4BC175A88B3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm.","url":"https://asof.is/claim/clm_D4BC175A88B3","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5FADE5727052","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2025, filed 2026-02-10"}},{"id":"clm_0394ED778E59","predicate":"shares_outstanding","value":"1,269,432,485 shares","valid_from":"2025-10-22","valid_to":"2026-02-04","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,269,432,485 shares\", as of 2025-10-22 (until 2026-02-04). Claim clm_0394ED778E59, https://asof.is/claim/clm_0394ED778E59, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_0394ED778E59","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CD167661C6C4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2025, filed 2025-10-29"}},{"id":"clm_0A041DAEF9A0","predicate":"quarterly_net_income","value":"-3,975,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: -3,975,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_0A041DAEF9A0, https://asof.is/claim/clm_0A041DAEF9A0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_0A041DAEF9A0","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FF31176E7782","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-29"}},{"id":"clm_2A1E9B23616D","predicate":"quarterly_operating_income","value":"-3,207,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: -3,207,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_2A1E9B23616D, https://asof.is/claim/clm_2A1E9B23616D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_2A1E9B23616D","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9CC86217BBF1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-29"}},{"id":"clm_500FE97E42FE","predicate":"quarterly_revenue","value":"102,871,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 102,871,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_500FE97E42FE, https://asof.is/claim/clm_500FE97E42FE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_500FE97E42FE","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_08828AE65EA2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2025, filed 2025-10-29"}},{"id":"clm_595EFD826535","predicate":"total_equity","value":"72,928,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 72,928,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_595EFD826535, https://asof.is/claim/clm_595EFD826535, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_595EFD826535","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_40C242560A21","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2025, filed 2025-10-29"}},{"id":"clm_C0107A345222","predicate":"total_assets","value":"255,327,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 255,327,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_C0107A345222, https://asof.is/claim/clm_C0107A345222, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_C0107A345222","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D4BC175A88B3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2025, filed 2025-10-29"}},{"id":"clm_E6500192AB53","predicate":"cash_and_equivalents","value":"9,098,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 9,098,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_E6500192AB53, https://asof.is/claim/clm_E6500192AB53, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_E6500192AB53","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A25A25B58E67","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-10-29"}},{"id":"clm_45CEA5DD9C5C","predicate":"shares_outstanding","value":"1,268,326,375 shares","valid_from":"2025-07-23","valid_to":"2025-10-22","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,268,326,375 shares\", as of 2025-07-23 (until 2025-10-22). Claim clm_45CEA5DD9C5C, https://asof.is/claim/clm_45CEA5DD9C5C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm.","url":"https://asof.is/claim/clm_45CEA5DD9C5C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0394ED778E59","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-07-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2025, filed 2025-07-31"}},{"id":"clm_2B1DAFC9D856","predicate":"quarterly_operating_income","value":"2,381,000,000 United States dollar","valid_from":"2025-06-30","valid_to":"2025-09-30","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,381,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_2B1DAFC9D856, https://asof.is/claim/clm_2B1DAFC9D856, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm.","url":"https://asof.is/claim/clm_2B1DAFC9D856","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2A1E9B23616D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-07-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2025, filed 2025-07-31"}},{"id":"clm_2CBB79B31C06","predicate":"total_equity","value":"77,379,000,000 United States dollar","valid_from":"2025-06-30","valid_to":"2025-09-30","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 77,379,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_2CBB79B31C06, https://asof.is/claim/clm_2CBB79B31C06, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm.","url":"https://asof.is/claim/clm_2CBB79B31C06","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_595EFD826535","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-07-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2025, filed 2025-07-31"}},{"id":"clm_411F8973618B","predicate":"cash_and_equivalents","value":"11,787,000,000 United States dollar","valid_from":"2025-06-30","valid_to":"2025-09-30","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 11,787,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_411F8973618B, https://asof.is/claim/clm_411F8973618B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm.","url":"https://asof.is/claim/clm_411F8973618B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E6500192AB53","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-07-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2025, filed 2025-07-31"}},{"id":"clm_59834B680961","predicate":"quarterly_net_income","value":"1,021,000,000 United States dollar","valid_from":"2025-06-30","valid_to":"2025-09-30","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,021,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_59834B680961, https://asof.is/claim/clm_59834B680961, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm.","url":"https://asof.is/claim/clm_59834B680961","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0A041DAEF9A0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-07-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2025, filed 2025-07-31"}},{"id":"clm_98E09DAA775B","predicate":"quarterly_revenue","value":"98,915,000,000 United States dollar","valid_from":"2025-06-30","valid_to":"2025-09-30","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 98,915,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_98E09DAA775B, https://asof.is/claim/clm_98E09DAA775B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm.","url":"https://asof.is/claim/clm_98E09DAA775B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_500FE97E42FE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-07-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2025, filed 2025-07-31"}},{"id":"clm_EDB9AA36EFB1","predicate":"total_assets","value":"258,343,000,000 United States dollar","valid_from":"2025-06-30","valid_to":"2025-09-30","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 258,343,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_EDB9AA36EFB1, https://asof.is/claim/clm_EDB9AA36EFB1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm.","url":"https://asof.is/claim/clm_EDB9AA36EFB1","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C0107A345222","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2025","published_at":"2025-07-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2025, filed 2025-07-31"}},{"id":"clm_D8BDE5FBAB36","predicate":"cfo","value":"Brian O. Newman","valid_from":"2025-05-01","valid_to":null,"published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cfo: Brian O. Newman\", as of 2025-05-01. Claim clm_D8BDE5FBAB36, https://asof.is/claim/clm_D8BDE5FBAB36, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/cvs-20251231.htm.","url":"https://asof.is/claim/clm_D8BDE5FBAB36","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/cvs-20251231.htm","tier":"primary","publisher":"SEC EDGAR 10-K","published_at":"2026-02-10T00:00:00+00:00"}],"evidence":{"by":"page-read","on":"2026-11-09","quote":"Brian O. Newman , age 57, has been the Executive Vice President and Chief Financial Officer of CVS Health Corporation since May 2025.","url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/cvs-20251231.htm"}},{"id":"clm_FAA8182E0E0A","predicate":"shares_outstanding","value":"1,265,019,429 shares","valid_from":"2025-04-23","valid_to":"2025-07-23","published":"2025-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,265,019,429 shares\", as of 2025-04-23 (until 2025-07-23). Claim clm_FAA8182E0E0A, https://asof.is/claim/clm_FAA8182E0E0A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm.","url":"https://asof.is/claim/clm_FAA8182E0E0A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_45CEA5DD9C5C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2025, filed 2025-05-01"}},{"id":"clm_1289773B2947","predicate":"quarterly_net_income","value":"1,779,000,000 United States dollar","valid_from":"2025-03-31","valid_to":"2025-06-30","published":"2025-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,779,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_1289773B2947, https://asof.is/claim/clm_1289773B2947, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm.","url":"https://asof.is/claim/clm_1289773B2947","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_59834B680961","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2025, filed 2025-05-01"}},{"id":"clm_2BE60C5B23A2","predicate":"quarterly_revenue","value":"94,588,000,000 United States dollar","valid_from":"2025-03-31","valid_to":"2025-06-30","published":"2025-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 94,588,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_2BE60C5B23A2, https://asof.is/claim/clm_2BE60C5B23A2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm.","url":"https://asof.is/claim/clm_2BE60C5B23A2","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_98E09DAA775B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2025, filed 2025-05-01"}},{"id":"clm_9165DC6EDBB5","predicate":"quarterly_operating_income","value":"3,374,000,000 United States dollar","valid_from":"2025-03-31","valid_to":"2025-06-30","published":"2025-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,374,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_9165DC6EDBB5, https://asof.is/claim/clm_9165DC6EDBB5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm.","url":"https://asof.is/claim/clm_9165DC6EDBB5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2B1DAFC9D856","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2025, filed 2025-05-01"}},{"id":"clm_9958F284302D","predicate":"total_assets","value":"255,585,000,000 United States dollar","valid_from":"2025-03-31","valid_to":"2025-06-30","published":"2025-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 255,585,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_9958F284302D, https://asof.is/claim/clm_9958F284302D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm.","url":"https://asof.is/claim/clm_9958F284302D","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EDB9AA36EFB1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2025, filed 2025-05-01"}},{"id":"clm_C3D8E3B4EAC5","predicate":"total_equity","value":"76,929,000,000 United States dollar","valid_from":"2025-03-31","valid_to":"2025-06-30","published":"2025-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 76,929,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_C3D8E3B4EAC5, https://asof.is/claim/clm_C3D8E3B4EAC5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm.","url":"https://asof.is/claim/clm_C3D8E3B4EAC5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2CBB79B31C06","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2025, filed 2025-05-01"}},{"id":"clm_E6D96DE44C4B","predicate":"cash_and_equivalents","value":"10,076,000,000 United States dollar","valid_from":"2025-03-31","valid_to":"2025-06-30","published":"2025-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 10,076,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_E6D96DE44C4B, https://asof.is/claim/clm_E6D96DE44C4B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm.","url":"https://asof.is/claim/clm_E6D96DE44C4B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_411F8973618B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2025, filed 2025-05-01"}},{"id":"clm_07C8467218B4","predicate":"shares_outstanding","value":"1,260,795,063 shares","valid_from":"2025-02-05","valid_to":"2025-04-23","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,260,795,063 shares\", as of 2025-02-05 (until 2025-04-23). Claim clm_07C8467218B4, https://asof.is/claim/clm_07C8467218B4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm.","url":"https://asof.is/claim/clm_07C8467218B4","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FAA8182E0E0A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-12T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2024, filed 2025-02-12"}},{"id":"clm_16FF91BAD829","predicate":"net_income","value":"4,614,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 4,614,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_16FF91BAD829, https://asof.is/claim/clm_16FF91BAD829, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm.","url":"https://asof.is/claim/clm_16FF91BAD829","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_96EA4714F001","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-12T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2024, filed 2025-02-12"}},{"id":"clm_1A2E653D169B","predicate":"operating_income","value":"8,516,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 8,516,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_1A2E653D169B, https://asof.is/claim/clm_1A2E653D169B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm.","url":"https://asof.is/claim/clm_1A2E653D169B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A89384995235","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-12T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2024, filed 2025-02-12"}},{"id":"clm_36137E0BB01C","predicate":"cash_and_equivalents","value":"8,586,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-03-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 8,586,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_36137E0BB01C, https://asof.is/claim/clm_36137E0BB01C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm.","url":"https://asof.is/claim/clm_36137E0BB01C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E6D96DE44C4B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-12T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2024, filed 2025-02-12"}},{"id":"clm_379AAA4E148A","predicate":"total_assets","value":"253,215,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-03-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 253,215,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_379AAA4E148A, https://asof.is/claim/clm_379AAA4E148A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm.","url":"https://asof.is/claim/clm_379AAA4E148A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9958F284302D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-12T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2024, filed 2025-02-12"}},{"id":"clm_444C7C41D426","predicate":"revenue","value":"372,809,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 372,809,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_444C7C41D426, https://asof.is/claim/clm_444C7C41D426, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm.","url":"https://asof.is/claim/clm_444C7C41D426","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B99511607945","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-12T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2024, filed 2025-02-12"}},{"id":"clm_DEB519DDC177","predicate":"total_equity","value":"75,560,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-03-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 75,560,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_DEB519DDC177, https://asof.is/claim/clm_DEB519DDC177, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm.","url":"https://asof.is/claim/clm_DEB519DDC177","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C3D8E3B4EAC5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-12T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2024, filed 2025-02-12"}},{"id":"clm_FF5979B5FD74","predicate":"shares_outstanding","value":"1,258,407,645 shares","valid_from":"2024-10-30","valid_to":"2025-02-05","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,258,407,645 shares\", as of 2024-10-30 (until 2025-02-05). Claim clm_FF5979B5FD74, https://asof.is/claim/clm_FF5979B5FD74, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm.","url":"https://asof.is/claim/clm_FF5979B5FD74","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_07C8467218B4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2024, filed 2024-11-06"}},{"id":"clm_1DD01150F17E","predicate":"cash_and_equivalents","value":"6,875,000,000 United States dollar","valid_from":"2024-09-30","valid_to":"2024-12-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 6,875,000,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_1DD01150F17E, https://asof.is/claim/clm_1DD01150F17E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm.","url":"https://asof.is/claim/clm_1DD01150F17E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_36137E0BB01C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2024, filed 2024-11-06"}},{"id":"clm_49B980847335","predicate":"total_assets","value":"252,427,000,000 United States dollar","valid_from":"2024-09-30","valid_to":"2024-12-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 252,427,000,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_49B980847335, https://asof.is/claim/clm_49B980847335, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm.","url":"https://asof.is/claim/clm_49B980847335","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_379AAA4E148A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2024, filed 2024-11-06"}},{"id":"clm_4C96AD03641F","predicate":"quarterly_net_income","value":"87,000,000 United States dollar","valid_from":"2024-09-30","valid_to":"2025-03-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 87,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_4C96AD03641F, https://asof.is/claim/clm_4C96AD03641F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm.","url":"https://asof.is/claim/clm_4C96AD03641F","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1289773B2947","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2024, filed 2024-11-06"}},{"id":"clm_6E82E4E75A68","predicate":"quarterly_revenue","value":"95,428,000,000 United States dollar","valid_from":"2024-09-30","valid_to":"2025-03-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 95,428,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_6E82E4E75A68, https://asof.is/claim/clm_6E82E4E75A68, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm.","url":"https://asof.is/claim/clm_6E82E4E75A68","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2BE60C5B23A2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2024, filed 2024-11-06"}},{"id":"clm_933FB499F121","predicate":"quarterly_operating_income","value":"832,000,000 United States dollar","valid_from":"2024-09-30","valid_to":"2025-03-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 832,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_933FB499F121, https://asof.is/claim/clm_933FB499F121, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm.","url":"https://asof.is/claim/clm_933FB499F121","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9165DC6EDBB5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2024, filed 2024-11-06"}},{"id":"clm_A7AFEE72948A","predicate":"total_equity","value":"74,944,000,000 United States dollar","valid_from":"2024-09-30","valid_to":"2024-12-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 74,944,000,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_A7AFEE72948A, https://asof.is/claim/clm_A7AFEE72948A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm.","url":"https://asof.is/claim/clm_A7AFEE72948A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DEB519DDC177","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2024","published_at":"2024-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2024, filed 2024-11-06"}},{"id":"clm_93760B459CB8","predicate":"shares_outstanding","value":"1,257,979,270 shares","valid_from":"2024-07-31","valid_to":"2024-10-30","published":"2024-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,257,979,270 shares\", as of 2024-07-31 (until 2024-10-30). Claim clm_93760B459CB8, https://asof.is/claim/clm_93760B459CB8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm.","url":"https://asof.is/claim/clm_93760B459CB8","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FF5979B5FD74","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2024, filed 2024-08-07"}},{"id":"clm_3191F85A5D78","predicate":"total_equity","value":"74,930,000,000 United States dollar","valid_from":"2024-06-30","valid_to":"2024-09-30","published":"2024-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 74,930,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_3191F85A5D78, https://asof.is/claim/clm_3191F85A5D78, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm.","url":"https://asof.is/claim/clm_3191F85A5D78","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A7AFEE72948A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2024, filed 2024-08-07"}},{"id":"clm_49336E6CCBA2","predicate":"quarterly_operating_income","value":"3,045,000,000 United States dollar","valid_from":"2024-06-30","valid_to":"2024-09-30","published":"2024-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,045,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_49336E6CCBA2, https://asof.is/claim/clm_49336E6CCBA2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm.","url":"https://asof.is/claim/clm_49336E6CCBA2","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_933FB499F121","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2024, filed 2024-08-07"}},{"id":"clm_77A3E2DDE97A","predicate":"total_assets","value":"252,481,000,000 United States dollar","valid_from":"2024-06-30","valid_to":"2024-09-30","published":"2024-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 252,481,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_77A3E2DDE97A, https://asof.is/claim/clm_77A3E2DDE97A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm.","url":"https://asof.is/claim/clm_77A3E2DDE97A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_49B980847335","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2024, filed 2024-08-07"}},{"id":"clm_8AAE75378A1C","predicate":"cash_and_equivalents","value":"12,507,000,000 United States dollar","valid_from":"2024-06-30","valid_to":"2024-09-30","published":"2024-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 12,507,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_8AAE75378A1C, https://asof.is/claim/clm_8AAE75378A1C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm.","url":"https://asof.is/claim/clm_8AAE75378A1C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1DD01150F17E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2024, filed 2024-08-07"}},{"id":"clm_E60B3917BA11","predicate":"quarterly_net_income","value":"1,770,000,000 United States dollar","valid_from":"2024-06-30","valid_to":"2024-09-30","published":"2024-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,770,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_E60B3917BA11, https://asof.is/claim/clm_E60B3917BA11, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm.","url":"https://asof.is/claim/clm_E60B3917BA11","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4C96AD03641F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2024, filed 2024-08-07"}},{"id":"clm_FEE1CD9EB899","predicate":"quarterly_revenue","value":"91,234,000,000 United States dollar","valid_from":"2024-06-30","valid_to":"2024-09-30","published":"2024-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 91,234,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_FEE1CD9EB899, https://asof.is/claim/clm_FEE1CD9EB899, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm.","url":"https://asof.is/claim/clm_FEE1CD9EB899","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6E82E4E75A68","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2024, filed 2024-08-07"}},{"id":"clm_3922B44C14BC","predicate":"shares_outstanding","value":"1,255,372,972 shares","valid_from":"2024-04-24","valid_to":"2024-07-31","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,255,372,972 shares\", as of 2024-04-24 (until 2024-07-31). Claim clm_3922B44C14BC, https://asof.is/claim/clm_3922B44C14BC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm.","url":"https://asof.is/claim/clm_3922B44C14BC","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_93760B459CB8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2024, filed 2024-05-01"}},{"id":"clm_00FC248C7D5C","predicate":"quarterly_net_income","value":"1,113,000,000 United States dollar","valid_from":"2024-03-31","valid_to":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,113,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_00FC248C7D5C, https://asof.is/claim/clm_00FC248C7D5C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm.","url":"https://asof.is/claim/clm_00FC248C7D5C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E60B3917BA11","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2024, filed 2024-05-01"}},{"id":"clm_29C2CC457D28","predicate":"total_equity","value":"73,968,000,000 United States dollar","valid_from":"2024-03-31","valid_to":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 73,968,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_29C2CC457D28, https://asof.is/claim/clm_29C2CC457D28, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm.","url":"https://asof.is/claim/clm_29C2CC457D28","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3191F85A5D78","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2024, filed 2024-05-01"}},{"id":"clm_29E68A1732F3","predicate":"total_assets","value":"249,743,000,000 United States dollar","valid_from":"2024-03-31","valid_to":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 249,743,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_29E68A1732F3, https://asof.is/claim/clm_29E68A1732F3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm.","url":"https://asof.is/claim/clm_29E68A1732F3","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_77A3E2DDE97A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2024, filed 2024-05-01"}},{"id":"clm_5DA1D60E06EA","predicate":"cash_and_equivalents","value":"9,801,000,000 United States dollar","valid_from":"2024-03-31","valid_to":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 9,801,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_5DA1D60E06EA, https://asof.is/claim/clm_5DA1D60E06EA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm.","url":"https://asof.is/claim/clm_5DA1D60E06EA","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8AAE75378A1C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2024, filed 2024-05-01"}},{"id":"clm_C9F16293F4D7","predicate":"quarterly_operating_income","value":"2,271,000,000 United States dollar","valid_from":"2024-03-31","valid_to":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,271,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_C9F16293F4D7, https://asof.is/claim/clm_C9F16293F4D7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm.","url":"https://asof.is/claim/clm_C9F16293F4D7","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_49336E6CCBA2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2024, filed 2024-05-01"}},{"id":"clm_DD8E2F00D0E1","predicate":"quarterly_revenue","value":"88,437,000,000 United States dollar","valid_from":"2024-03-31","valid_to":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 88,437,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_DD8E2F00D0E1, https://asof.is/claim/clm_DD8E2F00D0E1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm.","url":"https://asof.is/claim/clm_DD8E2F00D0E1","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FEE1CD9EB899","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2024","published_at":"2024-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2024, filed 2024-05-01"}},{"id":"clm_415D7BDC8501","predicate":"shares_outstanding","value":"1,258,449,553 shares","valid_from":"2024-01-31","valid_to":"2024-04-24","published":"2024-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,258,449,553 shares\", as of 2024-01-31 (until 2024-04-24). Claim clm_415D7BDC8501, https://asof.is/claim/clm_415D7BDC8501, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm.","url":"https://asof.is/claim/clm_415D7BDC8501","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3922B44C14BC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2023, filed 2024-02-07"}},{"id":"clm_1541A46F09F2","predicate":"operating_income","value":"13,743,000,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-12-31","published":"2024-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 13,743,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_1541A46F09F2, https://asof.is/claim/clm_1541A46F09F2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm.","url":"https://asof.is/claim/clm_1541A46F09F2","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1A2E653D169B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2023, filed 2024-02-07"}},{"id":"clm_4B26CD523A36","predicate":"total_assets","value":"249,728,000,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-03-31","published":"2024-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 249,728,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_4B26CD523A36, https://asof.is/claim/clm_4B26CD523A36, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm.","url":"https://asof.is/claim/clm_4B26CD523A36","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_29E68A1732F3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2023, filed 2024-02-07"}},{"id":"clm_629BFA7E5C2C","predicate":"net_income","value":"8,344,000,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-12-31","published":"2024-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 8,344,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_629BFA7E5C2C, https://asof.is/claim/clm_629BFA7E5C2C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm.","url":"https://asof.is/claim/clm_629BFA7E5C2C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_16FF91BAD829","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2023, filed 2024-02-07"}},{"id":"clm_7DA460205A66","predicate":"total_equity","value":"76,461,000,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-03-31","published":"2024-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 76,461,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_7DA460205A66, https://asof.is/claim/clm_7DA460205A66, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm.","url":"https://asof.is/claim/clm_7DA460205A66","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_29C2CC457D28","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2023, filed 2024-02-07"}},{"id":"clm_9F27B82CB10D","predicate":"cash_and_equivalents","value":"8,196,000,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-03-31","published":"2024-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 8,196,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_9F27B82CB10D, https://asof.is/claim/clm_9F27B82CB10D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm.","url":"https://asof.is/claim/clm_9F27B82CB10D","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5DA1D60E06EA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2023, filed 2024-02-07"}},{"id":"clm_FA3DB9B2E145","predicate":"revenue","value":"357,776,000,000 United States dollar","valid_from":"2023-12-31","valid_to":"2024-12-31","published":"2024-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 357,776,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_FA3DB9B2E145, https://asof.is/claim/clm_FA3DB9B2E145, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm.","url":"https://asof.is/claim/clm_FA3DB9B2E145","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_444C7C41D426","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2023, filed 2024-02-07"}},{"id":"clm_0921F5BECBAF","predicate":"shares_outstanding","value":"1,286,896,582 shares","valid_from":"2023-10-25","valid_to":"2024-01-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,286,896,582 shares\", as of 2023-10-25 (until 2024-01-31). Claim clm_0921F5BECBAF, https://asof.is/claim/clm_0921F5BECBAF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm.","url":"https://asof.is/claim/clm_0921F5BECBAF","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_415D7BDC8501","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2023, filed 2023-11-01"}},{"id":"clm_5A784AE3D6F2","predicate":"total_equity","value":"74,337,000,000 United States dollar","valid_from":"2023-09-30","valid_to":"2023-12-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 74,337,000,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_5A784AE3D6F2, https://asof.is/claim/clm_5A784AE3D6F2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm.","url":"https://asof.is/claim/clm_5A784AE3D6F2","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7DA460205A66","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2023, filed 2023-11-01"}},{"id":"clm_8C2421474C40","predicate":"quarterly_revenue","value":"89,764,000,000 United States dollar","valid_from":"2023-09-30","valid_to":"2024-03-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 89,764,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_8C2421474C40, https://asof.is/claim/clm_8C2421474C40, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm.","url":"https://asof.is/claim/clm_8C2421474C40","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DD8E2F00D0E1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2023, filed 2023-11-01"}},{"id":"clm_9CD318C8DD2C","predicate":"quarterly_operating_income","value":"3,690,000,000 United States dollar","valid_from":"2023-09-30","valid_to":"2024-03-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,690,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_9CD318C8DD2C, https://asof.is/claim/clm_9CD318C8DD2C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm.","url":"https://asof.is/claim/clm_9CD318C8DD2C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C9F16293F4D7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2023, filed 2023-11-01"}},{"id":"clm_B4C57668E301","predicate":"total_assets","value":"251,306,000,000 United States dollar","valid_from":"2023-09-30","valid_to":"2023-12-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 251,306,000,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_B4C57668E301, https://asof.is/claim/clm_B4C57668E301, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm.","url":"https://asof.is/claim/clm_B4C57668E301","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4B26CD523A36","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2023, filed 2023-11-01"}},{"id":"clm_E472BF97F1A0","predicate":"quarterly_net_income","value":"2,261,000,000 United States dollar","valid_from":"2023-09-30","valid_to":"2024-03-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,261,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_E472BF97F1A0, https://asof.is/claim/clm_E472BF97F1A0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm.","url":"https://asof.is/claim/clm_E472BF97F1A0","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_00FC248C7D5C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2023, filed 2023-11-01"}},{"id":"clm_EEB381BE39FE","predicate":"cash_and_equivalents","value":"13,043,000,000 United States dollar","valid_from":"2023-09-30","valid_to":"2023-12-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 13,043,000,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_EEB381BE39FE, https://asof.is/claim/clm_EEB381BE39FE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm.","url":"https://asof.is/claim/clm_EEB381BE39FE","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9F27B82CB10D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2023","published_at":"2023-11-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2023, filed 2023-11-01"}},{"id":"clm_C300733D77E7","predicate":"shares_outstanding","value":"1,284,398,968 shares","valid_from":"2023-07-26","valid_to":"2023-10-25","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,284,398,968 shares\", as of 2023-07-26 (until 2023-10-25). Claim clm_C300733D77E7, https://asof.is/claim/clm_C300733D77E7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm.","url":"https://asof.is/claim/clm_C300733D77E7","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0921F5BECBAF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2023, filed 2023-08-02"}},{"id":"clm_1585854A04BE","predicate":"cash_and_equivalents","value":"13,807,000,000 United States dollar","valid_from":"2023-06-30","valid_to":"2023-09-30","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 13,807,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_1585854A04BE, https://asof.is/claim/clm_1585854A04BE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm.","url":"https://asof.is/claim/clm_1585854A04BE","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EEB381BE39FE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2023, filed 2023-08-02"}},{"id":"clm_585C935A748C","predicate":"quarterly_operating_income","value":"3,234,000,000 United States dollar","valid_from":"2023-06-30","valid_to":"2023-09-30","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,234,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_585C935A748C, https://asof.is/claim/clm_585C935A748C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm.","url":"https://asof.is/claim/clm_585C935A748C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9CD318C8DD2C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2023, filed 2023-08-02"}},{"id":"clm_A3E20D792E37","predicate":"quarterly_net_income","value":"1,901,000,000 United States dollar","valid_from":"2023-06-30","valid_to":"2023-09-30","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,901,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_A3E20D792E37, https://asof.is/claim/clm_A3E20D792E37, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm.","url":"https://asof.is/claim/clm_A3E20D792E37","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E472BF97F1A0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2023, filed 2023-08-02"}},{"id":"clm_A9450C314428","predicate":"total_assets","value":"250,071,000,000 United States dollar","valid_from":"2023-06-30","valid_to":"2023-09-30","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 250,071,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_A9450C314428, https://asof.is/claim/clm_A9450C314428, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm.","url":"https://asof.is/claim/clm_A9450C314428","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B4C57668E301","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2023, filed 2023-08-02"}},{"id":"clm_ABD8AD76346E","predicate":"total_equity","value":"72,726,000,000 United States dollar","valid_from":"2023-06-30","valid_to":"2023-09-30","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 72,726,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_ABD8AD76346E, https://asof.is/claim/clm_ABD8AD76346E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm.","url":"https://asof.is/claim/clm_ABD8AD76346E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5A784AE3D6F2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2023, filed 2023-08-02"}},{"id":"clm_CD44708E7403","predicate":"quarterly_revenue","value":"88,921,000,000 United States dollar","valid_from":"2023-06-30","valid_to":"2023-09-30","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 88,921,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_CD44708E7403, https://asof.is/claim/clm_CD44708E7403, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm.","url":"https://asof.is/claim/clm_CD44708E7403","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8C2421474C40","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2023, filed 2023-08-02"}},{"id":"clm_C539D68FC63B","predicate":"shares_outstanding","value":"1,282,025,283 shares","valid_from":"2023-04-26","valid_to":"2023-07-26","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,282,025,283 shares\", as of 2023-04-26 (until 2023-07-26). Claim clm_C539D68FC63B, https://asof.is/claim/clm_C539D68FC63B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm.","url":"https://asof.is/claim/clm_C539D68FC63B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C300733D77E7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2023, filed 2023-05-03"}},{"id":"clm_2608DC96449F","predicate":"quarterly_net_income","value":"2,136,000,000 United States dollar","valid_from":"2023-03-31","valid_to":"2023-06-30","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,136,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_2608DC96449F, https://asof.is/claim/clm_2608DC96449F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm.","url":"https://asof.is/claim/clm_2608DC96449F","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A3E20D792E37","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2023, filed 2023-05-03"}},{"id":"clm_2D0C73E35714","predicate":"total_assets","value":"239,330,000,000 United States dollar","valid_from":"2023-03-31","valid_to":"2023-06-30","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 239,330,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_2D0C73E35714, https://asof.is/claim/clm_2D0C73E35714, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm.","url":"https://asof.is/claim/clm_2D0C73E35714","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A9450C314428","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2023, filed 2023-05-03"}},{"id":"clm_2EE2F8326DE5","predicate":"cash_and_equivalents","value":"14,618,000,000 United States dollar","valid_from":"2023-03-31","valid_to":"2023-06-30","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 14,618,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_2EE2F8326DE5, https://asof.is/claim/clm_2EE2F8326DE5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm.","url":"https://asof.is/claim/clm_2EE2F8326DE5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1585854A04BE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2023, filed 2023-05-03"}},{"id":"clm_4B3841636690","predicate":"quarterly_operating_income","value":"3,446,000,000 United States dollar","valid_from":"2023-03-31","valid_to":"2023-06-30","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,446,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_4B3841636690, https://asof.is/claim/clm_4B3841636690, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm.","url":"https://asof.is/claim/clm_4B3841636690","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_585C935A748C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2023, filed 2023-05-03"}},{"id":"clm_8A264A412163","predicate":"quarterly_revenue","value":"85,278,000,000 United States dollar","valid_from":"2023-03-31","valid_to":"2023-06-30","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 85,278,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_8A264A412163, https://asof.is/claim/clm_8A264A412163, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm.","url":"https://asof.is/claim/clm_8A264A412163","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CD44708E7403","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2023, filed 2023-05-03"}},{"id":"clm_E7DC446890AC","predicate":"total_equity","value":"71,382,000,000 United States dollar","valid_from":"2023-03-31","valid_to":"2023-06-30","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 71,382,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_E7DC446890AC, https://asof.is/claim/clm_E7DC446890AC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm.","url":"https://asof.is/claim/clm_E7DC446890AC","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_ABD8AD76346E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2023","published_at":"2023-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2023, filed 2023-05-03"}},{"id":"clm_0B66AAC34D7A","predicate":"shares_outstanding","value":"1,284,111,667 shares","valid_from":"2023-02-01","valid_to":"2023-04-26","published":"2023-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,284,111,667 shares\", as of 2023-02-01 (until 2023-04-26). Claim clm_0B66AAC34D7A, https://asof.is/claim/clm_0B66AAC34D7A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm.","url":"https://asof.is/claim/clm_0B66AAC34D7A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C539D68FC63B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2022, filed 2023-02-08"}},{"id":"clm_122AD0CA4FA7","predicate":"total_assets","value":"228,275,000,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-03-31","published":"2023-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 228,275,000,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_122AD0CA4FA7, https://asof.is/claim/clm_122AD0CA4FA7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm.","url":"https://asof.is/claim/clm_122AD0CA4FA7","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2D0C73E35714","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2022, filed 2023-02-08"}},{"id":"clm_540DCE22ED26","predicate":"operating_income","value":"7,746,000,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-12-31","published":"2023-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 7,746,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_540DCE22ED26, https://asof.is/claim/clm_540DCE22ED26, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm.","url":"https://asof.is/claim/clm_540DCE22ED26","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1541A46F09F2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2022, filed 2023-02-08"}},{"id":"clm_5D6CF2E0E3C9","predicate":"cash_and_equivalents","value":"12,945,000,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-03-31","published":"2023-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 12,945,000,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_5D6CF2E0E3C9, https://asof.is/claim/clm_5D6CF2E0E3C9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm.","url":"https://asof.is/claim/clm_5D6CF2E0E3C9","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2EE2F8326DE5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2022, filed 2023-02-08"}},{"id":"clm_80BE0785CE35","predicate":"total_equity","value":"71,015,000,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-03-31","published":"2023-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 71,015,000,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_80BE0785CE35, https://asof.is/claim/clm_80BE0785CE35, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm.","url":"https://asof.is/claim/clm_80BE0785CE35","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E7DC446890AC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2022, filed 2023-02-08"}},{"id":"clm_EE48295DE7F4","predicate":"net_income","value":"4,149,000,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-12-31","published":"2023-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 4,149,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_EE48295DE7F4, https://asof.is/claim/clm_EE48295DE7F4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm.","url":"https://asof.is/claim/clm_EE48295DE7F4","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_629BFA7E5C2C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2022, filed 2023-02-08"}},{"id":"clm_EE650D627F71","predicate":"revenue","value":"322,467,000,000 United States dollar","valid_from":"2022-12-31","valid_to":"2023-12-31","published":"2023-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 322,467,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_EE650D627F71, https://asof.is/claim/clm_EE650D627F71, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm.","url":"https://asof.is/claim/clm_EE650D627F71","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FA3DB9B2E145","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2022, filed 2023-02-08"}},{"id":"clm_124EAD2ADB64","predicate":"shares_outstanding","value":"1,313,966,912 shares","valid_from":"2022-10-26","valid_to":"2023-02-01","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,313,966,912 shares\", as of 2022-10-26 (until 2023-02-01). Claim clm_124EAD2ADB64, https://asof.is/claim/clm_124EAD2ADB64, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm.","url":"https://asof.is/claim/clm_124EAD2ADB64","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0B66AAC34D7A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2022, filed 2022-11-02"}},{"id":"clm_21D6EA020D4E","predicate":"total_assets","value":"231,212,000,000 United States dollar","valid_from":"2022-09-30","valid_to":"2022-12-31","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 231,212,000,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_21D6EA020D4E, https://asof.is/claim/clm_21D6EA020D4E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm.","url":"https://asof.is/claim/clm_21D6EA020D4E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_122AD0CA4FA7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2022, filed 2022-11-02"}},{"id":"clm_43D49ECF2A5D","predicate":"quarterly_net_income","value":"-3,416,000,000 United States dollar","valid_from":"2022-09-30","valid_to":"2023-03-31","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: -3,416,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_43D49ECF2A5D, https://asof.is/claim/clm_43D49ECF2A5D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm.","url":"https://asof.is/claim/clm_43D49ECF2A5D","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2608DC96449F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2022, filed 2022-11-02"}},{"id":"clm_81F6F1890B8C","predicate":"quarterly_operating_income","value":"-3,931,000,000 United States dollar","valid_from":"2022-09-30","valid_to":"2023-03-31","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: -3,931,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_81F6F1890B8C, https://asof.is/claim/clm_81F6F1890B8C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm.","url":"https://asof.is/claim/clm_81F6F1890B8C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4B3841636690","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2022, filed 2022-11-02"}},{"id":"clm_CB4E16C7A09C","predicate":"cash_and_equivalents","value":"17,197,000,000 United States dollar","valid_from":"2022-09-30","valid_to":"2022-12-31","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 17,197,000,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_CB4E16C7A09C, https://asof.is/claim/clm_CB4E16C7A09C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm.","url":"https://asof.is/claim/clm_CB4E16C7A09C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5D6CF2E0E3C9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2022, filed 2022-11-02"}},{"id":"clm_E09B736776FD","predicate":"quarterly_revenue","value":"81,159,000,000 United States dollar","valid_from":"2022-09-30","valid_to":"2023-03-31","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 81,159,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_E09B736776FD, https://asof.is/claim/clm_E09B736776FD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm.","url":"https://asof.is/claim/clm_E09B736776FD","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8A264A412163","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2022, filed 2022-11-02"}},{"id":"clm_E5795D7C3ABE","predicate":"total_equity","value":"70,683,000,000 United States dollar","valid_from":"2022-09-30","valid_to":"2022-12-31","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 70,683,000,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_E5795D7C3ABE, https://asof.is/claim/clm_E5795D7C3ABE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm.","url":"https://asof.is/claim/clm_E5795D7C3ABE","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_80BE0785CE35","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2022","published_at":"2022-11-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2022, filed 2022-11-02"}},{"id":"clm_2010CA190235","predicate":"shares_outstanding","value":"1,312,828,807 shares","valid_from":"2022-07-27","valid_to":"2022-10-26","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,312,828,807 shares\", as of 2022-07-27 (until 2022-10-26). Claim clm_2010CA190235, https://asof.is/claim/clm_2010CA190235, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm.","url":"https://asof.is/claim/clm_2010CA190235","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_124EAD2ADB64","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2022, filed 2022-08-03"}},{"id":"clm_10B3257B395E","predicate":"quarterly_revenue","value":"80,636,000,000 United States dollar","valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 80,636,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_10B3257B395E, https://asof.is/claim/clm_10B3257B395E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm.","url":"https://asof.is/claim/clm_10B3257B395E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E09B736776FD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2022, filed 2022-08-03"}},{"id":"clm_2C6F26651DC4","predicate":"quarterly_net_income","value":"2,951,000,000 United States dollar","valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,951,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_2C6F26651DC4, https://asof.is/claim/clm_2C6F26651DC4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm.","url":"https://asof.is/claim/clm_2C6F26651DC4","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_43D49ECF2A5D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2022, filed 2022-08-03"}},{"id":"clm_4A8881A62C6B","predicate":"total_assets","value":"230,279,000,000 United States dollar","valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 230,279,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_4A8881A62C6B, https://asof.is/claim/clm_4A8881A62C6B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm.","url":"https://asof.is/claim/clm_4A8881A62C6B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_21D6EA020D4E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2022, filed 2022-08-03"}},{"id":"clm_6A36BA10792E","predicate":"total_equity","value":"75,184,000,000 United States dollar","valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 75,184,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_6A36BA10792E, https://asof.is/claim/clm_6A36BA10792E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm.","url":"https://asof.is/claim/clm_6A36BA10792E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E5795D7C3ABE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2022, filed 2022-08-03"}},{"id":"clm_EB531E748181","predicate":"quarterly_operating_income","value":"4,569,000,000 United States dollar","valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 4,569,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_EB531E748181, https://asof.is/claim/clm_EB531E748181, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm.","url":"https://asof.is/claim/clm_EB531E748181","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_81F6F1890B8C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2022, filed 2022-08-03"}},{"id":"clm_ECD5EC10FA1A","predicate":"cash_and_equivalents","value":"12,116,000,000 United States dollar","valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 12,116,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_ECD5EC10FA1A, https://asof.is/claim/clm_ECD5EC10FA1A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm.","url":"https://asof.is/claim/clm_ECD5EC10FA1A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CB4E16C7A09C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2022, filed 2022-08-03"}},{"id":"clm_F3118F160F4B","predicate":"shares_outstanding","value":"1,311,309,074 shares","valid_from":"2022-04-27","valid_to":"2022-07-27","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,311,309,074 shares\", as of 2022-04-27 (until 2022-07-27). Claim clm_F3118F160F4B, https://asof.is/claim/clm_F3118F160F4B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm.","url":"https://asof.is/claim/clm_F3118F160F4B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2010CA190235","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2022, filed 2022-05-04"}},{"id":"clm_39167D9284D5","predicate":"quarterly_operating_income","value":"3,490,000,000 United States dollar","valid_from":"2022-03-31","valid_to":"2022-06-30","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,490,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_39167D9284D5, https://asof.is/claim/clm_39167D9284D5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm.","url":"https://asof.is/claim/clm_39167D9284D5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EB531E748181","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2022, filed 2022-05-04"}},{"id":"clm_4B8BD2E3C4AF","predicate":"total_equity","value":"73,830,000,000 United States dollar","valid_from":"2022-03-31","valid_to":"2022-06-30","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 73,830,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_4B8BD2E3C4AF, https://asof.is/claim/clm_4B8BD2E3C4AF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm.","url":"https://asof.is/claim/clm_4B8BD2E3C4AF","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6A36BA10792E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2022, filed 2022-05-04"}},{"id":"clm_6AE9A82E3FE8","predicate":"quarterly_revenue","value":"76,826,000,000 United States dollar","valid_from":"2022-03-31","valid_to":"2022-06-30","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 76,826,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_6AE9A82E3FE8, https://asof.is/claim/clm_6AE9A82E3FE8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm.","url":"https://asof.is/claim/clm_6AE9A82E3FE8","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_10B3257B395E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2022, filed 2022-05-04"}},{"id":"clm_7E343FF594A7","predicate":"cash_and_equivalents","value":"8,442,000,000 United States dollar","valid_from":"2022-03-31","valid_to":"2022-06-30","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 8,442,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_7E343FF594A7, https://asof.is/claim/clm_7E343FF594A7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm.","url":"https://asof.is/claim/clm_7E343FF594A7","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_ECD5EC10FA1A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2022, filed 2022-05-04"}},{"id":"clm_A8EECF5DEC95","predicate":"total_assets","value":"232,873,000,000 United States dollar","valid_from":"2022-03-31","valid_to":"2022-06-30","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 232,873,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_A8EECF5DEC95, https://asof.is/claim/clm_A8EECF5DEC95, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm.","url":"https://asof.is/claim/clm_A8EECF5DEC95","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4A8881A62C6B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2022, filed 2022-05-04"}},{"id":"clm_F147C5EEF39E","predicate":"quarterly_net_income","value":"2,312,000,000 United States dollar","valid_from":"2022-03-31","valid_to":"2022-06-30","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,312,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_F147C5EEF39E, https://asof.is/claim/clm_F147C5EEF39E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm.","url":"https://asof.is/claim/clm_F147C5EEF39E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2C6F26651DC4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2022","published_at":"2022-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2022, filed 2022-05-04"}},{"id":"clm_AEB044C5B803","predicate":"shares_outstanding","value":"1,312,510,426 shares","valid_from":"2022-02-02","valid_to":"2022-04-27","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,312,510,426 shares\", as of 2022-02-02 (until 2022-04-27). Claim clm_AEB044C5B803, https://asof.is/claim/clm_AEB044C5B803, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm.","url":"https://asof.is/claim/clm_AEB044C5B803","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F3118F160F4B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2021, filed 2022-02-09"}},{"id":"clm_12DBC5F1AD0A","predicate":"operating_income","value":"13,193,000,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-12-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 13,193,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_12DBC5F1AD0A, https://asof.is/claim/clm_12DBC5F1AD0A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm.","url":"https://asof.is/claim/clm_12DBC5F1AD0A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_540DCE22ED26","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2021, filed 2022-02-09"}},{"id":"clm_1DDD3D24C0F7","predicate":"revenue","value":"292,111,000,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-12-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 292,111,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_1DDD3D24C0F7, https://asof.is/claim/clm_1DDD3D24C0F7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm.","url":"https://asof.is/claim/clm_1DDD3D24C0F7","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EE650D627F71","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2021, filed 2022-02-09"}},{"id":"clm_9E820DC67260","predicate":"net_income","value":"7,910,000,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-12-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 7,910,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_9E820DC67260, https://asof.is/claim/clm_9E820DC67260, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm.","url":"https://asof.is/claim/clm_9E820DC67260","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EE48295DE7F4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2021, filed 2022-02-09"}},{"id":"clm_D74B4E70673C","predicate":"cash_and_equivalents","value":"9,408,000,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-03-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 9,408,000,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_D74B4E70673C, https://asof.is/claim/clm_D74B4E70673C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm.","url":"https://asof.is/claim/clm_D74B4E70673C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7E343FF594A7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2021, filed 2022-02-09"}},{"id":"clm_F8BC3DC5AD43","predicate":"total_assets","value":"232,999,000,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-03-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 232,999,000,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_F8BC3DC5AD43, https://asof.is/claim/clm_F8BC3DC5AD43, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm.","url":"https://asof.is/claim/clm_F8BC3DC5AD43","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A8EECF5DEC95","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2021, filed 2022-02-09"}},{"id":"clm_FA19BCC08288","predicate":"total_equity","value":"75,075,000,000 United States dollar","valid_from":"2021-12-31","valid_to":"2022-03-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 75,075,000,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_FA19BCC08288, https://asof.is/claim/clm_FA19BCC08288, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm.","url":"https://asof.is/claim/clm_FA19BCC08288","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4B8BD2E3C4AF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2021","published_at":"2022-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2021, filed 2022-02-09"}},{"id":"clm_3D8356C9D90B","predicate":"shares_outstanding","value":"1,320,058,657 shares","valid_from":"2021-10-27","valid_to":"2022-02-02","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,320,058,657 shares\", as of 2021-10-27 (until 2022-02-02). Claim clm_3D8356C9D90B, https://asof.is/claim/clm_3D8356C9D90B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm.","url":"https://asof.is/claim/clm_3D8356C9D90B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AEB044C5B803","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2021, filed 2021-11-03"}},{"id":"clm_781AA25BBC87","predicate":"total_equity","value":"74,308,000,000 United States dollar","valid_from":"2021-09-30","valid_to":"2021-12-31","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 74,308,000,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_781AA25BBC87, https://asof.is/claim/clm_781AA25BBC87, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm.","url":"https://asof.is/claim/clm_781AA25BBC87","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FA19BCC08288","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2021, filed 2021-11-03"}},{"id":"clm_B6AF55D24A35","predicate":"total_assets","value":"234,891,000,000 United States dollar","valid_from":"2021-09-30","valid_to":"2021-12-31","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 234,891,000,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_B6AF55D24A35, https://asof.is/claim/clm_B6AF55D24A35, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm.","url":"https://asof.is/claim/clm_B6AF55D24A35","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F8BC3DC5AD43","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2021, filed 2021-11-03"}},{"id":"clm_BF8853E4DF1C","predicate":"quarterly_operating_income","value":"3,061,000,000 United States dollar","valid_from":"2021-09-30","valid_to":"2022-03-31","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,061,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_BF8853E4DF1C, https://asof.is/claim/clm_BF8853E4DF1C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm.","url":"https://asof.is/claim/clm_BF8853E4DF1C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_39167D9284D5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2021, filed 2021-11-03"}},{"id":"clm_C67951D02A2A","predicate":"cash_and_equivalents","value":"9,826,000,000 United States dollar","valid_from":"2021-09-30","valid_to":"2021-12-31","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 9,826,000,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_C67951D02A2A, https://asof.is/claim/clm_C67951D02A2A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm.","url":"https://asof.is/claim/clm_C67951D02A2A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D74B4E70673C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2021, filed 2021-11-03"}},{"id":"clm_DA54CBCF7C9F","predicate":"quarterly_revenue","value":"73,794,000,000 United States dollar","valid_from":"2021-09-30","valid_to":"2022-03-31","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 73,794,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_DA54CBCF7C9F, https://asof.is/claim/clm_DA54CBCF7C9F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm.","url":"https://asof.is/claim/clm_DA54CBCF7C9F","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6AE9A82E3FE8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2021, filed 2021-11-03"}},{"id":"clm_FEE2D59D6DD3","predicate":"quarterly_net_income","value":"1,598,000,000 United States dollar","valid_from":"2021-09-30","valid_to":"2022-03-31","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,598,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_FEE2D59D6DD3, https://asof.is/claim/clm_FEE2D59D6DD3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm.","url":"https://asof.is/claim/clm_FEE2D59D6DD3","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F147C5EEF39E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2021","published_at":"2021-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2021, filed 2021-11-03"}},{"id":"clm_2E9DEBF523D5","predicate":"shares_outstanding","value":"1,319,574,744 shares","valid_from":"2021-07-28","valid_to":"2021-10-27","published":"2021-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,319,574,744 shares\", as of 2021-07-28 (until 2021-10-27). Claim clm_2E9DEBF523D5, https://asof.is/claim/clm_2E9DEBF523D5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm.","url":"https://asof.is/claim/clm_2E9DEBF523D5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3D8356C9D90B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2021, filed 2021-08-04"}},{"id":"clm_02909894A177","predicate":"total_equity","value":"73,244,000,000 United States dollar","valid_from":"2021-06-30","valid_to":"2021-09-30","published":"2021-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 73,244,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_02909894A177, https://asof.is/claim/clm_02909894A177, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm.","url":"https://asof.is/claim/clm_02909894A177","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_781AA25BBC87","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2021, filed 2021-08-04"}},{"id":"clm_0736E31637AC","predicate":"quarterly_operating_income","value":"4,326,000,000 United States dollar","valid_from":"2021-06-30","valid_to":"2021-09-30","published":"2021-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 4,326,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_0736E31637AC, https://asof.is/claim/clm_0736E31637AC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm.","url":"https://asof.is/claim/clm_0736E31637AC","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BF8853E4DF1C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2021, filed 2021-08-04"}},{"id":"clm_090B7A2B612F","predicate":"cash_and_equivalents","value":"7,119,000,000 United States dollar","valid_from":"2021-06-30","valid_to":"2021-09-30","published":"2021-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 7,119,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_090B7A2B612F, https://asof.is/claim/clm_090B7A2B612F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm.","url":"https://asof.is/claim/clm_090B7A2B612F","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C67951D02A2A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2021, filed 2021-08-04"}},{"id":"clm_22C6E4DC8099","predicate":"total_assets","value":"231,164,000,000 United States dollar","valid_from":"2021-06-30","valid_to":"2021-09-30","published":"2021-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 231,164,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_22C6E4DC8099, https://asof.is/claim/clm_22C6E4DC8099, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm.","url":"https://asof.is/claim/clm_22C6E4DC8099","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B6AF55D24A35","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2021, filed 2021-08-04"}},{"id":"clm_7A764C3EBBCD","predicate":"quarterly_net_income","value":"2,783,000,000 United States dollar","valid_from":"2021-06-30","valid_to":"2021-09-30","published":"2021-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,783,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_7A764C3EBBCD, https://asof.is/claim/clm_7A764C3EBBCD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm.","url":"https://asof.is/claim/clm_7A764C3EBBCD","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FEE2D59D6DD3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2021, filed 2021-08-04"}},{"id":"clm_830B66DEB6B5","predicate":"quarterly_revenue","value":"72,616,000,000 United States dollar","valid_from":"2021-06-30","valid_to":"2021-09-30","published":"2021-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 72,616,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_830B66DEB6B5, https://asof.is/claim/clm_830B66DEB6B5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm.","url":"https://asof.is/claim/clm_830B66DEB6B5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DA54CBCF7C9F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2021, filed 2021-08-04"}},{"id":"clm_632B0E597499","predicate":"shares_outstanding","value":"1,316,567,871 shares","valid_from":"2021-04-27","valid_to":"2021-07-28","published":"2021-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,316,567,871 shares\", as of 2021-04-27 (until 2021-07-28). Claim clm_632B0E597499, https://asof.is/claim/clm_632B0E597499, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm.","url":"https://asof.is/claim/clm_632B0E597499","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2E9DEBF523D5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2021, filed 2021-05-04"}},{"id":"clm_3FEC61B93944","predicate":"quarterly_net_income","value":"2,223,000,000 United States dollar","valid_from":"2021-03-31","valid_to":"2021-06-30","published":"2021-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,223,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_3FEC61B93944, https://asof.is/claim/clm_3FEC61B93944, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm.","url":"https://asof.is/claim/clm_3FEC61B93944","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7A764C3EBBCD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2021, filed 2021-05-04"}},{"id":"clm_5AFCDDE6A901","predicate":"cash_and_equivalents","value":"5,598,000,000 United States dollar","valid_from":"2021-03-31","valid_to":"2021-06-30","published":"2021-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 5,598,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_5AFCDDE6A901, https://asof.is/claim/clm_5AFCDDE6A901, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm.","url":"https://asof.is/claim/clm_5AFCDDE6A901","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_090B7A2B612F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2021, filed 2021-05-04"}},{"id":"clm_8B2017691F41","predicate":"quarterly_operating_income","value":"3,577,000,000 United States dollar","valid_from":"2021-03-31","valid_to":"2021-06-30","published":"2021-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,577,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_8B2017691F41, https://asof.is/claim/clm_8B2017691F41, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm.","url":"https://asof.is/claim/clm_8B2017691F41","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0736E31637AC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2021, filed 2021-05-04"}},{"id":"clm_8B2A5F0BECB2","predicate":"total_equity","value":"70,850,000,000 United States dollar","valid_from":"2021-03-31","valid_to":"2021-06-30","published":"2021-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 70,850,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_8B2A5F0BECB2, https://asof.is/claim/clm_8B2A5F0BECB2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm.","url":"https://asof.is/claim/clm_8B2A5F0BECB2","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_02909894A177","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2021, filed 2021-05-04"}},{"id":"clm_AB4E6B6B5F2F","predicate":"quarterly_revenue","value":"69,097,000,000 United States dollar","valid_from":"2021-03-31","valid_to":"2021-06-30","published":"2021-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 69,097,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_AB4E6B6B5F2F, https://asof.is/claim/clm_AB4E6B6B5F2F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm.","url":"https://asof.is/claim/clm_AB4E6B6B5F2F","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_830B66DEB6B5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2021, filed 2021-05-04"}},{"id":"clm_DD31B5100696","predicate":"total_assets","value":"229,606,000,000 United States dollar","valid_from":"2021-03-31","valid_to":"2021-06-30","published":"2021-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 229,606,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_DD31B5100696, https://asof.is/claim/clm_DD31B5100696, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm.","url":"https://asof.is/claim/clm_DD31B5100696","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_22C6E4DC8099","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2021","published_at":"2021-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2021, filed 2021-05-04"}},{"id":"clm_5873B8F70331","predicate":"shares_outstanding","value":"1,311,354,926 shares","valid_from":"2021-02-08","valid_to":"2021-04-27","published":"2021-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,311,354,926 shares\", as of 2021-02-08 (until 2021-04-27). Claim clm_5873B8F70331, https://asof.is/claim/clm_5873B8F70331, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm.","url":"https://asof.is/claim/clm_5873B8F70331","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_632B0E597499","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-16T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2020, filed 2021-02-16"}},{"id":"clm_33D78772923C","predicate":"total_assets","value":"230,715,000,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-03-31","published":"2021-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 230,715,000,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_33D78772923C, https://asof.is/claim/clm_33D78772923C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm.","url":"https://asof.is/claim/clm_33D78772923C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DD31B5100696","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-16T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2020, filed 2021-02-16"}},{"id":"clm_4D623BCD10E4","predicate":"cash_and_equivalents","value":"7,854,000,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-03-31","published":"2021-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 7,854,000,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_4D623BCD10E4, https://asof.is/claim/clm_4D623BCD10E4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm.","url":"https://asof.is/claim/clm_4D623BCD10E4","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5AFCDDE6A901","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-16T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2020, filed 2021-02-16"}},{"id":"clm_54D54DE804C0","predicate":"total_equity","value":"69,389,000,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-03-31","published":"2021-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 69,389,000,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_54D54DE804C0, https://asof.is/claim/clm_54D54DE804C0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm.","url":"https://asof.is/claim/clm_54D54DE804C0","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8B2A5F0BECB2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-16T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2020, filed 2021-02-16"}},{"id":"clm_73340BA17D18","predicate":"revenue","value":"268,706,000,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-12-31","published":"2021-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 268,706,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_73340BA17D18, https://asof.is/claim/clm_73340BA17D18, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm.","url":"https://asof.is/claim/clm_73340BA17D18","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1DDD3D24C0F7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-16T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2020, filed 2021-02-16"}},{"id":"clm_7F16BFA5AC70","predicate":"net_income","value":"7,179,000,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-12-31","published":"2021-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 7,179,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_7F16BFA5AC70, https://asof.is/claim/clm_7F16BFA5AC70, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm.","url":"https://asof.is/claim/clm_7F16BFA5AC70","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9E820DC67260","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-16T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2020, filed 2021-02-16"}},{"id":"clm_F58CE8B8F03F","predicate":"operating_income","value":"13,911,000,000 United States dollar","valid_from":"2020-12-31","valid_to":"2021-12-31","published":"2021-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 13,911,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_F58CE8B8F03F, https://asof.is/claim/clm_F58CE8B8F03F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm.","url":"https://asof.is/claim/clm_F58CE8B8F03F","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_12DBC5F1AD0A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2020","published_at":"2021-02-16T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2020, filed 2021-02-16"}},{"id":"clm_51EAEF7D944C","predicate":"shares_outstanding","value":"1,308,913,498 shares","valid_from":"2020-10-28","valid_to":"2021-02-08","published":"2020-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,308,913,498 shares\", as of 2020-10-28 (until 2021-02-08). Claim clm_51EAEF7D944C, https://asof.is/claim/clm_51EAEF7D944C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm.","url":"https://asof.is/claim/clm_51EAEF7D944C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5873B8F70331","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2020, filed 2020-11-06"}},{"id":"clm_0F320A1D11FD","predicate":"quarterly_revenue","value":"67,056,000,000 United States dollar","valid_from":"2020-09-30","valid_to":"2021-03-31","published":"2020-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 67,056,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_0F320A1D11FD, https://asof.is/claim/clm_0F320A1D11FD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm.","url":"https://asof.is/claim/clm_0F320A1D11FD","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AB4E6B6B5F2F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2020, filed 2020-11-06"}},{"id":"clm_3E5A2A78FF88","predicate":"cash_and_equivalents","value":"9,256,000,000 United States dollar","valid_from":"2020-09-30","valid_to":"2020-12-31","published":"2020-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 9,256,000,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_3E5A2A78FF88, https://asof.is/claim/clm_3E5A2A78FF88, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm.","url":"https://asof.is/claim/clm_3E5A2A78FF88","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4D623BCD10E4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2020, filed 2020-11-06"}},{"id":"clm_524F7F1991AC","predicate":"quarterly_operating_income","value":"3,249,000,000 United States dollar","valid_from":"2020-09-30","valid_to":"2021-03-31","published":"2020-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,249,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_524F7F1991AC, https://asof.is/claim/clm_524F7F1991AC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm.","url":"https://asof.is/claim/clm_524F7F1991AC","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8B2017691F41","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2020, filed 2020-11-06"}},{"id":"clm_80AC5611CFA9","predicate":"quarterly_net_income","value":"1,224,000,000 United States dollar","valid_from":"2020-09-30","valid_to":"2021-03-31","published":"2020-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,224,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_80AC5611CFA9, https://asof.is/claim/clm_80AC5611CFA9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm.","url":"https://asof.is/claim/clm_80AC5611CFA9","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3FEC61B93944","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2020, filed 2020-11-06"}},{"id":"clm_B0828F05DDB6","predicate":"total_assets","value":"232,898,000,000 United States dollar","valid_from":"2020-09-30","valid_to":"2020-12-31","published":"2020-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 232,898,000,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_B0828F05DDB6, https://asof.is/claim/clm_B0828F05DDB6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm.","url":"https://asof.is/claim/clm_B0828F05DDB6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_33D78772923C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2020, filed 2020-11-06"}},{"id":"clm_BA685302B123","predicate":"total_equity","value":"68,807,000,000 United States dollar","valid_from":"2020-09-30","valid_to":"2020-12-31","published":"2020-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 68,807,000,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_BA685302B123, https://asof.is/claim/clm_BA685302B123, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm.","url":"https://asof.is/claim/clm_BA685302B123","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_54D54DE804C0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2020","published_at":"2020-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2020, filed 2020-11-06"}},{"id":"clm_A604E7EAC886","predicate":"shares_outstanding","value":"1,308,703,450 shares","valid_from":"2020-07-27","valid_to":"2020-10-28","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,308,703,450 shares\", as of 2020-07-27 (until 2020-10-28). Claim clm_A604E7EAC886, https://asof.is/claim/clm_A604E7EAC886, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm.","url":"https://asof.is/claim/clm_A604E7EAC886","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_51EAEF7D944C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_38C4E23DD59E","predicate":"quarterly_net_income","value":"2,975,000,000 United States dollar","valid_from":"2020-06-30","valid_to":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,975,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_38C4E23DD59E, https://asof.is/claim/clm_38C4E23DD59E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm.","url":"https://asof.is/claim/clm_38C4E23DD59E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_80AC5611CFA9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_6FA2408C58BA","predicate":"total_equity","value":"68,022,000,000 United States dollar","valid_from":"2020-06-30","valid_to":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 68,022,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_6FA2408C58BA, https://asof.is/claim/clm_6FA2408C58BA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm.","url":"https://asof.is/claim/clm_6FA2408C58BA","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BA685302B123","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_B75E795E3431","predicate":"cash_and_equivalents","value":"14,869,000,000 United States dollar","valid_from":"2020-06-30","valid_to":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 14,869,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_B75E795E3431, https://asof.is/claim/clm_B75E795E3431, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm.","url":"https://asof.is/claim/clm_B75E795E3431","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3E5A2A78FF88","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_B80A73468D64","predicate":"quarterly_revenue","value":"65,341,000,000 United States dollar","valid_from":"2020-06-30","valid_to":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 65,341,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_B80A73468D64, https://asof.is/claim/clm_B80A73468D64, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm.","url":"https://asof.is/claim/clm_B80A73468D64","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0F320A1D11FD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_CF78A4E74373","predicate":"quarterly_operating_income","value":"4,680,000,000 United States dollar","valid_from":"2020-06-30","valid_to":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 4,680,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_CF78A4E74373, https://asof.is/claim/clm_CF78A4E74373, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm.","url":"https://asof.is/claim/clm_CF78A4E74373","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_524F7F1991AC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_E32838F5A44C","predicate":"total_assets","value":"235,495,000,000 United States dollar","valid_from":"2020-06-30","valid_to":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 235,495,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_E32838F5A44C, https://asof.is/claim/clm_E32838F5A44C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm.","url":"https://asof.is/claim/clm_E32838F5A44C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B0828F05DDB6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2020","published_at":"2020-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2020, filed 2020-08-05"}},{"id":"clm_29B659BCBDFA","predicate":"shares_outstanding","value":"1,307,090,830 shares","valid_from":"2020-04-27","valid_to":"2020-07-27","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,307,090,830 shares\", as of 2020-04-27 (until 2020-07-27). Claim clm_29B659BCBDFA, https://asof.is/claim/clm_29B659BCBDFA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm.","url":"https://asof.is/claim/clm_29B659BCBDFA","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A604E7EAC886","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_0262590009E5","predicate":"quarterly_net_income","value":"2,007,000,000 United States dollar","valid_from":"2020-03-31","valid_to":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,007,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_0262590009E5, https://asof.is/claim/clm_0262590009E5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm.","url":"https://asof.is/claim/clm_0262590009E5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_38C4E23DD59E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_5C58AE8D734A","predicate":"cash_and_equivalents","value":"10,081,000,000 United States dollar","valid_from":"2020-03-31","valid_to":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 10,081,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_5C58AE8D734A, https://asof.is/claim/clm_5C58AE8D734A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm.","url":"https://asof.is/claim/clm_5C58AE8D734A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B75E795E3431","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_813C010D1951","predicate":"total_assets","value":"230,639,000,000 United States dollar","valid_from":"2020-03-31","valid_to":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 230,639,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_813C010D1951, https://asof.is/claim/clm_813C010D1951, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm.","url":"https://asof.is/claim/clm_813C010D1951","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E32838F5A44C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_DD2B39DD9AFB","predicate":"total_equity","value":"65,140,000,000 United States dollar","valid_from":"2020-03-31","valid_to":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 65,140,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_DD2B39DD9AFB, https://asof.is/claim/clm_DD2B39DD9AFB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm.","url":"https://asof.is/claim/clm_DD2B39DD9AFB","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6FA2408C58BA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_DE56C8906253","predicate":"quarterly_operating_income","value":"3,458,000,000 United States dollar","valid_from":"2020-03-31","valid_to":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,458,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_DE56C8906253, https://asof.is/claim/clm_DE56C8906253, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm.","url":"https://asof.is/claim/clm_DE56C8906253","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CF78A4E74373","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_F6C0C41FB35A","predicate":"quarterly_revenue","value":"66,755,000,000 United States dollar","valid_from":"2020-03-31","valid_to":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 66,755,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_F6C0C41FB35A, https://asof.is/claim/clm_F6C0C41FB35A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm.","url":"https://asof.is/claim/clm_F6C0C41FB35A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B80A73468D64","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_DEE36FE2468C","predicate":"shares_outstanding","value":"1,304,159,680 shares","valid_from":"2020-02-12","valid_to":"2020-04-27","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,304,159,680 shares\", as of 2020-02-12 (until 2020-04-27). Claim clm_DEE36FE2468C, https://asof.is/claim/clm_DEE36FE2468C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm.","url":"https://asof.is/claim/clm_DEE36FE2468C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_29B659BCBDFA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-18T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2019, filed 2020-02-18"}},{"id":"clm_35EBF43D2102","predicate":"cash_and_equivalents","value":"5,683,000,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-03-31","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 5,683,000,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_35EBF43D2102, https://asof.is/claim/clm_35EBF43D2102, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm.","url":"https://asof.is/claim/clm_35EBF43D2102","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5C58AE8D734A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-18T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2019, filed 2020-02-18"}},{"id":"clm_64183B44EF91","predicate":"total_equity","value":"63,864,000,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-03-31","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 63,864,000,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_64183B44EF91, https://asof.is/claim/clm_64183B44EF91, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm.","url":"https://asof.is/claim/clm_64183B44EF91","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DD2B39DD9AFB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-18T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2019, filed 2020-02-18"}},{"id":"clm_6FE2165C13B9","predicate":"revenue","value":"256,776,000,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-12-31","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 256,776,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_6FE2165C13B9, https://asof.is/claim/clm_6FE2165C13B9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm.","url":"https://asof.is/claim/clm_6FE2165C13B9","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_73340BA17D18","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-18T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2019, filed 2020-02-18"}},{"id":"clm_A8E77F7A6042","predicate":"net_income","value":"6,634,000,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-12-31","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 6,634,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_A8E77F7A6042, https://asof.is/claim/clm_A8E77F7A6042, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm.","url":"https://asof.is/claim/clm_A8E77F7A6042","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7F16BFA5AC70","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-18T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2019, filed 2020-02-18"}},{"id":"clm_E2C57BC5B64E","predicate":"operating_income","value":"11,987,000,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-12-31","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 11,987,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_E2C57BC5B64E, https://asof.is/claim/clm_E2C57BC5B64E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm.","url":"https://asof.is/claim/clm_E2C57BC5B64E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F58CE8B8F03F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-18T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2019, filed 2020-02-18"}},{"id":"clm_F4AC657606C5","predicate":"total_assets","value":"222,449,000,000 United States dollar","valid_from":"2019-12-31","valid_to":"2020-03-31","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 222,449,000,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_F4AC657606C5, https://asof.is/claim/clm_F4AC657606C5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm.","url":"https://asof.is/claim/clm_F4AC657606C5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_813C010D1951","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-18T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2019, filed 2020-02-18"}},{"id":"clm_02DA54021B0A","predicate":"shares_outstanding","value":"1,300,964,007 shares","valid_from":"2019-10-29","valid_to":"2020-02-12","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,300,964,007 shares\", as of 2019-10-29 (until 2020-02-12). Claim clm_02DA54021B0A, https://asof.is/claim/clm_02DA54021B0A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm.","url":"https://asof.is/claim/clm_02DA54021B0A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DEE36FE2468C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2019, filed 2019-11-06"}},{"id":"clm_07B03D722E1D","predicate":"quarterly_operating_income","value":"2,928,000,000 United States dollar","valid_from":"2019-09-30","valid_to":"2020-03-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,928,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_07B03D722E1D, https://asof.is/claim/clm_07B03D722E1D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm.","url":"https://asof.is/claim/clm_07B03D722E1D","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DE56C8906253","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2019, filed 2019-11-06"}},{"id":"clm_0EC83651231B","predicate":"total_equity","value":"62,614,000,000 United States dollar","valid_from":"2019-09-30","valid_to":"2019-12-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 62,614,000,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_0EC83651231B, https://asof.is/claim/clm_0EC83651231B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm.","url":"https://asof.is/claim/clm_0EC83651231B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_64183B44EF91","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2019, filed 2019-11-06"}},{"id":"clm_9A5FE0282EBA","predicate":"total_assets","value":"220,113,000,000 United States dollar","valid_from":"2019-09-30","valid_to":"2019-12-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 220,113,000,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_9A5FE0282EBA, https://asof.is/claim/clm_9A5FE0282EBA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm.","url":"https://asof.is/claim/clm_9A5FE0282EBA","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F4AC657606C5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2019, filed 2019-11-06"}},{"id":"clm_B11370A9E8DF","predicate":"quarterly_net_income","value":"1,530,000,000 United States dollar","valid_from":"2019-09-30","valid_to":"2020-03-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,530,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_B11370A9E8DF, https://asof.is/claim/clm_B11370A9E8DF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm.","url":"https://asof.is/claim/clm_B11370A9E8DF","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0262590009E5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2019, filed 2019-11-06"}},{"id":"clm_B416C77C42A6","predicate":"cash_and_equivalents","value":"5,193,000,000 United States dollar","valid_from":"2019-09-30","valid_to":"2019-12-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 5,193,000,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_B416C77C42A6, https://asof.is/claim/clm_B416C77C42A6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm.","url":"https://asof.is/claim/clm_B416C77C42A6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_35EBF43D2102","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2019, filed 2019-11-06"}},{"id":"clm_E9A1B4215D15","predicate":"quarterly_revenue","value":"64,810,000,000 United States dollar","valid_from":"2019-09-30","valid_to":"2020-03-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 64,810,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_E9A1B4215D15, https://asof.is/claim/clm_E9A1B4215D15, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm.","url":"https://asof.is/claim/clm_E9A1B4215D15","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F6C0C41FB35A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2019","published_at":"2019-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2019, filed 2019-11-06"}},{"id":"clm_0EC3814BE2A2","predicate":"shares_outstanding","value":"1,300,496,722 shares","valid_from":"2019-07-30","valid_to":"2019-10-29","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,300,496,722 shares\", as of 2019-07-30 (until 2019-10-29). Claim clm_0EC3814BE2A2, https://asof.is/claim/clm_0EC3814BE2A2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm.","url":"https://asof.is/claim/clm_0EC3814BE2A2","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_02DA54021B0A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2019, filed 2019-08-07"}},{"id":"clm_069A365CCACA","predicate":"quarterly_revenue","value":"63,431,000,000 United States dollar","valid_from":"2019-06-30","valid_to":"2019-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 63,431,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_069A365CCACA, https://asof.is/claim/clm_069A365CCACA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm.","url":"https://asof.is/claim/clm_069A365CCACA","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E9A1B4215D15","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2019, filed 2019-08-07"}},{"id":"clm_1B5438C93082","predicate":"quarterly_net_income","value":"1,936,000,000 United States dollar","valid_from":"2019-06-30","valid_to":"2019-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,936,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_1B5438C93082, https://asof.is/claim/clm_1B5438C93082, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm.","url":"https://asof.is/claim/clm_1B5438C93082","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B11370A9E8DF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2019, filed 2019-08-07"}},{"id":"clm_616B790F76C3","predicate":"total_assets","value":"218,904,000,000 United States dollar","valid_from":"2019-06-30","valid_to":"2019-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 218,904,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_616B790F76C3, https://asof.is/claim/clm_616B790F76C3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm.","url":"https://asof.is/claim/clm_616B790F76C3","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9A5FE0282EBA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2019, filed 2019-08-07"}},{"id":"clm_97BB8243B715","predicate":"cash_and_equivalents","value":"6,063,000,000 United States dollar","valid_from":"2019-06-30","valid_to":"2019-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 6,063,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_97BB8243B715, https://asof.is/claim/clm_97BB8243B715, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm.","url":"https://asof.is/claim/clm_97BB8243B715","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B416C77C42A6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2019, filed 2019-08-07"}},{"id":"clm_C8C204F11FE0","predicate":"quarterly_operating_income","value":"3,332,000,000 United States dollar","valid_from":"2019-06-30","valid_to":"2019-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,332,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_C8C204F11FE0, https://asof.is/claim/clm_C8C204F11FE0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm.","url":"https://asof.is/claim/clm_C8C204F11FE0","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_07B03D722E1D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2019, filed 2019-08-07"}},{"id":"clm_D0632AD3ECF0","predicate":"total_equity","value":"61,282,000,000 United States dollar","valid_from":"2019-06-30","valid_to":"2019-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 61,282,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_D0632AD3ECF0, https://asof.is/claim/clm_D0632AD3ECF0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm.","url":"https://asof.is/claim/clm_D0632AD3ECF0","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0EC83651231B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2019","published_at":"2019-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2019, filed 2019-08-07"}},{"id":"clm_43E143E41D59","predicate":"shares_outstanding","value":"1,299,092,100 shares","valid_from":"2019-04-23","valid_to":"2019-07-30","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,299,092,100 shares\", as of 2019-04-23 (until 2019-07-30). Claim clm_43E143E41D59, https://asof.is/claim/clm_43E143E41D59, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000021/0000064803-19-000021-index.htm.","url":"https://asof.is/claim/clm_43E143E41D59","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0EC3814BE2A2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000021/0000064803-19-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2019, filed 2019-05-01"}},{"id":"clm_2FA8CB6161A4","predicate":"quarterly_operating_income","value":"2,690,000,000 United States dollar","valid_from":"2019-03-31","valid_to":"2019-06-30","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,690,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_2FA8CB6161A4, https://asof.is/claim/clm_2FA8CB6161A4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000021/0000064803-19-000021-index.htm.","url":"https://asof.is/claim/clm_2FA8CB6161A4","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C8C204F11FE0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000021/0000064803-19-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2019, filed 2019-05-01"}},{"id":"clm_53DA43511937","predicate":"cash_and_equivalents","value":"5,896,000,000 United States dollar","valid_from":"2019-03-31","valid_to":"2019-06-30","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 5,896,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_53DA43511937, https://asof.is/claim/clm_53DA43511937, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000021/0000064803-19-000021-index.htm.","url":"https://asof.is/claim/clm_53DA43511937","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_97BB8243B715","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000021/0000064803-19-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2019, filed 2019-05-01"}},{"id":"clm_678D300569C9","predicate":"quarterly_revenue","value":"61,646,000,000 United States dollar","valid_from":"2019-03-31","valid_to":"2019-06-30","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 61,646,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_678D300569C9, https://asof.is/claim/clm_678D300569C9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000021/0000064803-19-000021-index.htm.","url":"https://asof.is/claim/clm_678D300569C9","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_069A365CCACA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000021/0000064803-19-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2019, filed 2019-05-01"}},{"id":"clm_EBE9272EAD09","predicate":"quarterly_net_income","value":"1,421,000,000 United States dollar","valid_from":"2019-03-31","valid_to":"2019-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,421,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_EBE9272EAD09, https://asof.is/claim/clm_EBE9272EAD09, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm.","url":"https://asof.is/claim/clm_EBE9272EAD09","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1B5438C93082","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2020","published_at":"2020-05-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2020, filed 2020-05-06"}},{"id":"clm_EDA2265FA5DD","predicate":"total_assets","value":"219,768,000,000 United States dollar","valid_from":"2019-03-31","valid_to":"2019-06-30","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 219,768,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_EDA2265FA5DD, https://asof.is/claim/clm_EDA2265FA5DD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000021/0000064803-19-000021-index.htm.","url":"https://asof.is/claim/clm_EDA2265FA5DD","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_616B790F76C3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000021/0000064803-19-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2019, filed 2019-05-01"}},{"id":"clm_F78AFE03E957","predicate":"total_equity","value":"59,686,000,000 United States dollar","valid_from":"2019-03-31","valid_to":"2019-06-30","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 59,686,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_F78AFE03E957, https://asof.is/claim/clm_F78AFE03E957, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000021/0000064803-19-000021-index.htm.","url":"https://asof.is/claim/clm_F78AFE03E957","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D0632AD3ECF0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000021/0000064803-19-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2019","published_at":"2019-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2019, filed 2019-05-01"}},{"id":"clm_33DB4D57675A","predicate":"shares_outstanding","value":"1,297,082,165 shares","valid_from":"2019-02-19","valid_to":"2019-04-23","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,297,082,165 shares\", as of 2019-02-19 (until 2019-04-23). Claim clm_33DB4D57675A, https://asof.is/claim/clm_33DB4D57675A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm.","url":"https://asof.is/claim/clm_33DB4D57675A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_43E143E41D59","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2018, filed 2019-02-28"}},{"id":"clm_54CEAF7E3FA2","predicate":"total_equity","value":"58,403,000,000 United States dollar","valid_from":"2019-01-01","valid_to":"2019-03-31","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 58,403,000,000 United States dollar\", as of 2019-01-01 (until 2019-03-31). Claim clm_54CEAF7E3FA2, https://asof.is/claim/clm_54CEAF7E3FA2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm.","url":"https://asof.is/claim/clm_54CEAF7E3FA2","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F78AFE03E957","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-18T00:00:00+00:00"},{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2019, filed 2020-02-18"}},{"id":"clm_C25444693B38","predicate":"total_assets","value":"216,668,000,000 United States dollar","valid_from":"2019-01-01","valid_to":"2019-03-31","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 216,668,000,000 United States dollar\", as of 2019-01-01 (until 2019-03-31). Claim clm_C25444693B38, https://asof.is/claim/clm_C25444693B38, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm.","url":"https://asof.is/claim/clm_C25444693B38","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EDA2265FA5DD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2019","published_at":"2020-02-18T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2019, filed 2020-02-18"}},{"id":"clm_22FE9A0195E4","predicate":"revenue","value":"194,579,000,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-12-31","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 194,579,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_22FE9A0195E4, https://asof.is/claim/clm_22FE9A0195E4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm.","url":"https://asof.is/claim/clm_22FE9A0195E4","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6FE2165C13B9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2018, filed 2019-02-28"}},{"id":"clm_6E8F85489216","predicate":"operating_income","value":"4,021,000,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-12-31","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 4,021,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_6E8F85489216, https://asof.is/claim/clm_6E8F85489216, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm.","url":"https://asof.is/claim/clm_6E8F85489216","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E2C57BC5B64E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2018, filed 2019-02-28"}},{"id":"clm_7BACC1C3E4E6","predicate":"total_assets","value":"196,456,000,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-01-01","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 196,456,000,000 United States dollar\", as of 2018-12-31 (until 2019-01-01). Claim clm_7BACC1C3E4E6, https://asof.is/claim/clm_7BACC1C3E4E6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm.","url":"https://asof.is/claim/clm_7BACC1C3E4E6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C25444693B38","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2018, filed 2019-02-28"}},{"id":"clm_C4D977ABF281","predicate":"net_income","value":"-594,000,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-12-31","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: -594,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_C4D977ABF281, https://asof.is/claim/clm_C4D977ABF281, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm.","url":"https://asof.is/claim/clm_C4D977ABF281","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A8E77F7A6042","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2018, filed 2019-02-28"}},{"id":"clm_D614A0A5B4F9","predicate":"cash_and_equivalents","value":"4,059,000,000 United States dollar","valid_from":"2018-12-31","valid_to":"2019-03-31","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 4,059,000,000 United States dollar\", as of 2018-12-31 (until 2019-03-31). Claim clm_D614A0A5B4F9, https://asof.is/claim/clm_D614A0A5B4F9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm.","url":"https://asof.is/claim/clm_D614A0A5B4F9","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_53DA43511937","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2018","published_at":"2019-02-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2018, filed 2019-02-28"}},{"id":"clm_9DC059A9078C","predicate":"shares_outstanding","value":"1,018,799,080 shares","valid_from":"2018-10-31","valid_to":"2019-02-19","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,018,799,080 shares\", as of 2018-10-31 (until 2019-02-19). Claim clm_9DC059A9078C, https://asof.is/claim/clm_9DC059A9078C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm.","url":"https://asof.is/claim/clm_9DC059A9078C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_33DB4D57675A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2018, filed 2018-11-06"}},{"id":"clm_549D3855A38B","predicate":"quarterly_revenue","value":"47,269,000,000 United States dollar","valid_from":"2018-09-30","valid_to":"2019-03-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 47,269,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_549D3855A38B, https://asof.is/claim/clm_549D3855A38B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm.","url":"https://asof.is/claim/clm_549D3855A38B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_678D300569C9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2018, filed 2018-11-06"}},{"id":"clm_83D2BE6AB848","predicate":"cash_and_equivalents","value":"41,587,000,000 United States dollar","valid_from":"2018-09-30","valid_to":"2018-12-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 41,587,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_83D2BE6AB848, https://asof.is/claim/clm_83D2BE6AB848, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm.","url":"https://asof.is/claim/clm_83D2BE6AB848","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D614A0A5B4F9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2018, filed 2018-11-06"}},{"id":"clm_AECCD433D030","predicate":"total_equity","value":"36,618,000,000 United States dollar","valid_from":"2018-09-30","valid_to":"2018-12-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 36,618,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_AECCD433D030, https://asof.is/claim/clm_AECCD433D030, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm.","url":"https://asof.is/claim/clm_AECCD433D030","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_54CEAF7E3FA2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2018, filed 2018-11-06"}},{"id":"clm_C296DE4EC931","predicate":"quarterly_net_income","value":"1,390,000,000 United States dollar","valid_from":"2018-09-30","valid_to":"2019-03-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,390,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_C296DE4EC931, https://asof.is/claim/clm_C296DE4EC931, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm.","url":"https://asof.is/claim/clm_C296DE4EC931","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EBE9272EAD09","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2018, filed 2018-11-06"}},{"id":"clm_D9D0528E67ED","predicate":"quarterly_operating_income","value":"2,353,000,000 United States dollar","valid_from":"2018-09-30","valid_to":"2019-03-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,353,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_D9D0528E67ED, https://asof.is/claim/clm_D9D0528E67ED, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm.","url":"https://asof.is/claim/clm_D9D0528E67ED","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2FA8CB6161A4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2018, filed 2018-11-06"}},{"id":"clm_E76EC027CB61","predicate":"total_assets","value":"131,506,000,000 United States dollar","valid_from":"2018-09-30","valid_to":"2018-12-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 131,506,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_E76EC027CB61, https://asof.is/claim/clm_E76EC027CB61, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm.","url":"https://asof.is/claim/clm_E76EC027CB61","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7BACC1C3E4E6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2018","published_at":"2018-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2018, filed 2018-11-06"}},{"id":"clm_058AF2856DAF","predicate":"shares_outstanding","value":"1,018,063,785 shares","valid_from":"2018-08-01","valid_to":"2018-10-31","published":"2018-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,018,063,785 shares\", as of 2018-08-01 (until 2018-10-31). Claim clm_058AF2856DAF, https://asof.is/claim/clm_058AF2856DAF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm.","url":"https://asof.is/claim/clm_058AF2856DAF","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9DC059A9078C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2018, filed 2018-08-08"}},{"id":"clm_058C6BC1F84B","predicate":"quarterly_net_income","value":"-2,563,000,000 United States dollar","valid_from":"2018-06-30","valid_to":"2018-09-30","published":"2018-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: -2,563,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_058C6BC1F84B, https://asof.is/claim/clm_058C6BC1F84B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm.","url":"https://asof.is/claim/clm_058C6BC1F84B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C296DE4EC931","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2018, filed 2018-08-08"}},{"id":"clm_58D66CB8F24B","predicate":"quarterly_operating_income","value":"-1,587,000,000 United States dollar","valid_from":"2018-06-30","valid_to":"2018-09-30","published":"2018-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: -1,587,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_58D66CB8F24B, https://asof.is/claim/clm_58D66CB8F24B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm.","url":"https://asof.is/claim/clm_58D66CB8F24B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D9D0528E67ED","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2018, filed 2018-08-08"}},{"id":"clm_72C3FCD37BA2","predicate":"quarterly_revenue","value":"46,708,000,000 United States dollar","valid_from":"2018-06-30","valid_to":"2018-09-30","published":"2018-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 46,708,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_72C3FCD37BA2, https://asof.is/claim/clm_72C3FCD37BA2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm.","url":"https://asof.is/claim/clm_72C3FCD37BA2","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_549D3855A38B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2018, filed 2018-08-08"}},{"id":"clm_C73A016D6141","predicate":"total_equity","value":"35,607,000,000 United States dollar","valid_from":"2018-06-30","valid_to":"2018-09-30","published":"2018-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 35,607,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_C73A016D6141, https://asof.is/claim/clm_C73A016D6141, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm.","url":"https://asof.is/claim/clm_C73A016D6141","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AECCD433D030","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2018, filed 2018-08-08"}},{"id":"clm_FC2119598378","predicate":"cash_and_equivalents","value":"43,815,000,000 United States dollar","valid_from":"2018-06-30","valid_to":"2018-09-30","published":"2018-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 43,815,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_FC2119598378, https://asof.is/claim/clm_FC2119598378, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm.","url":"https://asof.is/claim/clm_FC2119598378","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_83D2BE6AB848","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2018, filed 2018-08-08"}},{"id":"clm_FFD12039E995","predicate":"total_assets","value":"133,290,000,000 United States dollar","valid_from":"2018-06-30","valid_to":"2018-09-30","published":"2018-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 133,290,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_FFD12039E995, https://asof.is/claim/clm_FFD12039E995, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm.","url":"https://asof.is/claim/clm_FFD12039E995","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E76EC027CB61","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2018, filed 2018-08-08"}},{"id":"clm_DD710DA94C1B","predicate":"shares_outstanding","value":"1,016,646,347 shares","valid_from":"2018-04-25","valid_to":"2018-08-01","published":"2018-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,016,646,347 shares\", as of 2018-04-25 (until 2018-08-01). Claim clm_DD710DA94C1B, https://asof.is/claim/clm_DD710DA94C1B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm.","url":"https://asof.is/claim/clm_DD710DA94C1B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_058AF2856DAF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2018, filed 2018-05-02"}},{"id":"clm_1D3144A96FB6","predicate":"quarterly_revenue","value":"45,693,000,000 United States dollar","valid_from":"2018-03-31","valid_to":"2018-06-30","published":"2018-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 45,693,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_1D3144A96FB6, https://asof.is/claim/clm_1D3144A96FB6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm.","url":"https://asof.is/claim/clm_1D3144A96FB6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_72C3FCD37BA2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2018, filed 2018-05-02"}},{"id":"clm_4713E1DB97C2","predicate":"cash_and_equivalents","value":"42,023,000,000 United States dollar","valid_from":"2018-03-31","valid_to":"2018-06-30","published":"2018-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 42,023,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_4713E1DB97C2, https://asof.is/claim/clm_4713E1DB97C2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm.","url":"https://asof.is/claim/clm_4713E1DB97C2","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FC2119598378","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2018, filed 2018-05-02"}},{"id":"clm_6E360E08CCAF","predicate":"total_equity","value":"38,673,000,000 United States dollar","valid_from":"2018-03-31","valid_to":"2018-06-30","published":"2018-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,673,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_6E360E08CCAF, https://asof.is/claim/clm_6E360E08CCAF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm.","url":"https://asof.is/claim/clm_6E360E08CCAF","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C73A016D6141","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2018, filed 2018-05-02"}},{"id":"clm_730F63401185","predicate":"quarterly_net_income","value":"998,000,000 United States dollar","valid_from":"2018-03-31","valid_to":"2018-06-30","published":"2018-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 998,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_730F63401185, https://asof.is/claim/clm_730F63401185, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm.","url":"https://asof.is/claim/clm_730F63401185","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_058C6BC1F84B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2018, filed 2018-05-02"}},{"id":"clm_BB54199A19FA","predicate":"total_assets","value":"135,139,000,000 United States dollar","valid_from":"2018-03-31","valid_to":"2018-06-30","published":"2018-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 135,139,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_BB54199A19FA, https://asof.is/claim/clm_BB54199A19FA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm.","url":"https://asof.is/claim/clm_BB54199A19FA","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FFD12039E995","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2018, filed 2018-05-02"}},{"id":"clm_D0F2FDACD007","predicate":"quarterly_operating_income","value":"1,946,000,000 United States dollar","valid_from":"2018-03-31","valid_to":"2018-06-30","published":"2018-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,946,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_D0F2FDACD007, https://asof.is/claim/clm_D0F2FDACD007, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm.","url":"https://asof.is/claim/clm_D0F2FDACD007","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_58D66CB8F24B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2018, filed 2018-05-02"}},{"id":"clm_1E2834EB330E","predicate":"shares_outstanding","value":"1,014,532,157 shares","valid_from":"2018-02-09","valid_to":"2018-04-25","published":"2018-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,014,532,157 shares\", as of 2018-02-09 (until 2018-04-25). Claim clm_1E2834EB330E, https://asof.is/claim/clm_1E2834EB330E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm.","url":"https://asof.is/claim/clm_1E2834EB330E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DD710DA94C1B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-02-14T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2017, filed 2018-02-14"}},{"id":"clm_1F4DA1D44D74","predicate":"total_equity","value":"37,678,000,000 United States dollar","valid_from":"2018-01-02","valid_to":"2018-03-31","published":"2018-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,678,000,000 United States dollar\", as of 2018-01-02 (until 2018-03-31). Claim clm_1F4DA1D44D74, https://asof.is/claim/clm_1F4DA1D44D74, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm.","url":"https://asof.is/claim/clm_1F4DA1D44D74","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6E360E08CCAF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-02-14T00:00:00+00:00"},{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2018","published_at":"2018-05-02T00:00:00+00:00"},{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2018","published_at":"2018-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2018, filed 2018-05-02"}},{"id":"clm_2BF12453BC0C","predicate":"net_income","value":"6,622,000,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-12-31","published":"2018-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 6,622,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_2BF12453BC0C, https://asof.is/claim/clm_2BF12453BC0C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm.","url":"https://asof.is/claim/clm_2BF12453BC0C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C4D977ABF281","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-02-14T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2017, filed 2018-02-14"}},{"id":"clm_337B1785477C","predicate":"revenue","value":"184,765,000,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-12-31","published":"2018-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 184,765,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_337B1785477C, https://asof.is/claim/clm_337B1785477C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm.","url":"https://asof.is/claim/clm_337B1785477C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_22FE9A0195E4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-02-14T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2017, filed 2018-02-14"}},{"id":"clm_7C0BEF4EB805","predicate":"cash_and_equivalents","value":"1,696,000,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-03-31","published":"2018-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,696,000,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_7C0BEF4EB805, https://asof.is/claim/clm_7C0BEF4EB805, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm.","url":"https://asof.is/claim/clm_7C0BEF4EB805","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4713E1DB97C2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-02-14T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2017, filed 2018-02-14"}},{"id":"clm_F2843B02C3FE","predicate":"operating_income","value":"9,517,000,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-12-31","published":"2018-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 9,517,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_F2843B02C3FE, https://asof.is/claim/clm_F2843B02C3FE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm.","url":"https://asof.is/claim/clm_F2843B02C3FE","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6E8F85489216","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-02-14T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2017, filed 2018-02-14"}},{"id":"clm_FF9874712D53","predicate":"total_assets","value":"95,131,000,000 United States dollar","valid_from":"2017-12-31","valid_to":"2018-03-31","published":"2018-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 95,131,000,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_FF9874712D53, https://asof.is/claim/clm_FF9874712D53, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm.","url":"https://asof.is/claim/clm_FF9874712D53","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BB54199A19FA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2017","published_at":"2018-02-14T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2017, filed 2018-02-14"}},{"id":"clm_FA130CD0E627","predicate":"shares_outstanding","value":"1,012,992,425 shares","valid_from":"2017-10-31","valid_to":"2018-02-09","published":"2017-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,012,992,425 shares\", as of 2017-10-31 (until 2018-02-09). Claim clm_FA130CD0E627, https://asof.is/claim/clm_FA130CD0E627, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm.","url":"https://asof.is/claim/clm_FA130CD0E627","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1E2834EB330E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2017, filed 2017-11-06"}},{"id":"clm_114D2AD73CB8","predicate":"cash_and_equivalents","value":"2,485,000,000 United States dollar","valid_from":"2017-09-30","valid_to":"2017-12-31","published":"2017-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,485,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_114D2AD73CB8, https://asof.is/claim/clm_114D2AD73CB8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm.","url":"https://asof.is/claim/clm_114D2AD73CB8","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7C0BEF4EB805","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2017, filed 2017-11-06"}},{"id":"clm_2712F40904E2","predicate":"quarterly_operating_income","value":"2,499,000,000 United States dollar","valid_from":"2017-09-30","valid_to":"2018-03-31","published":"2017-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,499,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_2712F40904E2, https://asof.is/claim/clm_2712F40904E2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm.","url":"https://asof.is/claim/clm_2712F40904E2","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D0F2FDACD007","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2017, filed 2017-11-06"}},{"id":"clm_9EAB35DC4545","predicate":"total_equity","value":"34,863,000,000 United States dollar","valid_from":"2017-09-30","valid_to":"2017-12-31","published":"2017-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 34,863,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_9EAB35DC4545, https://asof.is/claim/clm_9EAB35DC4545, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm.","url":"https://asof.is/claim/clm_9EAB35DC4545","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1F4DA1D44D74","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2017, filed 2017-11-06"}},{"id":"clm_ABBE3AA12826","predicate":"quarterly_net_income","value":"1,285,000,000 United States dollar","valid_from":"2017-09-30","valid_to":"2018-03-31","published":"2017-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,285,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_ABBE3AA12826, https://asof.is/claim/clm_ABBE3AA12826, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm.","url":"https://asof.is/claim/clm_ABBE3AA12826","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_730F63401185","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2017, filed 2017-11-06"}},{"id":"clm_D804E8321D94","predicate":"quarterly_revenue","value":"46,181,000,000 United States dollar","valid_from":"2017-09-30","valid_to":"2018-03-31","published":"2017-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 46,181,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_D804E8321D94, https://asof.is/claim/clm_D804E8321D94, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm.","url":"https://asof.is/claim/clm_D804E8321D94","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1D3144A96FB6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2017, filed 2017-11-06"}},{"id":"clm_FDE110F9E79A","predicate":"total_assets","value":"92,853,000,000 United States dollar","valid_from":"2017-09-30","valid_to":"2017-12-31","published":"2017-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 92,853,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_FDE110F9E79A, https://asof.is/claim/clm_FDE110F9E79A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm.","url":"https://asof.is/claim/clm_FDE110F9E79A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FF9874712D53","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2017, filed 2017-11-06"}},{"id":"clm_6F36A94D5FAB","predicate":"shares_outstanding","value":"1,016,564,728 shares","valid_from":"2017-08-01","valid_to":"2017-10-31","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,016,564,728 shares\", as of 2017-08-01 (until 2017-10-31). Claim clm_6F36A94D5FAB, https://asof.is/claim/clm_6F36A94D5FAB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm.","url":"https://asof.is/claim/clm_6F36A94D5FAB","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FA130CD0E627","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2017, filed 2017-08-08"}},{"id":"clm_27175681CD3D","predicate":"total_assets","value":"92,525,000,000 United States dollar","valid_from":"2017-06-30","valid_to":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 92,525,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_27175681CD3D, https://asof.is/claim/clm_27175681CD3D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm.","url":"https://asof.is/claim/clm_27175681CD3D","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FDE110F9E79A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2017, filed 2017-08-08"}},{"id":"clm_3C332F0CC388","predicate":"quarterly_net_income","value":"1,098,000,000 United States dollar","valid_from":"2017-06-30","valid_to":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,098,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_3C332F0CC388, https://asof.is/claim/clm_3C332F0CC388, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm.","url":"https://asof.is/claim/clm_3C332F0CC388","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_ABBE3AA12826","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2017, filed 2017-08-08"}},{"id":"clm_4B8FB47493DE","predicate":"quarterly_revenue","value":"45,685,000,000 United States dollar","valid_from":"2017-06-30","valid_to":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 45,685,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_4B8FB47493DE, https://asof.is/claim/clm_4B8FB47493DE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm.","url":"https://asof.is/claim/clm_4B8FB47493DE","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D804E8321D94","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2017, filed 2017-08-08"}},{"id":"clm_56155AB86BBC","predicate":"total_equity","value":"34,142,000,000 United States dollar","valid_from":"2017-06-30","valid_to":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 34,142,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_56155AB86BBC, https://asof.is/claim/clm_56155AB86BBC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm.","url":"https://asof.is/claim/clm_56155AB86BBC","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9EAB35DC4545","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2017, filed 2017-08-08"}},{"id":"clm_7A1F6114837C","predicate":"cash_and_equivalents","value":"2,094,000,000 United States dollar","valid_from":"2017-06-30","valid_to":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,094,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_7A1F6114837C, https://asof.is/claim/clm_7A1F6114837C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm.","url":"https://asof.is/claim/clm_7A1F6114837C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_114D2AD73CB8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2017, filed 2017-08-08"}},{"id":"clm_B81A1F8A714E","predicate":"quarterly_operating_income","value":"2,117,000,000 United States dollar","valid_from":"2017-06-30","valid_to":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,117,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_B81A1F8A714E, https://asof.is/claim/clm_B81A1F8A714E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm.","url":"https://asof.is/claim/clm_B81A1F8A714E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2712F40904E2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2017, filed 2017-08-08"}},{"id":"clm_D875B36C1505","predicate":"shares_outstanding","value":"1,018,795,398 shares","valid_from":"2017-04-26","valid_to":"2017-08-01","published":"2017-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,018,795,398 shares\", as of 2017-04-26 (until 2017-08-01). Claim clm_D875B36C1505, https://asof.is/claim/clm_D875B36C1505, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm.","url":"https://asof.is/claim/clm_D875B36C1505","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6F36A94D5FAB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2017, filed 2017-05-02"}},{"id":"clm_4C7A30DE9F7F","predicate":"quarterly_revenue","value":"44,514,000,000 United States dollar","valid_from":"2017-03-31","valid_to":"2017-06-30","published":"2017-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 44,514,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_4C7A30DE9F7F, https://asof.is/claim/clm_4C7A30DE9F7F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm.","url":"https://asof.is/claim/clm_4C7A30DE9F7F","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4B8FB47493DE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2017, filed 2017-05-02"}},{"id":"clm_80B6E4640134","predicate":"quarterly_operating_income","value":"1,793,000,000 United States dollar","valid_from":"2017-03-31","valid_to":"2017-06-30","published":"2017-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,793,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_80B6E4640134, https://asof.is/claim/clm_80B6E4640134, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm.","url":"https://asof.is/claim/clm_80B6E4640134","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B81A1F8A714E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2017, filed 2017-05-02"}},{"id":"clm_C73053867711","predicate":"total_equity","value":"33,837,000,000 United States dollar","valid_from":"2017-03-31","valid_to":"2017-06-30","published":"2017-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 33,837,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_C73053867711, https://asof.is/claim/clm_C73053867711, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm.","url":"https://asof.is/claim/clm_C73053867711","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_56155AB86BBC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2017, filed 2017-05-02"}},{"id":"clm_D498959355B1","predicate":"quarterly_net_income","value":"952,000,000 United States dollar","valid_from":"2017-03-31","valid_to":"2017-06-30","published":"2017-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 952,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_D498959355B1, https://asof.is/claim/clm_D498959355B1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm.","url":"https://asof.is/claim/clm_D498959355B1","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3C332F0CC388","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2017, filed 2017-05-02"}},{"id":"clm_E04E3C0945E8","predicate":"total_assets","value":"92,670,000,000 United States dollar","valid_from":"2017-03-31","valid_to":"2017-06-30","published":"2017-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 92,670,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_E04E3C0945E8, https://asof.is/claim/clm_E04E3C0945E8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm.","url":"https://asof.is/claim/clm_E04E3C0945E8","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_27175681CD3D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2017, filed 2017-05-02"}},{"id":"clm_E75875DAC1AE","predicate":"cash_and_equivalents","value":"2,217,000,000 United States dollar","valid_from":"2017-03-31","valid_to":"2017-06-30","published":"2017-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,217,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_E75875DAC1AE, https://asof.is/claim/clm_E75875DAC1AE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm.","url":"https://asof.is/claim/clm_E75875DAC1AE","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7A1F6114837C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2017, filed 2017-05-02"}},{"id":"clm_1C761E542BA5","predicate":"shares_outstanding","value":"1,025,699,605 shares","valid_from":"2017-02-03","valid_to":"2017-04-26","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,025,699,605 shares\", as of 2017-02-03 (until 2017-04-26). Claim clm_1C761E542BA5, https://asof.is/claim/clm_1C761E542BA5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm.","url":"https://asof.is/claim/clm_1C761E542BA5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D875B36C1505","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2016, filed 2017-02-09"}},{"id":"clm_3A0693FD4FE3","predicate":"total_equity","value":"36,830,000,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-03-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 36,830,000,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_3A0693FD4FE3, https://asof.is/claim/clm_3A0693FD4FE3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm.","url":"https://asof.is/claim/clm_3A0693FD4FE3","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C73053867711","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2016, filed 2017-02-09"}},{"id":"clm_4BAFF2CC12C1","predicate":"total_assets","value":"94,462,000,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-03-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 94,462,000,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_4BAFF2CC12C1, https://asof.is/claim/clm_4BAFF2CC12C1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm.","url":"https://asof.is/claim/clm_4BAFF2CC12C1","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E04E3C0945E8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2016, filed 2017-02-09"}},{"id":"clm_99DABE9D980E","predicate":"cash_and_equivalents","value":"3,371,000,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-03-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 3,371,000,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_99DABE9D980E, https://asof.is/claim/clm_99DABE9D980E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm.","url":"https://asof.is/claim/clm_99DABE9D980E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E75875DAC1AE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2016, filed 2017-02-09"}},{"id":"clm_DEBBEE596B86","predicate":"net_income","value":"5,317,000,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-12-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 5,317,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_DEBBEE596B86, https://asof.is/claim/clm_DEBBEE596B86, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm.","url":"https://asof.is/claim/clm_DEBBEE596B86","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2BF12453BC0C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2016, filed 2017-02-09"}},{"id":"clm_F69CB5AB3FCF","predicate":"revenue","value":"177,526,000,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-12-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 177,526,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_F69CB5AB3FCF, https://asof.is/claim/clm_F69CB5AB3FCF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm.","url":"https://asof.is/claim/clm_F69CB5AB3FCF","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_337B1785477C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2016, filed 2017-02-09"}},{"id":"clm_F961C72D4391","predicate":"operating_income","value":"10,338,000,000 United States dollar","valid_from":"2016-12-31","valid_to":"2017-12-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 10,338,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_F961C72D4391, https://asof.is/claim/clm_F961C72D4391, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm.","url":"https://asof.is/claim/clm_F961C72D4391","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F2843B02C3FE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2016, filed 2017-02-09"}},{"id":"clm_B8EEE1E1ADD1","predicate":"shares_outstanding","value":"1,066,439,174 shares","valid_from":"2016-11-01","valid_to":"2017-02-03","published":"2016-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,066,439,174 shares\", as of 2016-11-01 (until 2017-02-03). Claim clm_B8EEE1E1ADD1, https://asof.is/claim/clm_B8EEE1E1ADD1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000097/0000064803-16-000097-index.htm.","url":"https://asof.is/claim/clm_B8EEE1E1ADD1","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1C761E542BA5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000097/0000064803-16-000097-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2016","published_at":"2016-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2016, filed 2016-11-08"}},{"id":"clm_02E131615484","predicate":"quarterly_revenue","value":"44,615,000,000 United States dollar","valid_from":"2016-09-30","valid_to":"2017-03-31","published":"2016-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 44,615,000,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_02E131615484, https://asof.is/claim/clm_02E131615484, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000097/0000064803-16-000097-index.htm.","url":"https://asof.is/claim/clm_02E131615484","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4C7A30DE9F7F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000097/0000064803-16-000097-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2016","published_at":"2016-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2016, filed 2016-11-08"}},{"id":"clm_2A026021B5BE","predicate":"quarterly_operating_income","value":"2,817,000,000 United States dollar","valid_from":"2016-09-30","valid_to":"2017-03-31","published":"2016-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,817,000,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_2A026021B5BE, https://asof.is/claim/clm_2A026021B5BE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000097/0000064803-16-000097-index.htm.","url":"https://asof.is/claim/clm_2A026021B5BE","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_80B6E4640134","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000097/0000064803-16-000097-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2016","published_at":"2016-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2016, filed 2016-11-08"}},{"id":"clm_6825C2E37216","predicate":"total_assets","value":"94,156,000,000 United States dollar","valid_from":"2016-09-30","valid_to":"2016-12-31","published":"2016-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 94,156,000,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_6825C2E37216, https://asof.is/claim/clm_6825C2E37216, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000097/0000064803-16-000097-index.htm.","url":"https://asof.is/claim/clm_6825C2E37216","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4BAFF2CC12C1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000097/0000064803-16-000097-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2016","published_at":"2016-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2016, filed 2016-11-08"}},{"id":"clm_B4D622D9654E","predicate":"quarterly_net_income","value":"1,540,000,000 United States dollar","valid_from":"2016-09-30","valid_to":"2017-03-31","published":"2017-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,540,000,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_B4D622D9654E, https://asof.is/claim/clm_B4D622D9654E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm.","url":"https://asof.is/claim/clm_B4D622D9654E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D498959355B1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2017","published_at":"2017-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2017, filed 2017-11-06"}},{"id":"clm_D02FEEEE3C59","predicate":"cash_and_equivalents","value":"2,189,000,000 United States dollar","valid_from":"2016-09-30","valid_to":"2016-12-31","published":"2016-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,189,000,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_D02FEEEE3C59, https://asof.is/claim/clm_D02FEEEE3C59, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000097/0000064803-16-000097-index.htm.","url":"https://asof.is/claim/clm_D02FEEEE3C59","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_99DABE9D980E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000097/0000064803-16-000097-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2016","published_at":"2016-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2016, filed 2016-11-08"}},{"id":"clm_D0DF0D80A7FD","predicate":"total_equity","value":"35,949,000,000 United States dollar","valid_from":"2016-09-30","valid_to":"2016-12-31","published":"2016-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 35,949,000,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_D0DF0D80A7FD, https://asof.is/claim/clm_D0DF0D80A7FD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000097/0000064803-16-000097-index.htm.","url":"https://asof.is/claim/clm_D0DF0D80A7FD","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3A0693FD4FE3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000097/0000064803-16-000097-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2016","published_at":"2016-11-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2016, filed 2016-11-08"}},{"id":"clm_C3EE1E781CAE","predicate":"shares_outstanding","value":"1,066,214,990 shares","valid_from":"2016-07-26","valid_to":"2016-11-01","published":"2016-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,066,214,990 shares\", as of 2016-07-26 (until 2016-11-01). Claim clm_C3EE1E781CAE, https://asof.is/claim/clm_C3EE1E781CAE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000090/0000064803-16-000090-index.htm.","url":"https://asof.is/claim/clm_C3EE1E781CAE","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B8EEE1E1ADD1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000090/0000064803-16-000090-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2016","published_at":"2016-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2016, filed 2016-08-02"}},{"id":"clm_3D0AD6A590A1","predicate":"quarterly_revenue","value":"43,725,000,000 United States dollar","valid_from":"2016-06-30","valid_to":"2016-09-30","published":"2016-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 43,725,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_3D0AD6A590A1, https://asof.is/claim/clm_3D0AD6A590A1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000090/0000064803-16-000090-index.htm.","url":"https://asof.is/claim/clm_3D0AD6A590A1","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_02E131615484","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000090/0000064803-16-000090-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2016","published_at":"2016-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2016, filed 2016-08-02"}},{"id":"clm_3E557A31E9C6","predicate":"cash_and_equivalents","value":"1,127,000,000 United States dollar","valid_from":"2016-06-30","valid_to":"2016-09-30","published":"2016-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,127,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_3E557A31E9C6, https://asof.is/claim/clm_3E557A31E9C6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000090/0000064803-16-000090-index.htm.","url":"https://asof.is/claim/clm_3E557A31E9C6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D02FEEEE3C59","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000090/0000064803-16-000090-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2016","published_at":"2016-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2016, filed 2016-08-02"}},{"id":"clm_AA5E29CE5F89","predicate":"total_assets","value":"92,748,000,000 United States dollar","valid_from":"2016-06-30","valid_to":"2016-09-30","published":"2016-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 92,748,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_AA5E29CE5F89, https://asof.is/claim/clm_AA5E29CE5F89, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000090/0000064803-16-000090-index.htm.","url":"https://asof.is/claim/clm_AA5E29CE5F89","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6825C2E37216","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000090/0000064803-16-000090-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2016","published_at":"2016-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2016, filed 2016-08-02"}},{"id":"clm_B7CE9B9F1660","predicate":"quarterly_net_income","value":"924,000,000 United States dollar","valid_from":"2016-06-30","valid_to":"2016-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 924,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_B7CE9B9F1660, https://asof.is/claim/clm_B7CE9B9F1660, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm.","url":"https://asof.is/claim/clm_B7CE9B9F1660","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B4D622D9654E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2017","published_at":"2017-08-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2017, filed 2017-08-08"}},{"id":"clm_B99173B142D3","predicate":"quarterly_operating_income","value":"2,350,000,000 United States dollar","valid_from":"2016-06-30","valid_to":"2016-09-30","published":"2016-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,350,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_B99173B142D3, https://asof.is/claim/clm_B99173B142D3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000090/0000064803-16-000090-index.htm.","url":"https://asof.is/claim/clm_B99173B142D3","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2A026021B5BE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000090/0000064803-16-000090-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2016","published_at":"2016-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2016, filed 2016-08-02"}},{"id":"clm_C2F292BA1314","predicate":"total_equity","value":"34,760,000,000 United States dollar","valid_from":"2016-06-30","valid_to":"2016-09-30","published":"2016-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 34,760,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_C2F292BA1314, https://asof.is/claim/clm_C2F292BA1314, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000090/0000064803-16-000090-index.htm.","url":"https://asof.is/claim/clm_C2F292BA1314","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D0DF0D80A7FD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000090/0000064803-16-000090-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2016","published_at":"2016-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2016, filed 2016-08-02"}},{"id":"clm_66AAE216C81B","predicate":"shares_outstanding","value":"1,074,022,092 shares","valid_from":"2016-04-26","valid_to":"2016-07-26","published":"2016-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,074,022,092 shares\", as of 2016-04-26 (until 2016-07-26). Claim clm_66AAE216C81B, https://asof.is/claim/clm_66AAE216C81B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000080/0000064803-16-000080-index.htm.","url":"https://asof.is/claim/clm_66AAE216C81B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C3EE1E781CAE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000080/0000064803-16-000080-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2016, filed 2016-05-03"}},{"id":"clm_16122543838E","predicate":"cash_and_equivalents","value":"1,779,000,000 United States dollar","valid_from":"2016-03-31","valid_to":"2016-06-30","published":"2016-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,779,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_16122543838E, https://asof.is/claim/clm_16122543838E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000080/0000064803-16-000080-index.htm.","url":"https://asof.is/claim/clm_16122543838E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3E557A31E9C6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000080/0000064803-16-000080-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2016, filed 2016-05-03"}},{"id":"clm_17C2574D0891","predicate":"total_equity","value":"36,025,000,000 United States dollar","valid_from":"2016-03-31","valid_to":"2016-06-30","published":"2016-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 36,025,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_17C2574D0891, https://asof.is/claim/clm_17C2574D0891, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000080/0000064803-16-000080-index.htm.","url":"https://asof.is/claim/clm_17C2574D0891","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C2F292BA1314","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000080/0000064803-16-000080-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2016, filed 2016-05-03"}},{"id":"clm_602541C9F06D","predicate":"total_assets","value":"92,634,000,000 United States dollar","valid_from":"2016-03-31","valid_to":"2016-06-30","published":"2016-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 92,634,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_602541C9F06D, https://asof.is/claim/clm_602541C9F06D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000080/0000064803-16-000080-index.htm.","url":"https://asof.is/claim/clm_602541C9F06D","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AA5E29CE5F89","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000080/0000064803-16-000080-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2016, filed 2016-05-03"}},{"id":"clm_9349FB67BD24","predicate":"quarterly_operating_income","value":"2,176,000,000 United States dollar","valid_from":"2016-03-31","valid_to":"2016-06-30","published":"2016-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,176,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_9349FB67BD24, https://asof.is/claim/clm_9349FB67BD24, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000080/0000064803-16-000080-index.htm.","url":"https://asof.is/claim/clm_9349FB67BD24","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B99173B142D3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000080/0000064803-16-000080-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2016, filed 2016-05-03"}},{"id":"clm_ABD4A1B36C8B","predicate":"quarterly_revenue","value":"43,215,000,000 United States dollar","valid_from":"2016-03-31","valid_to":"2016-06-30","published":"2016-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 43,215,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_ABD4A1B36C8B, https://asof.is/claim/clm_ABD4A1B36C8B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000080/0000064803-16-000080-index.htm.","url":"https://asof.is/claim/clm_ABD4A1B36C8B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3D0AD6A590A1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000080/0000064803-16-000080-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2016","published_at":"2016-05-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2016, filed 2016-05-03"}},{"id":"clm_FF72BB722144","predicate":"quarterly_net_income","value":"1,146,000,000 United States dollar","valid_from":"2016-03-31","valid_to":"2016-06-30","published":"2017-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,146,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_FF72BB722144, https://asof.is/claim/clm_FF72BB722144, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm.","url":"https://asof.is/claim/clm_FF72BB722144","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B7CE9B9F1660","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2017, filed 2017-05-02"}},{"id":"clm_2F4D95C14815","predicate":"shares_outstanding","value":"1,098,490,835 shares","valid_from":"2016-02-03","valid_to":"2016-04-26","published":"2016-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,098,490,835 shares\", as of 2016-02-03 (until 2016-04-26). Claim clm_2F4D95C14815, https://asof.is/claim/clm_2F4D95C14815, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/0000064803-16-000074-index.htm.","url":"https://asof.is/claim/clm_2F4D95C14815","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_66AAE216C81B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/0000064803-16-000074-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2015","published_at":"2016-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2015, filed 2016-02-09"}},{"id":"clm_03CCAB6392C9","predicate":"revenue","value":"153,290,000,000 United States dollar","valid_from":"2015-12-31","valid_to":"2016-12-31","published":"2016-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 153,290,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_03CCAB6392C9, https://asof.is/claim/clm_03CCAB6392C9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/0000064803-16-000074-index.htm.","url":"https://asof.is/claim/clm_03CCAB6392C9","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F69CB5AB3FCF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/0000064803-16-000074-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2015","published_at":"2016-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2015, filed 2016-02-09"}},{"id":"clm_43B0623465B5","predicate":"cash_and_equivalents","value":"2,459,000,000 United States dollar","valid_from":"2015-12-31","valid_to":"2016-03-31","published":"2016-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,459,000,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_43B0623465B5, https://asof.is/claim/clm_43B0623465B5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/0000064803-16-000074-index.htm.","url":"https://asof.is/claim/clm_43B0623465B5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_16122543838E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/0000064803-16-000074-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2015","published_at":"2016-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2016-02-09"}},{"id":"clm_46DF20062000","predicate":"net_income","value":"5,237,000,000 United States dollar","valid_from":"2015-12-31","valid_to":"2016-12-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 5,237,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_46DF20062000, https://asof.is/claim/clm_46DF20062000, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm.","url":"https://asof.is/claim/clm_46DF20062000","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DEBBEE596B86","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2016, filed 2017-02-09"}},{"id":"clm_66784B5E7CFF","predicate":"total_assets","value":"93,657,000,000 United States dollar","valid_from":"2015-12-31","valid_to":"2016-03-31","published":"2016-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 93,657,000,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_66784B5E7CFF, https://asof.is/claim/clm_66784B5E7CFF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/0000064803-16-000074-index.htm.","url":"https://asof.is/claim/clm_66784B5E7CFF","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_602541C9F06D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/0000064803-16-000074-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2015","published_at":"2016-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2015, filed 2016-02-09"}},{"id":"clm_B6D623B4D3F5","predicate":"operating_income","value":"9,454,000,000 United States dollar","valid_from":"2015-12-31","valid_to":"2016-12-31","published":"2016-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 9,454,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_B6D623B4D3F5, https://asof.is/claim/clm_B6D623B4D3F5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/0000064803-16-000074-index.htm.","url":"https://asof.is/claim/clm_B6D623B4D3F5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F961C72D4391","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/0000064803-16-000074-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2015","published_at":"2016-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2015, filed 2016-02-09"}},{"id":"clm_BA19696EADC9","predicate":"total_equity","value":"37,196,000,000 United States dollar","valid_from":"2015-12-31","valid_to":"2016-03-31","published":"2016-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,196,000,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_BA19696EADC9, https://asof.is/claim/clm_BA19696EADC9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/0000064803-16-000074-index.htm.","url":"https://asof.is/claim/clm_BA19696EADC9","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_17C2574D0891","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/0000064803-16-000074-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2015","published_at":"2016-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2015, filed 2016-02-09"}},{"id":"clm_ED4EBAE5A1B4","predicate":"shares_outstanding","value":"1,107,317,129 shares","valid_from":"2015-10-23","valid_to":"2016-02-03","published":"2015-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,107,317,129 shares\", as of 2015-10-23 (until 2016-02-03). Claim clm_ED4EBAE5A1B4, https://asof.is/claim/clm_ED4EBAE5A1B4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000064/0000064803-15-000064-index.htm.","url":"https://asof.is/claim/clm_ED4EBAE5A1B4","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2F4D95C14815","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000064/0000064803-15-000064-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2015","published_at":"2015-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2015, filed 2015-10-30"}},{"id":"clm_38F5DE45DF22","predicate":"total_assets","value":"92,362,000,000 United States dollar","valid_from":"2015-09-30","valid_to":"2015-12-31","published":"2015-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 92,362,000,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_38F5DE45DF22, https://asof.is/claim/clm_38F5DE45DF22, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000064/0000064803-15-000064-index.htm.","url":"https://asof.is/claim/clm_38F5DE45DF22","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_66784B5E7CFF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000064/0000064803-15-000064-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2015","published_at":"2015-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2015, filed 2015-10-30"}},{"id":"clm_59D0E0626803","predicate":"cash_and_equivalents","value":"2,890,000,000 United States dollar","valid_from":"2015-09-30","valid_to":"2015-12-31","published":"2015-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,890,000,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_59D0E0626803, https://asof.is/claim/clm_59D0E0626803, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000064/0000064803-15-000064-index.htm.","url":"https://asof.is/claim/clm_59D0E0626803","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_43B0623465B5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000064/0000064803-15-000064-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2015","published_at":"2015-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2015, filed 2015-10-30"}},{"id":"clm_682FA9806BE5","predicate":"quarterly_revenue","value":"38,644,000,000 United States dollar","valid_from":"2015-09-30","valid_to":"2016-03-31","published":"2015-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 38,644,000,000 United States dollar\", as of 2015-09-30 (until 2016-03-31). Claim clm_682FA9806BE5, https://asof.is/claim/clm_682FA9806BE5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000064/0000064803-15-000064-index.htm.","url":"https://asof.is/claim/clm_682FA9806BE5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_ABD4A1B36C8B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000064/0000064803-15-000064-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2015","published_at":"2015-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2015, filed 2015-10-30"}},{"id":"clm_867B5F8B0DCA","predicate":"quarterly_operating_income","value":"2,331,000,000 United States dollar","valid_from":"2015-09-30","valid_to":"2016-03-31","published":"2015-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,331,000,000 United States dollar\", as of 2015-09-30 (until 2016-03-31). Claim clm_867B5F8B0DCA, https://asof.is/claim/clm_867B5F8B0DCA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000064/0000064803-15-000064-index.htm.","url":"https://asof.is/claim/clm_867B5F8B0DCA","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9349FB67BD24","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000064/0000064803-15-000064-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2015","published_at":"2015-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2015, filed 2015-10-30"}},{"id":"clm_F176D32019B1","predicate":"total_equity","value":"37,174,000,000 United States dollar","valid_from":"2015-09-30","valid_to":"2015-12-31","published":"2015-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,174,000,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_F176D32019B1, https://asof.is/claim/clm_F176D32019B1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000064/0000064803-15-000064-index.htm.","url":"https://asof.is/claim/clm_F176D32019B1","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BA19696EADC9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000064/0000064803-15-000064-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2015","published_at":"2015-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2015, filed 2015-10-30"}},{"id":"clm_655CD272AB6F","predicate":"shares_outstanding","value":"1,114,486,195 shares","valid_from":"2015-07-29","valid_to":"2015-10-23","published":"2015-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,114,486,195 shares\", as of 2015-07-29 (until 2015-10-23). Claim clm_655CD272AB6F, https://asof.is/claim/clm_655CD272AB6F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000054/0000064803-15-000054-index.htm.","url":"https://asof.is/claim/clm_655CD272AB6F","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_ED4EBAE5A1B4","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000054/0000064803-15-000054-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2015","published_at":"2015-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2015, filed 2015-08-04"}},{"id":"clm_41B5A8306497","predicate":"total_assets","value":"74,668,000,000 United States dollar","valid_from":"2015-06-30","valid_to":"2015-09-30","published":"2015-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 74,668,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_41B5A8306497, https://asof.is/claim/clm_41B5A8306497, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000054/0000064803-15-000054-index.htm.","url":"https://asof.is/claim/clm_41B5A8306497","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_38F5DE45DF22","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000054/0000064803-15-000054-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2015","published_at":"2015-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2015, filed 2015-08-04"}},{"id":"clm_72BDB4F4A762","predicate":"quarterly_operating_income","value":"2,262,000,000 United States dollar","valid_from":"2015-06-30","valid_to":"2015-09-30","published":"2015-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,262,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_72BDB4F4A762, https://asof.is/claim/clm_72BDB4F4A762, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000054/0000064803-15-000054-index.htm.","url":"https://asof.is/claim/clm_72BDB4F4A762","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_867B5F8B0DCA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000054/0000064803-15-000054-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2015","published_at":"2015-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2015, filed 2015-08-04"}},{"id":"clm_882861D45BCA","predicate":"quarterly_revenue","value":"37,169,000,000 United States dollar","valid_from":"2015-06-30","valid_to":"2015-09-30","published":"2015-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 37,169,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_882861D45BCA, https://asof.is/claim/clm_882861D45BCA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000054/0000064803-15-000054-index.htm.","url":"https://asof.is/claim/clm_882861D45BCA","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_682FA9806BE5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000054/0000064803-15-000054-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2015","published_at":"2015-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2015, filed 2015-08-04"}},{"id":"clm_F480A33F6549","predicate":"total_equity","value":"37,127,000,000 United States dollar","valid_from":"2015-06-30","valid_to":"2015-09-30","published":"2015-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,127,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_F480A33F6549, https://asof.is/claim/clm_F480A33F6549, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000054/0000064803-15-000054-index.htm.","url":"https://asof.is/claim/clm_F480A33F6549","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F176D32019B1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000054/0000064803-15-000054-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2015","published_at":"2015-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2015, filed 2015-08-04"}},{"id":"clm_F690F0DF2351","predicate":"cash_and_equivalents","value":"1,244,000,000 United States dollar","valid_from":"2015-06-30","valid_to":"2015-09-30","published":"2015-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,244,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_F690F0DF2351, https://asof.is/claim/clm_F690F0DF2351, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000054/0000064803-15-000054-index.htm.","url":"https://asof.is/claim/clm_F690F0DF2351","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_59D0E0626803","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000054/0000064803-15-000054-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2015","published_at":"2015-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2015, filed 2015-08-04"}},{"id":"clm_CBE2C70BF913","predicate":"shares_outstanding","value":"1,128,330,774 shares","valid_from":"2015-04-24","valid_to":"2015-07-29","published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,128,330,774 shares\", as of 2015-04-24 (until 2015-07-29). Claim clm_CBE2C70BF913, https://asof.is/claim/clm_CBE2C70BF913, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000023/0000064803-15-000023-index.htm.","url":"https://asof.is/claim/clm_CBE2C70BF913","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_655CD272AB6F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000023/0000064803-15-000023-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2015, filed 2015-05-01"}},{"id":"clm_31E0013CF10B","predicate":"cash_and_equivalents","value":"1,518,000,000 United States dollar","valid_from":"2015-03-31","valid_to":"2015-06-30","published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,518,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_31E0013CF10B, https://asof.is/claim/clm_31E0013CF10B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000023/0000064803-15-000023-index.htm.","url":"https://asof.is/claim/clm_31E0013CF10B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F690F0DF2351","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000023/0000064803-15-000023-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2015, filed 2015-05-01"}},{"id":"clm_34A4A5D49F1E","predicate":"total_assets","value":"73,930,000,000 United States dollar","valid_from":"2015-03-31","valid_to":"2015-06-30","published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 73,930,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_34A4A5D49F1E, https://asof.is/claim/clm_34A4A5D49F1E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000023/0000064803-15-000023-index.htm.","url":"https://asof.is/claim/clm_34A4A5D49F1E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_41B5A8306497","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000023/0000064803-15-000023-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2015, filed 2015-05-01"}},{"id":"clm_416656D8A201","predicate":"quarterly_revenue","value":"36,332,000,000 United States dollar","valid_from":"2015-03-31","valid_to":"2015-06-30","published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 36,332,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_416656D8A201, https://asof.is/claim/clm_416656D8A201, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000023/0000064803-15-000023-index.htm.","url":"https://asof.is/claim/clm_416656D8A201","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_882861D45BCA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000023/0000064803-15-000023-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2015, filed 2015-05-01"}},{"id":"clm_9A112D08AF33","predicate":"quarterly_operating_income","value":"2,132,000,000 United States dollar","valid_from":"2015-03-31","valid_to":"2015-06-30","published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,132,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_9A112D08AF33, https://asof.is/claim/clm_9A112D08AF33, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000023/0000064803-15-000023-index.htm.","url":"https://asof.is/claim/clm_9A112D08AF33","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_72BDB4F4A762","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000023/0000064803-15-000023-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2015, filed 2015-05-01"}},{"id":"clm_D82459EE0CCC","predicate":"total_equity","value":"36,990,000,000 United States dollar","valid_from":"2015-03-31","valid_to":"2015-06-30","published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 36,990,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_D82459EE0CCC, https://asof.is/claim/clm_D82459EE0CCC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000023/0000064803-15-000023-index.htm.","url":"https://asof.is/claim/clm_D82459EE0CCC","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F480A33F6549","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000023/0000064803-15-000023-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2015, filed 2015-05-01"}},{"id":"clm_5FD8C22A2318","predicate":"shares_outstanding","value":"1,125,252,739 shares","valid_from":"2015-02-03","valid_to":"2015-04-24","published":"2015-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,125,252,739 shares\", as of 2015-02-03 (until 2015-04-24). Claim clm_5FD8C22A2318, https://asof.is/claim/clm_5FD8C22A2318, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm.","url":"https://asof.is/claim/clm_5FD8C22A2318","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CBE2C70BF913","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2014, filed 2015-02-10"}},{"id":"clm_2E115262B388","predicate":"cash_and_equivalents","value":"2,481,000,000 United States dollar","valid_from":"2014-12-31","valid_to":"2015-03-31","published":"2015-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,481,000,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_2E115262B388, https://asof.is/claim/clm_2E115262B388, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm.","url":"https://asof.is/claim/clm_2E115262B388","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_31E0013CF10B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2014, filed 2015-02-10"}},{"id":"clm_32FD104D9928","predicate":"total_assets","value":"74,252,000,000 United States dollar","valid_from":"2014-12-31","valid_to":"2015-03-31","published":"2015-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 74,252,000,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_32FD104D9928, https://asof.is/claim/clm_32FD104D9928, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm.","url":"https://asof.is/claim/clm_32FD104D9928","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_34A4A5D49F1E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2014, filed 2015-02-10"}},{"id":"clm_53BDA260419A","predicate":"net_income","value":"4,644,000,000 United States dollar","valid_from":"2014-12-31","valid_to":"2015-12-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 4,644,000,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_53BDA260419A, https://asof.is/claim/clm_53BDA260419A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm.","url":"https://asof.is/claim/clm_53BDA260419A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_46DF20062000","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2016","published_at":"2017-02-09T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2016, filed 2017-02-09"}},{"id":"clm_A051D3585779","predicate":"total_equity","value":"37,958,000,000 United States dollar","valid_from":"2014-12-31","valid_to":"2015-03-31","published":"2015-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,958,000,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_A051D3585779, https://asof.is/claim/clm_A051D3585779, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm.","url":"https://asof.is/claim/clm_A051D3585779","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D82459EE0CCC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2014, filed 2015-02-10"}},{"id":"clm_C0286CE451B9","predicate":"revenue","value":"139,367,000,000 United States dollar","valid_from":"2014-12-31","valid_to":"2015-12-31","published":"2015-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 139,367,000,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_C0286CE451B9, https://asof.is/claim/clm_C0286CE451B9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm.","url":"https://asof.is/claim/clm_C0286CE451B9","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_03CCAB6392C9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2014, filed 2015-02-10"}},{"id":"clm_F1BC9A217A25","predicate":"operating_income","value":"8,799,000,000 United States dollar","valid_from":"2014-12-31","valid_to":"2015-12-31","published":"2015-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 8,799,000,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_F1BC9A217A25, https://asof.is/claim/clm_F1BC9A217A25, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm.","url":"https://asof.is/claim/clm_F1BC9A217A25","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B6D623B4D3F5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2014, filed 2015-02-10"}},{"id":"clm_3496C463804C","predicate":"shares_outstanding","value":"1,146,383,477 shares","valid_from":"2014-10-30","valid_to":"2015-02-03","published":"2014-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,146,383,477 shares\", as of 2014-10-30 (until 2015-02-03). Claim clm_3496C463804C, https://asof.is/claim/clm_3496C463804C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000036/0000064803-14-000036-index.htm.","url":"https://asof.is/claim/clm_3496C463804C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5FD8C22A2318","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000036/0000064803-14-000036-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2014","published_at":"2014-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2014, filed 2014-11-04"}},{"id":"clm_11F9194CADD7","predicate":"quarterly_operating_income","value":"2,246,000,000 United States dollar","valid_from":"2014-09-30","valid_to":"2015-03-31","published":"2014-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,246,000,000 United States dollar\", as of 2014-09-30 (until 2015-03-31). Claim clm_11F9194CADD7, https://asof.is/claim/clm_11F9194CADD7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000036/0000064803-14-000036-index.htm.","url":"https://asof.is/claim/clm_11F9194CADD7","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9A112D08AF33","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000036/0000064803-14-000036-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2014","published_at":"2014-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2014, filed 2014-11-04"}},{"id":"clm_190894DBFFF5","predicate":"cash_and_equivalents","value":"1,132,000,000 United States dollar","valid_from":"2014-09-30","valid_to":"2014-12-31","published":"2014-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,132,000,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_190894DBFFF5, https://asof.is/claim/clm_190894DBFFF5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000036/0000064803-14-000036-index.htm.","url":"https://asof.is/claim/clm_190894DBFFF5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2E115262B388","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000036/0000064803-14-000036-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2014","published_at":"2014-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2014, filed 2014-11-04"}},{"id":"clm_8A4D15A9F73A","predicate":"total_assets","value":"73,576,000,000 United States dollar","valid_from":"2014-09-30","valid_to":"2014-12-31","published":"2014-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 73,576,000,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_8A4D15A9F73A, https://asof.is/claim/clm_8A4D15A9F73A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000036/0000064803-14-000036-index.htm.","url":"https://asof.is/claim/clm_8A4D15A9F73A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_32FD104D9928","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000036/0000064803-14-000036-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2014","published_at":"2014-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2014, filed 2014-11-04"}},{"id":"clm_A7E7408BACF8","predicate":"total_equity","value":"38,104,000,000 United States dollar","valid_from":"2014-09-30","valid_to":"2014-12-31","published":"2014-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,104,000,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_A7E7408BACF8, https://asof.is/claim/clm_A7E7408BACF8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000036/0000064803-14-000036-index.htm.","url":"https://asof.is/claim/clm_A7E7408BACF8","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A051D3585779","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000036/0000064803-14-000036-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2014","published_at":"2014-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2014, filed 2014-11-04"}},{"id":"clm_C80E36F25265","predicate":"quarterly_revenue","value":"35,021,000,000 United States dollar","valid_from":"2014-09-30","valid_to":"2015-03-31","published":"2014-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 35,021,000,000 United States dollar\", as of 2014-09-30 (until 2015-03-31). Claim clm_C80E36F25265, https://asof.is/claim/clm_C80E36F25265, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000036/0000064803-14-000036-index.htm.","url":"https://asof.is/claim/clm_C80E36F25265","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_416656D8A201","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000036/0000064803-14-000036-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2014","published_at":"2014-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2014, filed 2014-11-04"}},{"id":"clm_7541D7D93CC7","predicate":"registrant_name","value":"CVS HEALTH Corp","valid_from":"2014-09-03","valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health registrant name: CVS HEALTH Corp\", as of 2014-09-03. Claim clm_7541D7D93CC7, https://asof.is/claim/clm_7541D7D93CC7, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_7541D7D93CC7","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_FFA148FB5240","predicate":"shares_outstanding","value":"1,158,126,112 shares","valid_from":"2014-07-31","valid_to":"2014-10-30","published":"2014-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,158,126,112 shares\", as of 2014-07-31 (until 2014-10-30). Claim clm_FFA148FB5240, https://asof.is/claim/clm_FFA148FB5240, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000028/0000064803-14-000028-index.htm.","url":"https://asof.is/claim/clm_FFA148FB5240","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3496C463804C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000028/0000064803-14-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2014, filed 2014-08-05"}},{"id":"clm_0062EA9B2DC3","predicate":"cash_and_equivalents","value":"1,612,000,000 United States dollar","valid_from":"2014-06-30","valid_to":"2014-09-30","published":"2014-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,612,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_0062EA9B2DC3, https://asof.is/claim/clm_0062EA9B2DC3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000028/0000064803-14-000028-index.htm.","url":"https://asof.is/claim/clm_0062EA9B2DC3","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_190894DBFFF5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000028/0000064803-14-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2014, filed 2014-08-05"}},{"id":"clm_CAD2F10183B6","predicate":"total_assets","value":"72,593,000,000 United States dollar","valid_from":"2014-06-30","valid_to":"2014-09-30","published":"2014-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 72,593,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_CAD2F10183B6, https://asof.is/claim/clm_CAD2F10183B6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000028/0000064803-14-000028-index.htm.","url":"https://asof.is/claim/clm_CAD2F10183B6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8A4D15A9F73A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000028/0000064803-14-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2014, filed 2014-08-05"}},{"id":"clm_D81C8E807F5A","predicate":"total_equity","value":"38,130,000,000 United States dollar","valid_from":"2014-06-30","valid_to":"2014-09-30","published":"2014-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,130,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_D81C8E807F5A, https://asof.is/claim/clm_D81C8E807F5A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000028/0000064803-14-000028-index.htm.","url":"https://asof.is/claim/clm_D81C8E807F5A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A7E7408BACF8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000028/0000064803-14-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2014, filed 2014-08-05"}},{"id":"clm_DBBBA3F38780","predicate":"quarterly_operating_income","value":"2,208,000,000 United States dollar","valid_from":"2014-06-30","valid_to":"2014-09-30","published":"2014-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,208,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_DBBBA3F38780, https://asof.is/claim/clm_DBBBA3F38780, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000028/0000064803-14-000028-index.htm.","url":"https://asof.is/claim/clm_DBBBA3F38780","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_11F9194CADD7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000028/0000064803-14-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2014, filed 2014-08-05"}},{"id":"clm_F0E8759CEF9A","predicate":"quarterly_revenue","value":"34,602,000,000 United States dollar","valid_from":"2014-06-30","valid_to":"2014-09-30","published":"2014-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 34,602,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_F0E8759CEF9A, https://asof.is/claim/clm_F0E8759CEF9A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000028/0000064803-14-000028-index.htm.","url":"https://asof.is/claim/clm_F0E8759CEF9A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C80E36F25265","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000028/0000064803-14-000028-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2014","published_at":"2014-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2014, filed 2014-08-05"}},{"id":"clm_DB8265FBEAE6","predicate":"shares_outstanding","value":"1,169,230,063 shares","valid_from":"2014-04-25","valid_to":"2014-07-31","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,169,230,063 shares\", as of 2014-04-25 (until 2014-07-31). Claim clm_DB8265FBEAE6, https://asof.is/claim/clm_DB8265FBEAE6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000017/0000064803-14-000017-index.htm.","url":"https://asof.is/claim/clm_DB8265FBEAE6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FFA148FB5240","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000017/0000064803-14-000017-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2014","published_at":"2014-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2014, filed 2014-05-02"}},{"id":"clm_6A78D8933ECE","predicate":"total_equity","value":"38,210,000,000 United States dollar","valid_from":"2014-03-31","valid_to":"2014-06-30","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,210,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_6A78D8933ECE, https://asof.is/claim/clm_6A78D8933ECE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000017/0000064803-14-000017-index.htm.","url":"https://asof.is/claim/clm_6A78D8933ECE","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D81C8E807F5A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000017/0000064803-14-000017-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2014","published_at":"2014-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2014, filed 2014-05-02"}},{"id":"clm_802C2AB083A6","predicate":"quarterly_operating_income","value":"2,024,000,000 United States dollar","valid_from":"2014-03-31","valid_to":"2014-06-30","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,024,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_802C2AB083A6, https://asof.is/claim/clm_802C2AB083A6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000017/0000064803-14-000017-index.htm.","url":"https://asof.is/claim/clm_802C2AB083A6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DBBBA3F38780","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000017/0000064803-14-000017-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2014","published_at":"2014-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2014, filed 2014-05-02"}},{"id":"clm_9BDF5324740F","predicate":"total_assets","value":"72,822,000,000 United States dollar","valid_from":"2014-03-31","valid_to":"2014-06-30","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 72,822,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_9BDF5324740F, https://asof.is/claim/clm_9BDF5324740F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000017/0000064803-14-000017-index.htm.","url":"https://asof.is/claim/clm_9BDF5324740F","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CAD2F10183B6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000017/0000064803-14-000017-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2014","published_at":"2014-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2014, filed 2014-05-02"}},{"id":"clm_AE7A26C762D8","predicate":"quarterly_revenue","value":"32,689,000,000 United States dollar","valid_from":"2014-03-31","valid_to":"2014-06-30","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 32,689,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_AE7A26C762D8, https://asof.is/claim/clm_AE7A26C762D8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000017/0000064803-14-000017-index.htm.","url":"https://asof.is/claim/clm_AE7A26C762D8","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F0E8759CEF9A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000017/0000064803-14-000017-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2014","published_at":"2014-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2014, filed 2014-05-02"}},{"id":"clm_F4062F44C518","predicate":"cash_and_equivalents","value":"2,766,000,000 United States dollar","valid_from":"2014-03-31","valid_to":"2014-06-30","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,766,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_F4062F44C518, https://asof.is/claim/clm_F4062F44C518, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000017/0000064803-14-000017-index.htm.","url":"https://asof.is/claim/clm_F4062F44C518","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0062EA9B2DC3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000017/0000064803-14-000017-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2014","published_at":"2014-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2014, filed 2014-05-02"}},{"id":"clm_30A6AA4AA343","predicate":"shares_outstanding","value":"1,182,427,156 shares","valid_from":"2014-02-04","valid_to":"2014-04-25","published":"2014-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,182,427,156 shares\", as of 2014-02-04 (until 2014-04-25). Claim clm_30A6AA4AA343, https://asof.is/claim/clm_30A6AA4AA343, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000008/0000064803-14-000008-index.htm.","url":"https://asof.is/claim/clm_30A6AA4AA343","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DB8265FBEAE6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000008/0000064803-14-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2013","published_at":"2014-02-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2013, filed 2014-02-11"}},{"id":"clm_03CB99F7AA8C","predicate":"operating_income","value":"8,037,000,000 United States dollar","valid_from":"2013-12-31","valid_to":"2014-12-31","published":"2014-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 8,037,000,000 United States dollar\", as of 2013-12-31 (until 2014-12-31). Claim clm_03CB99F7AA8C, https://asof.is/claim/clm_03CB99F7AA8C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000008/0000064803-14-000008-index.htm.","url":"https://asof.is/claim/clm_03CB99F7AA8C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F1BC9A217A25","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000008/0000064803-14-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2013","published_at":"2014-02-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2013, filed 2014-02-11"}},{"id":"clm_72B099E22975","predicate":"revenue","value":"126,761,000,000 United States dollar","valid_from":"2013-12-31","valid_to":"2014-12-31","published":"2014-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 126,761,000,000 United States dollar\", as of 2013-12-31 (until 2014-12-31). Claim clm_72B099E22975, https://asof.is/claim/clm_72B099E22975, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000008/0000064803-14-000008-index.htm.","url":"https://asof.is/claim/clm_72B099E22975","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C0286CE451B9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000008/0000064803-14-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2013","published_at":"2014-02-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2013, filed 2014-02-11"}},{"id":"clm_D8AC3E324205","predicate":"total_equity","value":"37,938,000,000 United States dollar","valid_from":"2013-12-31","valid_to":"2014-03-31","published":"2015-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,938,000,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_D8AC3E324205, https://asof.is/claim/clm_D8AC3E324205, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm.","url":"https://asof.is/claim/clm_D8AC3E324205","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6A78D8933ECE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2014, filed 2015-02-10"}},{"id":"clm_F32A1FE1563D","predicate":"total_assets","value":"71,526,000,000 United States dollar","valid_from":"2013-12-31","valid_to":"2014-03-31","published":"2014-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 71,526,000,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_F32A1FE1563D, https://asof.is/claim/clm_F32A1FE1563D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000008/0000064803-14-000008-index.htm.","url":"https://asof.is/claim/clm_F32A1FE1563D","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9BDF5324740F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000008/0000064803-14-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2013","published_at":"2014-02-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2013, filed 2014-02-11"}},{"id":"clm_FD0625E7D168","predicate":"cash_and_equivalents","value":"4,089,000,000 United States dollar","valid_from":"2013-12-31","valid_to":"2014-03-31","published":"2014-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 4,089,000,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_FD0625E7D168, https://asof.is/claim/clm_FD0625E7D168, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000008/0000064803-14-000008-index.htm.","url":"https://asof.is/claim/clm_FD0625E7D168","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F4062F44C518","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480314000008/0000064803-14-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2013","published_at":"2014-02-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2013, filed 2014-02-11"}},{"id":"clm_F97AE65695D6","predicate":"shares_outstanding","value":"1,190,254,167 shares","valid_from":"2013-10-31","valid_to":"2014-02-04","published":"2013-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,190,254,167 shares\", as of 2013-10-31 (until 2014-02-04). Claim clm_F97AE65695D6, https://asof.is/claim/clm_F97AE65695D6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000027/0000064803-13-000027-index.htm.","url":"https://asof.is/claim/clm_F97AE65695D6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_30A6AA4AA343","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480313000027/0000064803-13-000027-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2013","published_at":"2013-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2013, filed 2013-11-05"}},{"id":"clm_16C833BA5250","predicate":"total_equity","value":"38,534,000,000 United States dollar","valid_from":"2013-09-30","valid_to":"2013-12-31","published":"2013-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,534,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_16C833BA5250, https://asof.is/claim/clm_16C833BA5250, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000027/0000064803-13-000027-index.htm.","url":"https://asof.is/claim/clm_16C833BA5250","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D8AC3E324205","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480313000027/0000064803-13-000027-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2013","published_at":"2013-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2013, filed 2013-11-05"}},{"id":"clm_3478C3700B59","predicate":"quarterly_operating_income","value":"2,161,000,000 United States dollar","valid_from":"2013-09-30","valid_to":"2014-03-31","published":"2013-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,161,000,000 United States dollar\", as of 2013-09-30 (until 2014-03-31). Claim clm_3478C3700B59, https://asof.is/claim/clm_3478C3700B59, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000027/0000064803-13-000027-index.htm.","url":"https://asof.is/claim/clm_3478C3700B59","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_802C2AB083A6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480313000027/0000064803-13-000027-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2013","published_at":"2013-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2013, filed 2013-11-05"}},{"id":"clm_871B13BFED4C","predicate":"total_assets","value":"67,805,000,000 United States dollar","valid_from":"2013-09-30","valid_to":"2013-12-31","published":"2013-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 67,805,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_871B13BFED4C, https://asof.is/claim/clm_871B13BFED4C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000027/0000064803-13-000027-index.htm.","url":"https://asof.is/claim/clm_871B13BFED4C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F32A1FE1563D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480313000027/0000064803-13-000027-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2013","published_at":"2013-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2013, filed 2013-11-05"}},{"id":"clm_8D6C15778B8C","predicate":"quarterly_revenue","value":"31,968,000,000 United States dollar","valid_from":"2013-09-30","valid_to":"2014-03-31","published":"2013-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 31,968,000,000 United States dollar\", as of 2013-09-30 (until 2014-03-31). Claim clm_8D6C15778B8C, https://asof.is/claim/clm_8D6C15778B8C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000027/0000064803-13-000027-index.htm.","url":"https://asof.is/claim/clm_8D6C15778B8C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AE7A26C762D8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480313000027/0000064803-13-000027-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2013","published_at":"2013-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2013, filed 2013-11-05"}},{"id":"clm_AF6B771B42C0","predicate":"cash_and_equivalents","value":"1,505,000,000 United States dollar","valid_from":"2013-09-30","valid_to":"2013-12-31","published":"2013-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,505,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_AF6B771B42C0, https://asof.is/claim/clm_AF6B771B42C0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000027/0000064803-13-000027-index.htm.","url":"https://asof.is/claim/clm_AF6B771B42C0","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FD0625E7D168","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480313000027/0000064803-13-000027-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2013","published_at":"2013-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2013, filed 2013-11-05"}},{"id":"clm_D07C5B5A5157","predicate":"shares_outstanding","value":"1,228,369,418 shares","valid_from":"2013-07-31","valid_to":"2013-10-31","published":"2013-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,228,369,418 shares\", as of 2013-07-31 (until 2013-10-31). Claim clm_D07C5B5A5157, https://asof.is/claim/clm_D07C5B5A5157, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000021/0000064803-13-000021-index.htm.","url":"https://asof.is/claim/clm_D07C5B5A5157","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F97AE65695D6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480313000021/0000064803-13-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2013","published_at":"2013-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2013, filed 2013-08-06"}},{"id":"clm_0BB1DBB449DC","predicate":"total_equity","value":"38,906,000,000 United States dollar","valid_from":"2013-06-30","valid_to":"2013-09-30","published":"2013-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,906,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_0BB1DBB449DC, https://asof.is/claim/clm_0BB1DBB449DC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000021/0000064803-13-000021-index.htm.","url":"https://asof.is/claim/clm_0BB1DBB449DC","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_16C833BA5250","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480313000021/0000064803-13-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2013","published_at":"2013-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2013, filed 2013-08-06"}},{"id":"clm_38858C3F0F85","predicate":"quarterly_operating_income","value":"1,968,000,000 United States dollar","valid_from":"2013-06-30","valid_to":"2013-09-30","published":"2013-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,968,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_38858C3F0F85, https://asof.is/claim/clm_38858C3F0F85, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000021/0000064803-13-000021-index.htm.","url":"https://asof.is/claim/clm_38858C3F0F85","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3478C3700B59","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480313000021/0000064803-13-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2013","published_at":"2013-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2013, filed 2013-08-06"}},{"id":"clm_48E32B2EF1B8","predicate":"total_assets","value":"66,284,000,000 United States dollar","valid_from":"2013-06-30","valid_to":"2013-09-30","published":"2013-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 66,284,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_48E32B2EF1B8, https://asof.is/claim/clm_48E32B2EF1B8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000021/0000064803-13-000021-index.htm.","url":"https://asof.is/claim/clm_48E32B2EF1B8","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_871B13BFED4C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480313000021/0000064803-13-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2013","published_at":"2013-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2013, filed 2013-08-06"}},{"id":"clm_A362E79433B6","predicate":"cash_and_equivalents","value":"1,174,000,000 United States dollar","valid_from":"2013-06-30","valid_to":"2013-09-30","published":"2013-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,174,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_A362E79433B6, https://asof.is/claim/clm_A362E79433B6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000021/0000064803-13-000021-index.htm.","url":"https://asof.is/claim/clm_A362E79433B6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AF6B771B42C0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480313000021/0000064803-13-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2013","published_at":"2013-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2013, filed 2013-08-06"}},{"id":"clm_EB8C67D51319","predicate":"quarterly_revenue","value":"31,248,000,000 United States dollar","valid_from":"2013-06-30","valid_to":"2013-09-30","published":"2013-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 31,248,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_EB8C67D51319, https://asof.is/claim/clm_EB8C67D51319, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000021/0000064803-13-000021-index.htm.","url":"https://asof.is/claim/clm_EB8C67D51319","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8D6C15778B8C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480313000021/0000064803-13-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2013","published_at":"2013-08-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2013, filed 2013-08-06"}},{"id":"clm_769901855ECE","predicate":"shares_outstanding","value":"1,224,392,685 shares","valid_from":"2013-04-24","valid_to":"2013-07-31","published":"2013-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,224,392,685 shares\", as of 2013-04-24 (until 2013-07-31). Claim clm_769901855ECE, https://asof.is/claim/clm_769901855ECE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000005/0000064803-13-000005-index.htm.","url":"https://asof.is/claim/clm_769901855ECE","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D07C5B5A5157","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480313000005/0000064803-13-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2013, filed 2013-05-01"}},{"id":"clm_400B14564B79","predicate":"total_assets","value":"66,068,000,000 United States dollar","valid_from":"2013-03-31","valid_to":"2013-06-30","published":"2013-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 66,068,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_400B14564B79, https://asof.is/claim/clm_400B14564B79, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000005/0000064803-13-000005-index.htm.","url":"https://asof.is/claim/clm_400B14564B79","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_48E32B2EF1B8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480313000005/0000064803-13-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2013, filed 2013-05-01"}},{"id":"clm_49C50072AC52","predicate":"total_equity","value":"38,209,000,000 United States dollar","valid_from":"2013-03-31","valid_to":"2013-06-30","published":"2013-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,209,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_49C50072AC52, https://asof.is/claim/clm_49C50072AC52, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000005/0000064803-13-000005-index.htm.","url":"https://asof.is/claim/clm_49C50072AC52","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0BB1DBB449DC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480313000005/0000064803-13-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2013, filed 2013-05-01"}},{"id":"clm_524DA83F9EF1","predicate":"quarterly_revenue","value":"30,763,000,000 United States dollar","valid_from":"2013-03-31","valid_to":"2013-06-30","published":"2013-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 30,763,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_524DA83F9EF1, https://asof.is/claim/clm_524DA83F9EF1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000005/0000064803-13-000005-index.htm.","url":"https://asof.is/claim/clm_524DA83F9EF1","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EB8C67D51319","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480313000005/0000064803-13-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2013, filed 2013-05-01"}},{"id":"clm_A1759AC00B39","predicate":"quarterly_operating_income","value":"1,699,000,000 United States dollar","valid_from":"2013-03-31","valid_to":"2013-06-30","published":"2013-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,699,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_A1759AC00B39, https://asof.is/claim/clm_A1759AC00B39, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000005/0000064803-13-000005-index.htm.","url":"https://asof.is/claim/clm_A1759AC00B39","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_38858C3F0F85","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480313000005/0000064803-13-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2013, filed 2013-05-01"}},{"id":"clm_EAE1D2F45317","predicate":"cash_and_equivalents","value":"1,551,000,000 United States dollar","valid_from":"2013-03-31","valid_to":"2013-06-30","published":"2013-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,551,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_EAE1D2F45317, https://asof.is/claim/clm_EAE1D2F45317, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000005/0000064803-13-000005-index.htm.","url":"https://asof.is/claim/clm_EAE1D2F45317","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A362E79433B6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480313000005/0000064803-13-000005-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2013, filed 2013-05-01"}},{"id":"clm_50863D8B9695","predicate":"shares_outstanding","value":"1,231,194,296 shares","valid_from":"2013-02-08","valid_to":"2013-04-24","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,231,194,296 shares\", as of 2013-02-08 (until 2013-04-24). Claim clm_50863D8B9695, https://asof.is/claim/clm_50863D8B9695, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465913011354/0001104659-13-011354-index.htm.","url":"https://asof.is/claim/clm_50863D8B9695","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_769901855ECE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465913011354/0001104659-13-011354-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2012","published_at":"2013-02-15T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2012, filed 2013-02-15"}},{"id":"clm_0515A780FBF9","predicate":"operating_income","value":"7,228,000,000 United States dollar","valid_from":"2012-12-31","valid_to":"2013-12-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 7,228,000,000 United States dollar\", as of 2012-12-31 (until 2013-12-31). Claim clm_0515A780FBF9, https://asof.is/claim/clm_0515A780FBF9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465913011354/0001104659-13-011354-index.htm.","url":"https://asof.is/claim/clm_0515A780FBF9","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_03CB99F7AA8C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465913011354/0001104659-13-011354-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2012","published_at":"2013-02-15T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2012, filed 2013-02-15"}},{"id":"clm_48533819A894","predicate":"cash_and_equivalents","value":"1,375,000,000 United States dollar","valid_from":"2012-12-31","valid_to":"2013-03-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,375,000,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_48533819A894, https://asof.is/claim/clm_48533819A894, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465913011354/0001104659-13-011354-index.htm.","url":"https://asof.is/claim/clm_48533819A894","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EAE1D2F45317","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465913011354/0001104659-13-011354-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2012","published_at":"2013-02-15T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2012, filed 2013-02-15"}},{"id":"clm_77DA6E00509F","predicate":"total_equity","value":"37,653,000,000 United States dollar","valid_from":"2012-12-31","valid_to":"2013-03-31","published":"2015-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,653,000,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_77DA6E00509F, https://asof.is/claim/clm_77DA6E00509F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm.","url":"https://asof.is/claim/clm_77DA6E00509F","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_49C50072AC52","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-10T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2014, filed 2015-02-10"}},{"id":"clm_77F2D7209D00","predicate":"revenue","value":"123,133,000,000 United States dollar","valid_from":"2012-12-31","valid_to":"2013-12-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 123,133,000,000 United States dollar\", as of 2012-12-31 (until 2013-12-31). Claim clm_77F2D7209D00, https://asof.is/claim/clm_77F2D7209D00, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465913011354/0001104659-13-011354-index.htm.","url":"https://asof.is/claim/clm_77F2D7209D00","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_72B099E22975","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465913011354/0001104659-13-011354-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2012","published_at":"2013-02-15T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2012, filed 2013-02-15"}},{"id":"clm_8011084849F0","predicate":"total_assets","value":"65,912,000,000 United States dollar","valid_from":"2012-12-31","valid_to":"2013-03-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 65,912,000,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_8011084849F0, https://asof.is/claim/clm_8011084849F0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465913011354/0001104659-13-011354-index.htm.","url":"https://asof.is/claim/clm_8011084849F0","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_400B14564B79","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465913011354/0001104659-13-011354-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2012","published_at":"2013-02-15T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2012, filed 2013-02-15"}},{"id":"clm_CB68D0893CFC","predicate":"shares_outstanding","value":"1,246,692,587 shares","valid_from":"2012-10-31","valid_to":"2013-02-08","published":"2012-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,246,692,587 shares\", as of 2012-10-31 (until 2013-02-08). Claim clm_CB68D0893CFC, https://asof.is/claim/clm_CB68D0893CFC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912074770/0001104659-12-074770-index.htm.","url":"https://asof.is/claim/clm_CB68D0893CFC","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_50863D8B9695","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912074770/0001104659-12-074770-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2012","published_at":"2012-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2012, filed 2012-11-06"}},{"id":"clm_04B029B40CE3","predicate":"quarterly_revenue","value":"30,227,000,000 United States dollar","valid_from":"2012-09-30","valid_to":"2013-03-31","published":"2012-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 30,227,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_04B029B40CE3, https://asof.is/claim/clm_04B029B40CE3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912074770/0001104659-12-074770-index.htm.","url":"https://asof.is/claim/clm_04B029B40CE3","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_524DA83F9EF1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912074770/0001104659-12-074770-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2012","published_at":"2012-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2012, filed 2012-11-06"}},{"id":"clm_24910244F13D","predicate":"total_assets","value":"64,796,000,000 United States dollar","valid_from":"2012-09-30","valid_to":"2012-12-31","published":"2012-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 64,796,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_24910244F13D, https://asof.is/claim/clm_24910244F13D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912074770/0001104659-12-074770-index.htm.","url":"https://asof.is/claim/clm_24910244F13D","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8011084849F0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912074770/0001104659-12-074770-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2012","published_at":"2012-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2012, filed 2012-11-06"}},{"id":"clm_562D478C481E","predicate":"total_equity","value":"36,916,000,000 United States dollar","valid_from":"2012-09-30","valid_to":"2012-12-31","published":"2012-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 36,916,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_562D478C481E, https://asof.is/claim/clm_562D478C481E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912074770/0001104659-12-074770-index.htm.","url":"https://asof.is/claim/clm_562D478C481E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_77DA6E00509F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912074770/0001104659-12-074770-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2012","published_at":"2012-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2012, filed 2012-11-06"}},{"id":"clm_7CC35C92D732","predicate":"cash_and_equivalents","value":"1,233,000,000 United States dollar","valid_from":"2012-09-30","valid_to":"2012-12-31","published":"2012-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,233,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_7CC35C92D732, https://asof.is/claim/clm_7CC35C92D732, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912074770/0001104659-12-074770-index.htm.","url":"https://asof.is/claim/clm_7CC35C92D732","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_48533819A894","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912074770/0001104659-12-074770-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2012","published_at":"2012-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2012, filed 2012-11-06"}},{"id":"clm_998D85B63E1E","predicate":"quarterly_operating_income","value":"1,814,000,000 United States dollar","valid_from":"2012-09-30","valid_to":"2013-03-31","published":"2012-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,814,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_998D85B63E1E, https://asof.is/claim/clm_998D85B63E1E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912074770/0001104659-12-074770-index.htm.","url":"https://asof.is/claim/clm_998D85B63E1E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A1759AC00B39","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912074770/0001104659-12-074770-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2012","published_at":"2012-11-06T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2012, filed 2012-11-06"}},{"id":"clm_429A3AC1B3B8","predicate":"shares_outstanding","value":"1,272,235,875 shares","valid_from":"2012-07-31","valid_to":"2012-10-31","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,272,235,875 shares\", as of 2012-07-31 (until 2012-10-31). Claim clm_429A3AC1B3B8, https://asof.is/claim/clm_429A3AC1B3B8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912055261/0001104659-12-055261-index.htm.","url":"https://asof.is/claim/clm_429A3AC1B3B8","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CB68D0893CFC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912055261/0001104659-12-055261-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2012","published_at":"2012-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2012, filed 2012-08-07"}},{"id":"clm_727D6ABA0B7D","predicate":"total_assets","value":"65,589,000,000 United States dollar","valid_from":"2012-06-30","valid_to":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 65,589,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_727D6ABA0B7D, https://asof.is/claim/clm_727D6ABA0B7D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912055261/0001104659-12-055261-index.htm.","url":"https://asof.is/claim/clm_727D6ABA0B7D","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_24910244F13D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912055261/0001104659-12-055261-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2012","published_at":"2012-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2012, filed 2012-08-07"}},{"id":"clm_8031D34447F7","predicate":"total_equity","value":"37,913,000,000 United States dollar","valid_from":"2012-06-30","valid_to":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,913,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_8031D34447F7, https://asof.is/claim/clm_8031D34447F7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912055261/0001104659-12-055261-index.htm.","url":"https://asof.is/claim/clm_8031D34447F7","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_562D478C481E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912055261/0001104659-12-055261-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2012","published_at":"2012-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2012, filed 2012-08-07"}},{"id":"clm_89652E2CD3C6","predicate":"quarterly_revenue","value":"30,714,000,000 United States dollar","valid_from":"2012-06-30","valid_to":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 30,714,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_89652E2CD3C6, https://asof.is/claim/clm_89652E2CD3C6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912055261/0001104659-12-055261-index.htm.","url":"https://asof.is/claim/clm_89652E2CD3C6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_04B029B40CE3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912055261/0001104659-12-055261-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2012","published_at":"2012-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2012, filed 2012-08-07"}},{"id":"clm_DCF1A7C83598","predicate":"quarterly_operating_income","value":"1,708,000,000 United States dollar","valid_from":"2012-06-30","valid_to":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,708,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_DCF1A7C83598, https://asof.is/claim/clm_DCF1A7C83598, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912055261/0001104659-12-055261-index.htm.","url":"https://asof.is/claim/clm_DCF1A7C83598","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_998D85B63E1E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912055261/0001104659-12-055261-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2012","published_at":"2012-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2012, filed 2012-08-07"}},{"id":"clm_F12B29C069BA","predicate":"cash_and_equivalents","value":"1,823,000,000 United States dollar","valid_from":"2012-06-30","valid_to":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,823,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_F12B29C069BA, https://asof.is/claim/clm_F12B29C069BA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912055261/0001104659-12-055261-index.htm.","url":"https://asof.is/claim/clm_F12B29C069BA","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7CC35C92D732","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912055261/0001104659-12-055261-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2012","published_at":"2012-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2012, filed 2012-08-07"}},{"id":"clm_05C857D4B4F7","predicate":"shares_outstanding","value":"1,281,502,470 shares","valid_from":"2012-04-25","valid_to":"2012-07-31","published":"2012-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,281,502,470 shares\", as of 2012-04-25 (until 2012-07-31). Claim clm_05C857D4B4F7, https://asof.is/claim/clm_05C857D4B4F7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912031650/0001104659-12-031650-index.htm.","url":"https://asof.is/claim/clm_05C857D4B4F7","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_429A3AC1B3B8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912031650/0001104659-12-031650-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2012, filed 2012-05-02"}},{"id":"clm_0B618A5D771D","predicate":"total_equity","value":"38,053,000,000 United States dollar","valid_from":"2012-03-31","valid_to":"2012-06-30","published":"2012-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,053,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_0B618A5D771D, https://asof.is/claim/clm_0B618A5D771D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912031650/0001104659-12-031650-index.htm.","url":"https://asof.is/claim/clm_0B618A5D771D","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8031D34447F7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912031650/0001104659-12-031650-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2012, filed 2012-05-02"}},{"id":"clm_0F62DCB0C1F6","predicate":"total_assets","value":"66,006,000,000 United States dollar","valid_from":"2012-03-31","valid_to":"2012-06-30","published":"2012-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 66,006,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_0F62DCB0C1F6, https://asof.is/claim/clm_0F62DCB0C1F6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912031650/0001104659-12-031650-index.htm.","url":"https://asof.is/claim/clm_0F62DCB0C1F6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_727D6ABA0B7D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912031650/0001104659-12-031650-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2012, filed 2012-05-02"}},{"id":"clm_393E718E2280","predicate":"cash_and_equivalents","value":"2,211,000,000 United States dollar","valid_from":"2012-03-31","valid_to":"2012-06-30","published":"2012-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,211,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_393E718E2280, https://asof.is/claim/clm_393E718E2280, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912031650/0001104659-12-031650-index.htm.","url":"https://asof.is/claim/clm_393E718E2280","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F12B29C069BA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912031650/0001104659-12-031650-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2012, filed 2012-05-02"}},{"id":"clm_94D54D753862","predicate":"quarterly_operating_income","value":"1,404,000,000 United States dollar","valid_from":"2012-03-31","valid_to":"2012-06-30","published":"2012-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,404,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_94D54D753862, https://asof.is/claim/clm_94D54D753862, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912031650/0001104659-12-031650-index.htm.","url":"https://asof.is/claim/clm_94D54D753862","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DCF1A7C83598","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912031650/0001104659-12-031650-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2012, filed 2012-05-02"}},{"id":"clm_FBE945FCA80A","predicate":"quarterly_revenue","value":"30,798,000,000 United States dollar","valid_from":"2012-03-31","valid_to":"2012-06-30","published":"2012-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 30,798,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_FBE945FCA80A, https://asof.is/claim/clm_FBE945FCA80A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912031650/0001104659-12-031650-index.htm.","url":"https://asof.is/claim/clm_FBE945FCA80A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_89652E2CD3C6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912031650/0001104659-12-031650-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2012, filed 2012-05-02"}},{"id":"clm_38A976004E28","predicate":"shares_outstanding","value":"1,302,378,570 shares","valid_from":"2012-02-10","valid_to":"2012-04-25","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,302,378,570 shares\", as of 2012-02-10 (until 2012-04-25). Claim clm_38A976004E28, https://asof.is/claim/clm_38A976004E28, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912010850/0001104659-12-010850-index.htm.","url":"https://asof.is/claim/clm_38A976004E28","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_05C857D4B4F7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912010850/0001104659-12-010850-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-17T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2011, filed 2012-02-17"}},{"id":"clm_54CAF97DBF42","predicate":"total_assets","value":"64,543,000,000 United States dollar","valid_from":"2011-12-31","valid_to":"2012-03-31","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 64,543,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_54CAF97DBF42, https://asof.is/claim/clm_54CAF97DBF42, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912010850/0001104659-12-010850-index.htm.","url":"https://asof.is/claim/clm_54CAF97DBF42","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0F62DCB0C1F6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912010850/0001104659-12-010850-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-17T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2011, filed 2012-02-17"}},{"id":"clm_5792B3BD0CBD","predicate":"total_equity","value":"38,051,000,000 United States dollar","valid_from":"2011-12-31","valid_to":"2012-03-31","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,051,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_5792B3BD0CBD, https://asof.is/claim/clm_5792B3BD0CBD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912010850/0001104659-12-010850-index.htm.","url":"https://asof.is/claim/clm_5792B3BD0CBD","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0B618A5D771D","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912010850/0001104659-12-010850-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-17T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2011, filed 2012-02-17"}},{"id":"clm_6F77E17ED1B6","predicate":"operating_income","value":"6,330,000,000 United States dollar","valid_from":"2011-12-31","valid_to":"2012-12-31","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 6,330,000,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_6F77E17ED1B6, https://asof.is/claim/clm_6F77E17ED1B6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912010850/0001104659-12-010850-index.htm.","url":"https://asof.is/claim/clm_6F77E17ED1B6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0515A780FBF9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912010850/0001104659-12-010850-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-17T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2011, filed 2012-02-17"}},{"id":"clm_950EFBAE5640","predicate":"revenue","value":"107,100,000,000 United States dollar","valid_from":"2011-12-31","valid_to":"2012-12-31","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 107,100,000,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_950EFBAE5640, https://asof.is/claim/clm_950EFBAE5640, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912010850/0001104659-12-010850-index.htm.","url":"https://asof.is/claim/clm_950EFBAE5640","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_77F2D7209D00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912010850/0001104659-12-010850-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-17T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2011, filed 2012-02-17"}},{"id":"clm_A3BDDC34E1D0","predicate":"cash_and_equivalents","value":"1,413,000,000 United States dollar","valid_from":"2011-12-31","valid_to":"2012-03-31","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,413,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_A3BDDC34E1D0, https://asof.is/claim/clm_A3BDDC34E1D0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912010850/0001104659-12-010850-index.htm.","url":"https://asof.is/claim/clm_A3BDDC34E1D0","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_393E718E2280","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465912010850/0001104659-12-010850-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-17T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2011, filed 2012-02-17"}},{"id":"clm_00F5E2031B0C","predicate":"shares_outstanding","value":"1,301,630,309 shares","valid_from":"2011-10-31","valid_to":"2012-02-10","published":"2011-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,301,630,309 shares\", as of 2011-10-31 (until 2012-02-10). Claim clm_00F5E2031B0C, https://asof.is/claim/clm_00F5E2031B0C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911060566/0001104659-11-060566-index.htm.","url":"https://asof.is/claim/clm_00F5E2031B0C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_38A976004E28","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911060566/0001104659-11-060566-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2011","published_at":"2011-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2011, filed 2011-11-03"}},{"id":"clm_013047F869DB","predicate":"quarterly_operating_income","value":"1,584,000,000 United States dollar","valid_from":"2011-09-30","valid_to":"2012-03-31","published":"2011-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,584,000,000 United States dollar\", as of 2011-09-30 (until 2012-03-31). Claim clm_013047F869DB, https://asof.is/claim/clm_013047F869DB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911060566/0001104659-11-060566-index.htm.","url":"https://asof.is/claim/clm_013047F869DB","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_94D54D753862","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911060566/0001104659-11-060566-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2011","published_at":"2011-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2011, filed 2011-11-03"}},{"id":"clm_44BD387AAD67","predicate":"total_equity","value":"37,487,000,000 United States dollar","valid_from":"2011-09-30","valid_to":"2011-12-31","published":"2011-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,487,000,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_44BD387AAD67, https://asof.is/claim/clm_44BD387AAD67, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911060566/0001104659-11-060566-index.htm.","url":"https://asof.is/claim/clm_44BD387AAD67","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5792B3BD0CBD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911060566/0001104659-11-060566-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2011","published_at":"2011-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2011, filed 2011-11-03"}},{"id":"clm_4919AB7D44C1","predicate":"cash_and_equivalents","value":"1,707,000,000 United States dollar","valid_from":"2011-09-30","valid_to":"2011-12-31","published":"2011-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,707,000,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_4919AB7D44C1, https://asof.is/claim/clm_4919AB7D44C1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911060566/0001104659-11-060566-index.htm.","url":"https://asof.is/claim/clm_4919AB7D44C1","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A3BDDC34E1D0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911060566/0001104659-11-060566-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2011","published_at":"2011-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2011, filed 2011-11-03"}},{"id":"clm_8CDE1C48CD9E","predicate":"quarterly_revenue","value":"26,674,000,000 United States dollar","valid_from":"2011-09-30","valid_to":"2012-03-31","published":"2011-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 26,674,000,000 United States dollar\", as of 2011-09-30 (until 2012-03-31). Claim clm_8CDE1C48CD9E, https://asof.is/claim/clm_8CDE1C48CD9E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911060566/0001104659-11-060566-index.htm.","url":"https://asof.is/claim/clm_8CDE1C48CD9E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FBE945FCA80A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911060566/0001104659-11-060566-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2011","published_at":"2011-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2011, filed 2011-11-03"}},{"id":"clm_CA1F675152AF","predicate":"total_assets","value":"65,251,000,000 United States dollar","valid_from":"2011-09-30","valid_to":"2011-12-31","published":"2011-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 65,251,000,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_CA1F675152AF, https://asof.is/claim/clm_CA1F675152AF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911060566/0001104659-11-060566-index.htm.","url":"https://asof.is/claim/clm_CA1F675152AF","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_54CAF97DBF42","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911060566/0001104659-11-060566-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2011","published_at":"2011-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2011, filed 2011-11-03"}},{"id":"clm_B752A883AFD8","predicate":"shares_outstanding","value":"1,344,841,045 shares","valid_from":"2011-07-29","valid_to":"2011-10-31","published":"2011-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,344,841,045 shares\", as of 2011-07-29 (until 2011-10-31). Claim clm_B752A883AFD8, https://asof.is/claim/clm_B752A883AFD8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm.","url":"https://asof.is/claim/clm_B752A883AFD8","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_00F5E2031B0C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2011, filed 2011-08-04"}},{"id":"clm_23451111C08F","predicate":"quarterly_operating_income","value":"1,490,000,000 United States dollar","valid_from":"2011-06-30","valid_to":"2011-09-30","published":"2011-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,490,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_23451111C08F, https://asof.is/claim/clm_23451111C08F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm.","url":"https://asof.is/claim/clm_23451111C08F","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_013047F869DB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2011, filed 2011-08-04"}},{"id":"clm_4E523A328E3E","predicate":"total_equity","value":"38,244,000,000 United States dollar","valid_from":"2011-06-30","valid_to":"2011-09-30","published":"2011-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,244,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_4E523A328E3E, https://asof.is/claim/clm_4E523A328E3E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm.","url":"https://asof.is/claim/clm_4E523A328E3E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_44BD387AAD67","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2011, filed 2011-08-04"}},{"id":"clm_BA6E2B734BEB","predicate":"total_assets","value":"65,487,000,000 United States dollar","valid_from":"2011-06-30","valid_to":"2011-09-30","published":"2011-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 65,487,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_BA6E2B734BEB, https://asof.is/claim/clm_BA6E2B734BEB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm.","url":"https://asof.is/claim/clm_BA6E2B734BEB","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CA1F675152AF","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2011, filed 2011-08-04"}},{"id":"clm_C2FF5773C0AD","predicate":"quarterly_revenue","value":"26,629,000,000 United States dollar","valid_from":"2011-06-30","valid_to":"2011-09-30","published":"2011-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 26,629,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_C2FF5773C0AD, https://asof.is/claim/clm_C2FF5773C0AD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm.","url":"https://asof.is/claim/clm_C2FF5773C0AD","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8CDE1C48CD9E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2011, filed 2011-08-04"}},{"id":"clm_CD91138D9347","predicate":"quarterly_net_income","value":"816,000,000 United States dollar","valid_from":"2011-06-30","valid_to":"2016-03-31","published":"2011-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 816,000,000 United States dollar\", as of 2011-06-30 (until 2016-03-31). Claim clm_CD91138D9347, https://asof.is/claim/clm_CD91138D9347, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm.","url":"https://asof.is/claim/clm_CD91138D9347","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_FF72BB722144","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2011, filed 2011-08-04"}},{"id":"clm_D302E5B67A4F","predicate":"cash_and_equivalents","value":"2,228,000,000 United States dollar","valid_from":"2011-06-30","valid_to":"2011-09-30","published":"2011-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,228,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_D302E5B67A4F, https://asof.is/claim/clm_D302E5B67A4F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm.","url":"https://asof.is/claim/clm_D302E5B67A4F","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4919AB7D44C1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2011, filed 2011-08-04"}},{"id":"clm_394873F1BD37","predicate":"shares_outstanding","value":"1,355,941,242 shares","valid_from":"2011-04-29","valid_to":"2011-07-29","published":"2011-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,355,941,242 shares\", as of 2011-04-29 (until 2011-07-29). Claim clm_394873F1BD37, https://asof.is/claim/clm_394873F1BD37, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm.","url":"https://asof.is/claim/clm_394873F1BD37","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B752A883AFD8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2011, filed 2011-05-05"}},{"id":"clm_1FAACEC6850B","predicate":"total_equity","value":"37,919,000,000 United States dollar","valid_from":"2011-03-31","valid_to":"2011-06-30","published":"2011-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,919,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_1FAACEC6850B, https://asof.is/claim/clm_1FAACEC6850B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm.","url":"https://asof.is/claim/clm_1FAACEC6850B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4E523A328E3E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2011, filed 2011-05-05"}},{"id":"clm_571AF9D63EF3","predicate":"quarterly_operating_income","value":"1,311,000,000 United States dollar","valid_from":"2011-03-31","valid_to":"2011-06-30","published":"2011-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,311,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_571AF9D63EF3, https://asof.is/claim/clm_571AF9D63EF3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm.","url":"https://asof.is/claim/clm_571AF9D63EF3","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_23451111C08F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2011, filed 2011-05-05"}},{"id":"clm_70E2BF9DD77A","predicate":"cash_and_equivalents","value":"2,162,000,000 United States dollar","valid_from":"2011-03-31","valid_to":"2011-06-30","published":"2011-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,162,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_70E2BF9DD77A, https://asof.is/claim/clm_70E2BF9DD77A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm.","url":"https://asof.is/claim/clm_70E2BF9DD77A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D302E5B67A4F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2011, filed 2011-05-05"}},{"id":"clm_76D997B79302","predicate":"quarterly_net_income","value":"713,000,000 United States dollar","valid_from":"2011-03-31","valid_to":"2011-06-30","published":"2011-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 713,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_76D997B79302, https://asof.is/claim/clm_76D997B79302, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm.","url":"https://asof.is/claim/clm_76D997B79302","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CD91138D9347","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2011, filed 2011-05-05"}},{"id":"clm_DE49094F54B6","predicate":"total_assets","value":"62,828,000,000 United States dollar","valid_from":"2011-03-31","valid_to":"2011-06-30","published":"2011-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 62,828,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_DE49094F54B6, https://asof.is/claim/clm_DE49094F54B6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm.","url":"https://asof.is/claim/clm_DE49094F54B6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BA6E2B734BEB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2011, filed 2011-05-05"}},{"id":"clm_F35B20E53539","predicate":"quarterly_revenue","value":"25,880,000,000 United States dollar","valid_from":"2011-03-31","valid_to":"2011-06-30","published":"2011-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 25,880,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_F35B20E53539, https://asof.is/claim/clm_F35B20E53539, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm.","url":"https://asof.is/claim/clm_F35B20E53539","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C2FF5773C0AD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2011","published_at":"2011-05-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2011, filed 2011-05-05"}},{"id":"clm_907C53145432","predicate":"shares_outstanding","value":"1,368,174,000 shares","valid_from":"2011-02-11","valid_to":"2011-04-29","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,368,174,000 shares\", as of 2011-02-11 (until 2011-04-29). Claim clm_907C53145432, https://asof.is/claim/clm_907C53145432, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm.","url":"https://asof.is/claim/clm_907C53145432","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_394873F1BD37","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-18T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2010, filed 2011-02-18"}},{"id":"clm_02EB11074A80","predicate":"total_assets","value":"62,169,000,000 United States dollar","valid_from":"2010-12-31","valid_to":"2011-03-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 62,169,000,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_02EB11074A80, https://asof.is/claim/clm_02EB11074A80, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm.","url":"https://asof.is/claim/clm_02EB11074A80","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DE49094F54B6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-18T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2010, filed 2011-02-18"}},{"id":"clm_4928F9324A46","predicate":"total_equity","value":"37,700,000,000 United States dollar","valid_from":"2010-12-31","valid_to":"2011-03-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,700,000,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_4928F9324A46, https://asof.is/claim/clm_4928F9324A46, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm.","url":"https://asof.is/claim/clm_4928F9324A46","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1FAACEC6850B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-18T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2010, filed 2011-02-18"}},{"id":"clm_73C91EB55980","predicate":"cash_and_equivalents","value":"1,427,000,000 United States dollar","valid_from":"2010-12-31","valid_to":"2011-03-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,427,000,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_73C91EB55980, https://asof.is/claim/clm_73C91EB55980, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm.","url":"https://asof.is/claim/clm_73C91EB55980","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_70E2BF9DD77A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-18T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2010, filed 2011-02-18"}},{"id":"clm_A41A9DD69A73","predicate":"revenue","value":"96,413,000,000 United States dollar","valid_from":"2010-12-31","valid_to":"2011-12-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 96,413,000,000 United States dollar\", as of 2010-12-31 (until 2011-12-31). Claim clm_A41A9DD69A73, https://asof.is/claim/clm_A41A9DD69A73, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm.","url":"https://asof.is/claim/clm_A41A9DD69A73","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_950EFBAE5640","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-18T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2010, filed 2011-02-18"}},{"id":"clm_AB3C88CE2DD9","predicate":"operating_income","value":"6,165,000,000 United States dollar","valid_from":"2010-12-31","valid_to":"2011-12-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 6,165,000,000 United States dollar\", as of 2010-12-31 (until 2011-12-31). Claim clm_AB3C88CE2DD9, https://asof.is/claim/clm_AB3C88CE2DD9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm.","url":"https://asof.is/claim/clm_AB3C88CE2DD9","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6F77E17ED1B6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-18T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2010, filed 2011-02-18"}},{"id":"clm_C1146987D775","predicate":"net_income","value":"3,427,000,000 United States dollar","valid_from":"2010-12-31","valid_to":"2014-12-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 3,427,000,000 United States dollar\", as of 2010-12-31 (until 2014-12-31). Claim clm_C1146987D775, https://asof.is/claim/clm_C1146987D775, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm.","url":"https://asof.is/claim/clm_C1146987D775","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_53BDA260419A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2010","published_at":"2011-02-18T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2010, filed 2011-02-18"}},{"id":"clm_4319D21E1898","predicate":"shares_outstanding","value":"1,358,800,000 shares","valid_from":"2010-10-26","valid_to":"2011-02-11","published":"2010-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,358,800,000 shares\", as of 2010-10-26 (until 2011-02-11). Claim clm_4319D21E1898, https://asof.is/claim/clm_4319D21E1898, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm.","url":"https://asof.is/claim/clm_4319D21E1898","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_907C53145432","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2010, filed 2010-11-03"}},{"id":"clm_28DDAA471DC3","predicate":"quarterly_revenue","value":"23,875,000,000 United States dollar","valid_from":"2010-09-30","valid_to":"2011-03-31","published":"2010-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 23,875,000,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_28DDAA471DC3, https://asof.is/claim/clm_28DDAA471DC3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm.","url":"https://asof.is/claim/clm_28DDAA471DC3","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F35B20E53539","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2010, filed 2010-11-03"}},{"id":"clm_2E38972CB5E9","predicate":"quarterly_operating_income","value":"1,484,000,000 United States dollar","valid_from":"2010-09-30","valid_to":"2011-03-31","published":"2010-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,484,000,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_2E38972CB5E9, https://asof.is/claim/clm_2E38972CB5E9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm.","url":"https://asof.is/claim/clm_2E38972CB5E9","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_571AF9D63EF3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2010, filed 2010-11-03"}},{"id":"clm_3B53B17B2A97","predicate":"cash_and_equivalents","value":"979,000,000 United States dollar","valid_from":"2010-09-30","valid_to":"2010-12-31","published":"2010-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 979,000,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_3B53B17B2A97, https://asof.is/claim/clm_3B53B17B2A97, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm.","url":"https://asof.is/claim/clm_3B53B17B2A97","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_73C91EB55980","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2010, filed 2010-11-03"}},{"id":"clm_47421BFD9F4C","predicate":"total_assets","value":"61,713,000,000 United States dollar","valid_from":"2010-09-30","valid_to":"2010-12-31","published":"2010-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 61,713,000,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_47421BFD9F4C, https://asof.is/claim/clm_47421BFD9F4C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm.","url":"https://asof.is/claim/clm_47421BFD9F4C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_02EB11074A80","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2010, filed 2010-11-03"}},{"id":"clm_799E6F1AEC0F","predicate":"total_equity","value":"36,637,000,000 United States dollar","valid_from":"2010-09-30","valid_to":"2010-12-31","published":"2010-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 36,637,000,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_799E6F1AEC0F, https://asof.is/claim/clm_799E6F1AEC0F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm.","url":"https://asof.is/claim/clm_799E6F1AEC0F","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4928F9324A46","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2010, filed 2010-11-03"}},{"id":"clm_AE4E52A40E41","predicate":"quarterly_net_income","value":"809,000,000 United States dollar","valid_from":"2010-09-30","valid_to":"2011-03-31","published":"2010-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 809,000,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_AE4E52A40E41, https://asof.is/claim/clm_AE4E52A40E41, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm.","url":"https://asof.is/claim/clm_AE4E52A40E41","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_76D997B79302","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2010","published_at":"2010-11-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2010, filed 2010-11-03"}},{"id":"clm_6E5CED96DD58","predicate":"shares_outstanding","value":"1,358,218,000 shares","valid_from":"2010-07-21","valid_to":"2010-10-26","published":"2010-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,358,218,000 shares\", as of 2010-07-21 (until 2010-10-26). Claim clm_6E5CED96DD58, https://asof.is/claim/clm_6E5CED96DD58, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm.","url":"https://asof.is/claim/clm_6E5CED96DD58","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4319D21E1898","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-07-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2010, filed 2010-07-29"}},{"id":"clm_0A74429D3DCB","predicate":"quarterly_operating_income","value":"1,501,000,000 United States dollar","valid_from":"2010-06-30","valid_to":"2010-09-30","published":"2010-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,501,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_0A74429D3DCB, https://asof.is/claim/clm_0A74429D3DCB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm.","url":"https://asof.is/claim/clm_0A74429D3DCB","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2E38972CB5E9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-07-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2010, filed 2010-07-29"}},{"id":"clm_162CE4C8ABDA","predicate":"cash_and_equivalents","value":"1,107,000,000 United States dollar","valid_from":"2010-06-30","valid_to":"2010-09-30","published":"2010-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,107,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_162CE4C8ABDA, https://asof.is/claim/clm_162CE4C8ABDA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm.","url":"https://asof.is/claim/clm_162CE4C8ABDA","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3B53B17B2A97","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-07-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2010, filed 2010-07-29"}},{"id":"clm_1DBB9E5179B9","predicate":"quarterly_revenue","value":"24,007,000,000 United States dollar","valid_from":"2010-06-30","valid_to":"2010-09-30","published":"2010-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 24,007,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_1DBB9E5179B9, https://asof.is/claim/clm_1DBB9E5179B9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm.","url":"https://asof.is/claim/clm_1DBB9E5179B9","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_28DDAA471DC3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-07-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2010, filed 2010-07-29"}},{"id":"clm_B24CBEB3EBFB","predicate":"total_equity","value":"35,872,000,000 United States dollar","valid_from":"2010-06-30","valid_to":"2010-09-30","published":"2010-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 35,872,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_B24CBEB3EBFB, https://asof.is/claim/clm_B24CBEB3EBFB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm.","url":"https://asof.is/claim/clm_B24CBEB3EBFB","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_799E6F1AEC0F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-07-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2010, filed 2010-07-29"}},{"id":"clm_C8745D9479C2","predicate":"quarterly_net_income","value":"821,000,000 United States dollar","valid_from":"2010-06-30","valid_to":"2010-09-30","published":"2010-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 821,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_C8745D9479C2, https://asof.is/claim/clm_C8745D9479C2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm.","url":"https://asof.is/claim/clm_C8745D9479C2","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AE4E52A40E41","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-07-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2010, filed 2010-07-29"}},{"id":"clm_DE991CE0CCDA","predicate":"total_assets","value":"61,524,000,000 United States dollar","valid_from":"2010-06-30","valid_to":"2010-09-30","published":"2010-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 61,524,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_DE991CE0CCDA, https://asof.is/claim/clm_DE991CE0CCDA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm.","url":"https://asof.is/claim/clm_DE991CE0CCDA","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_47421BFD9F4C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2010","published_at":"2010-07-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2010, filed 2010-07-29"}},{"id":"clm_BFC53AFA1C77","predicate":"shares_outstanding","value":"1,360,884,000 shares","valid_from":"2010-04-27","valid_to":"2010-07-21","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,360,884,000 shares\", as of 2010-04-27 (until 2010-07-21). Claim clm_BFC53AFA1C77, https://asof.is/claim/clm_BFC53AFA1C77, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_BFC53AFA1C77","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6E5CED96DD58","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2010, filed 2010-05-04"}},{"id":"clm_065E8F2A3A52","predicate":"cash_and_equivalents","value":"1,047,000,000 United States dollar","valid_from":"2010-03-31","valid_to":"2010-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,047,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_065E8F2A3A52, https://asof.is/claim/clm_065E8F2A3A52, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_065E8F2A3A52","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_162CE4C8ABDA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2010, filed 2010-05-04"}},{"id":"clm_21F82BBF1383","predicate":"total_equity","value":"35,694,000,000 United States dollar","valid_from":"2010-03-31","valid_to":"2010-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 35,694,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_21F82BBF1383, https://asof.is/claim/clm_21F82BBF1383, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_21F82BBF1383","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_B24CBEB3EBFB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2010, filed 2010-05-04"}},{"id":"clm_A291B3B94CEA","predicate":"quarterly_operating_income","value":"1,410,000,000 United States dollar","valid_from":"2010-03-31","valid_to":"2010-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,410,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_A291B3B94CEA, https://asof.is/claim/clm_A291B3B94CEA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_A291B3B94CEA","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0A74429D3DCB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2010, filed 2010-05-04"}},{"id":"clm_AF53CED866C5","predicate":"quarterly_revenue","value":"23,760,000,000 United States dollar","valid_from":"2010-03-31","valid_to":"2010-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 23,760,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_AF53CED866C5, https://asof.is/claim/clm_AF53CED866C5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_AF53CED866C5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1DBB9E5179B9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2010, filed 2010-05-04"}},{"id":"clm_BC1B665D20FB","predicate":"quarterly_net_income","value":"771,000,000 United States dollar","valid_from":"2010-03-31","valid_to":"2010-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 771,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_BC1B665D20FB, https://asof.is/claim/clm_BC1B665D20FB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_BC1B665D20FB","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C8745D9479C2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2010, filed 2010-05-04"}},{"id":"clm_F239CEAFDBD5","predicate":"total_assets","value":"61,284,000,000 United States dollar","valid_from":"2010-03-31","valid_to":"2010-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 61,284,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_F239CEAFDBD5, https://asof.is/claim/clm_F239CEAFDBD5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_F239CEAFDBD5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DE991CE0CCDA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2010, filed 2010-05-04"}},{"id":"clm_5F34FC7AB83A","predicate":"x_username","value":"CVSHealth","valid_from":"2010-03-12","valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health x username: CVSHealth\", as of 2010-03-12. Claim clm_5F34FC7AB83A, https://asof.is/claim/clm_5F34FC7AB83A, accessed 2026-11-09. Source: https://www.wikidata.org/wiki/Q624375.","url":"https://asof.is/claim/clm_5F34FC7AB83A","accessed":"2026-11-09"},"confidence":0.6,"status":"unverified","assertable":false,"why_not":"unverified","superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q624375","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"own-site","on":"2026-11-08","quote":"https://twitter.com/CVSHealth","url":"https://cvshealth.com/"}},{"id":"clm_407ADC534926","predicate":"shares_outstanding","value":"1,390,515,000 shares","valid_from":"2010-02-22","valid_to":"2010-04-27","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,390,515,000 shares\", as of 2010-02-22 (until 2010-04-27). Claim clm_407ADC534926, https://asof.is/claim/clm_407ADC534926, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_407ADC534926","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BFC53AFA1C77","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_149DDD91B9E2","predicate":"revenue","value":"98,729,000,000 United States dollar","valid_from":"2009-12-31","valid_to":"2010-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 98,729,000,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_149DDD91B9E2, https://asof.is/claim/clm_149DDD91B9E2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_149DDD91B9E2","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A41A9DD69A73","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_21B383A440A8","predicate":"total_equity","value":"35,768,000,000 United States dollar","valid_from":"2009-12-31","valid_to":"2010-03-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 35,768,000,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_21B383A440A8, https://asof.is/claim/clm_21B383A440A8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_21B383A440A8","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_21F82BBF1383","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_308D469AD34E","predicate":"operating_income","value":"6,438,000,000 United States dollar","valid_from":"2009-12-31","valid_to":"2010-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 6,438,000,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_308D469AD34E, https://asof.is/claim/clm_308D469AD34E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_308D469AD34E","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AB3C88CE2DD9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_42DC25F3160F","predicate":"net_income","value":"3,696,000,000 United States dollar","valid_from":"2009-12-31","valid_to":"2010-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 3,696,000,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_42DC25F3160F, https://asof.is/claim/clm_42DC25F3160F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_42DC25F3160F","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C1146987D775","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_9414E2F838FA","predicate":"cash_and_equivalents","value":"1,086,000,000 United States dollar","valid_from":"2009-12-31","valid_to":"2010-03-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,086,000,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_9414E2F838FA, https://asof.is/claim/clm_9414E2F838FA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_9414E2F838FA","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_065E8F2A3A52","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_CA5E9D4C83BE","predicate":"total_assets","value":"61,641,000,000 United States dollar","valid_from":"2009-12-31","valid_to":"2010-03-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 61,641,000,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_CA5E9D4C83BE, https://asof.is/claim/clm_CA5E9D4C83BE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_CA5E9D4C83BE","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F239CEAFDBD5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_89E5FAD01015","predicate":"shares_outstanding","value":"1,410,543,000 shares","valid_from":"2009-10-29","valid_to":"2010-02-22","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,410,543,000 shares\", as of 2009-10-29 (until 2010-02-22). Claim clm_89E5FAD01015, https://asof.is/claim/clm_89E5FAD01015, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_89E5FAD01015","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_407ADC534926","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2009, filed 2009-11-05"}},{"id":"clm_146514D06952","predicate":"quarterly_operating_income","value":"1,565,900,000 United States dollar","valid_from":"2009-09-30","valid_to":"2010-03-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,565,900,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_146514D06952, https://asof.is/claim/clm_146514D06952, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_146514D06952","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_A291B3B94CEA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2009, filed 2009-11-05"}},{"id":"clm_202FD9CF9441","predicate":"quarterly_net_income","value":"1,021,300,000 United States dollar","valid_from":"2009-09-30","valid_to":"2010-03-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,021,300,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_202FD9CF9441, https://asof.is/claim/clm_202FD9CF9441, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_202FD9CF9441","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BC1B665D20FB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2009, filed 2009-11-05"}},{"id":"clm_5D6FB1F459B0","predicate":"total_equity","value":"35,674,900,000 United States dollar","valid_from":"2009-09-30","valid_to":"2009-12-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 35,674,900,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_5D6FB1F459B0, https://asof.is/claim/clm_5D6FB1F459B0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_5D6FB1F459B0","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_21B383A440A8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2009, filed 2009-11-05"}},{"id":"clm_660A734BA45A","predicate":"total_assets","value":"61,879,300,000 United States dollar","valid_from":"2009-09-30","valid_to":"2009-12-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 61,879,300,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_660A734BA45A, https://asof.is/claim/clm_660A734BA45A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_660A734BA45A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CA5E9D4C83BE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2009, filed 2009-11-05"}},{"id":"clm_BEC2720CF92C","predicate":"cash_and_equivalents","value":"1,130,600,000 United States dollar","valid_from":"2009-09-30","valid_to":"2009-12-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,130,600,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_BEC2720CF92C, https://asof.is/claim/clm_BEC2720CF92C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_BEC2720CF92C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9414E2F838FA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2009, filed 2009-11-05"}},{"id":"clm_C8D5F7F6A041","predicate":"quarterly_revenue","value":"24,641,900,000 United States dollar","valid_from":"2009-09-30","valid_to":"2010-03-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 24,641,900,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_C8D5F7F6A041, https://asof.is/claim/clm_C8D5F7F6A041, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_C8D5F7F6A041","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AF53CED866C5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2009, filed 2009-11-05"}},{"id":"clm_53866C90908A","predicate":"shares_outstanding","value":"1,443,232,000 shares","valid_from":"2009-07-30","valid_to":"2009-10-29","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,443,232,000 shares\", as of 2009-07-30 (until 2009-10-29). Claim clm_53866C90908A, https://asof.is/claim/clm_53866C90908A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_53866C90908A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_89E5FAD01015","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2009, filed 2009-08-04"}},{"id":"clm_2B250EFA4E44","predicate":"total_assets","value":"61,036,000,000 United States dollar","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 61,036,000,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_2B250EFA4E44, https://asof.is/claim/clm_2B250EFA4E44, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_2B250EFA4E44","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_660A734BA45A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2009, filed 2009-08-04"}},{"id":"clm_3566EA2BC7EC","predicate":"cash_and_equivalents","value":"1,225,300,000 United States dollar","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,225,300,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_3566EA2BC7EC, https://asof.is/claim/clm_3566EA2BC7EC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_3566EA2BC7EC","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BEC2720CF92C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2009, filed 2009-08-04"}},{"id":"clm_6D565851ABA6","predicate":"quarterly_operating_income","value":"1,599,800,000 United States dollar","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,599,800,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_6D565851ABA6, https://asof.is/claim/clm_6D565851ABA6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_6D565851ABA6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_146514D06952","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2009, filed 2009-08-04"}},{"id":"clm_7685184D60D1","predicate":"quarterly_net_income","value":"886,500,000 United States dollar","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 886,500,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_7685184D60D1, https://asof.is/claim/clm_7685184D60D1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_7685184D60D1","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_202FD9CF9441","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2009, filed 2009-08-04"}},{"id":"clm_7FA7E48202CE","predicate":"quarterly_revenue","value":"24,871,100,000 United States dollar","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 24,871,100,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_7FA7E48202CE, https://asof.is/claim/clm_7FA7E48202CE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_7FA7E48202CE","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C8D5F7F6A041","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2009, filed 2009-08-04"}},{"id":"clm_C7A67C4FF2D3","predicate":"total_equity","value":"36,151,600,000 United States dollar","valid_from":"2009-06-30","valid_to":"2009-09-30","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 36,151,600,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_C7A67C4FF2D3, https://asof.is/claim/clm_C7A67C4FF2D3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_C7A67C4FF2D3","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_5D6FB1F459B0","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2009, filed 2009-08-04"}},{"id":"clm_26C62C7EED6C","predicate":"cash_and_equivalents","value":"997,000,000 United States dollar","valid_from":"2009-03-31","valid_to":"2009-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 997,000,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_26C62C7EED6C, https://asof.is/claim/clm_26C62C7EED6C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_26C62C7EED6C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3566EA2BC7EC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2010, filed 2010-05-04"}},{"id":"clm_683A5AEBE079","predicate":"quarterly_net_income","value":"738,000,000 United States dollar","valid_from":"2009-03-31","valid_to":"2009-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 738,000,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_683A5AEBE079, https://asof.is/claim/clm_683A5AEBE079, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_683A5AEBE079","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7685184D60D1","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2010, filed 2010-05-04"}},{"id":"clm_C5A027BA6BA6","predicate":"quarterly_revenue","value":"23,394,000,000 United States dollar","valid_from":"2009-03-31","valid_to":"2009-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 23,394,000,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_C5A027BA6BA6, https://asof.is/claim/clm_C5A027BA6BA6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_C5A027BA6BA6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7FA7E48202CE","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2010, filed 2010-05-04"}},{"id":"clm_E4679E7DBBC8","predicate":"quarterly_operating_income","value":"1,377,000,000 United States dollar","valid_from":"2009-03-31","valid_to":"2009-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,377,000,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_E4679E7DBBC8, https://asof.is/claim/clm_E4679E7DBBC8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_E4679E7DBBC8","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6D565851ABA6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2010","published_at":"2010-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2010, filed 2010-05-04"}},{"id":"clm_12D5D7B0BC13","predicate":"total_equity","value":"34,574,000,000 United States dollar","valid_from":"2008-12-31","valid_to":"2009-06-30","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 34,574,000,000 United States dollar\", as of 2008-12-31 (until 2009-06-30). Claim clm_12D5D7B0BC13, https://asof.is/claim/clm_12D5D7B0BC13, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_12D5D7B0BC13","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C7A67C4FF2D3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_18A6BBA7194A","predicate":"total_assets","value":"60,960,000,000 United States dollar","valid_from":"2008-12-31","valid_to":"2009-06-30","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 60,960,000,000 United States dollar\", as of 2008-12-31 (until 2009-06-30). Claim clm_18A6BBA7194A, https://asof.is/claim/clm_18A6BBA7194A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_18A6BBA7194A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2B250EFA4E44","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_3B1FF259314F","predicate":"operating_income","value":"6,046,000,000 United States dollar","valid_from":"2008-12-31","valid_to":"2009-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 6,046,000,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_3B1FF259314F, https://asof.is/claim/clm_3B1FF259314F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_3B1FF259314F","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_308D469AD34E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_4133571B66D3","predicate":"revenue","value":"87,472,000,000 United States dollar","valid_from":"2008-12-31","valid_to":"2009-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 87,472,000,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_4133571B66D3, https://asof.is/claim/clm_4133571B66D3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_4133571B66D3","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_149DDD91B9E2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_C06C87619274","predicate":"net_income","value":"3,212,000,000 United States dollar","valid_from":"2008-12-31","valid_to":"2009-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 3,212,000,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_C06C87619274, https://asof.is/claim/clm_C06C87619274, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_C06C87619274","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_42DC25F3160F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_F6983DCDAD55","predicate":"cash_and_equivalents","value":"1,352,000,000 United States dollar","valid_from":"2008-12-31","valid_to":"2009-03-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,352,000,000 United States dollar\", as of 2008-12-31 (until 2009-03-31). Claim clm_F6983DCDAD55, https://asof.is/claim/clm_F6983DCDAD55, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_F6983DCDAD55","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_26C62C7EED6C","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_110CA014AF54","predicate":"quarterly_revenue","value":"20,863,400,000 United States dollar","valid_from":"2008-09-27","valid_to":"2009-03-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 20,863,400,000 United States dollar\", as of 2008-09-27 (until 2009-03-31). Claim clm_110CA014AF54, https://asof.is/claim/clm_110CA014AF54, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_110CA014AF54","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C5A027BA6BA6","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2009, filed 2009-11-05"}},{"id":"clm_7B3884C156E2","predicate":"quarterly_net_income","value":"736,000,000 United States dollar","valid_from":"2008-09-27","valid_to":"2009-03-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 736,000,000 United States dollar\", as of 2008-09-27 (until 2009-03-31). Claim clm_7B3884C156E2, https://asof.is/claim/clm_7B3884C156E2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_7B3884C156E2","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_683A5AEBE079","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2009, filed 2009-11-05"}},{"id":"clm_CFD1908B3329","predicate":"cash_and_equivalents","value":"1,282,300,000 United States dollar","valid_from":"2008-09-27","valid_to":"2008-12-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,282,300,000 United States dollar\", as of 2008-09-27 (until 2008-12-31). Claim clm_CFD1908B3329, https://asof.is/claim/clm_CFD1908B3329, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_CFD1908B3329","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F6983DCDAD55","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2009, filed 2009-11-05"}},{"id":"clm_DF12B8BDD36A","predicate":"quarterly_operating_income","value":"1,466,200,000 United States dollar","valid_from":"2008-09-27","valid_to":"2009-03-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,466,200,000 United States dollar\", as of 2008-09-27 (until 2009-03-31). Claim clm_DF12B8BDD36A, https://asof.is/claim/clm_DF12B8BDD36A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_DF12B8BDD36A","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E4679E7DBBC8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2009","published_at":"2009-11-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2009, filed 2009-11-05"}},{"id":"clm_224F3CBF883C","predicate":"quarterly_net_income","value":"774,800,000 United States dollar","valid_from":"2008-06-28","valid_to":"2008-09-27","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 774,800,000 United States dollar\", as of 2008-06-28 (until 2008-09-27). Claim clm_224F3CBF883C, https://asof.is/claim/clm_224F3CBF883C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_224F3CBF883C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7B3884C156E2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2009, filed 2009-08-04"}},{"id":"clm_44E797921657","predicate":"cash_and_equivalents","value":"615,700,000 United States dollar","valid_from":"2008-06-28","valid_to":"2008-09-27","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 615,700,000 United States dollar\", as of 2008-06-28 (until 2008-09-27). Claim clm_44E797921657, https://asof.is/claim/clm_44E797921657, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_44E797921657","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_CFD1908B3329","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2009, filed 2009-08-04"}},{"id":"clm_63B651C00A1B","predicate":"quarterly_revenue","value":"21,140,300,000 United States dollar","valid_from":"2008-06-28","valid_to":"2008-09-27","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 21,140,300,000 United States dollar\", as of 2008-06-28 (until 2008-09-27). Claim clm_63B651C00A1B, https://asof.is/claim/clm_63B651C00A1B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_63B651C00A1B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_110CA014AF54","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2009, filed 2009-08-04"}},{"id":"clm_AAF029A69E3F","predicate":"quarterly_operating_income","value":"1,478,100,000 United States dollar","valid_from":"2008-06-28","valid_to":"2008-09-27","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,478,100,000 United States dollar\", as of 2008-06-28 (until 2008-09-27). Claim clm_AAF029A69E3F, https://asof.is/claim/clm_AAF029A69E3F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_AAF029A69E3F","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DF12B8BDD36A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2009","published_at":"2009-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2009, filed 2009-08-04"}},{"id":"clm_2AF158DF1FE2","predicate":"operating_income","value":"4,794,000,000 United States dollar","valid_from":"2007-12-29","valid_to":"2008-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 4,794,000,000 United States dollar\", as of 2007-12-29 (until 2008-12-31). Claim clm_2AF158DF1FE2, https://asof.is/claim/clm_2AF158DF1FE2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_2AF158DF1FE2","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3B1FF259314F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_7E1F7CBED152","predicate":"net_income","value":"2,637,000,000 United States dollar","valid_from":"2007-12-29","valid_to":"2008-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 2,637,000,000 United States dollar\", as of 2007-12-29 (until 2008-12-31). Claim clm_7E1F7CBED152, https://asof.is/claim/clm_7E1F7CBED152, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_7E1F7CBED152","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C06C87619274","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_92178B650D71","predicate":"cash_and_equivalents","value":"1,056,000,000 United States dollar","valid_from":"2007-12-29","valid_to":"2008-06-28","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,056,000,000 United States dollar\", as of 2007-12-29 (until 2008-06-28). Claim clm_92178B650D71, https://asof.is/claim/clm_92178B650D71, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_92178B650D71","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_44E797921657","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_A9EEF659A6BC","predicate":"revenue","value":"76,330,000,000 United States dollar","valid_from":"2007-12-29","valid_to":"2008-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 76,330,000,000 United States dollar\", as of 2007-12-29 (until 2008-12-31). Claim clm_A9EEF659A6BC, https://asof.is/claim/clm_A9EEF659A6BC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_A9EEF659A6BC","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4133571B66D3","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_D74D7052495C","predicate":"total_equity","value":"31,322,000,000 United States dollar","valid_from":"2007-12-29","valid_to":"2008-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 31,322,000,000 United States dollar\", as of 2007-12-29 (until 2008-12-31). Claim clm_D74D7052495C, https://asof.is/claim/clm_D74D7052495C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_D74D7052495C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_12D5D7B0BC13","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_EDC23D1272A2","predicate":"registrant_name","value":"CVS/CAREMARK CORP","valid_from":"2007-03-23","valid_to":"2007-05-08","published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health registrant name: CVS/CAREMARK CORP\", as of 2007-03-23 (until 2007-05-08). Claim clm_EDC23D1272A2, https://asof.is/claim/clm_EDC23D1272A2, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_EDC23D1272A2","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7541D7D93CC7","sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_781070A37B50","predicate":"cash_and_equivalents","value":"530,000,000 United States dollar","valid_from":"2006-12-30","valid_to":"2007-12-29","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 530,000,000 United States dollar\", as of 2006-12-30 (until 2007-12-29). Claim clm_781070A37B50, https://asof.is/claim/clm_781070A37B50, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_781070A37B50","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_92178B650D71","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2009","published_at":"2010-02-26T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-26"}},{"id":"clm_C62B73F173B9","predicate":"registrant_name","value":"CVS CAREMARK CORP","valid_from":"2006-12-27","valid_to":"2007-03-23","published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health registrant name: CVS CAREMARK CORP\", as of 2006-12-27 (until 2007-03-23). Claim clm_C62B73F173B9, https://asof.is/claim/clm_C62B73F173B9, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_C62B73F173B9","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_EDC23D1272A2","sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_09D30AF4F61B","predicate":"registrant_name","value":"CVS CORP","valid_from":"1997-02-07","valid_to":"2006-12-27","published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health registrant name: CVS CORP\", as of 1997-02-07 (until 2006-12-27). Claim clm_09D30AF4F61B, https://asof.is/claim/clm_09D30AF4F61B, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_09D30AF4F61B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_C62B73F173B9","sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_7648F63B044B","predicate":"registrant_name","value":"MELVILLE CORP","valid_from":"1994-03-31","valid_to":"1997-01-10","published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health registrant name: MELVILLE CORP\", as of 1994-03-31 (until 1997-01-10). Claim clm_7648F63B044B, https://asof.is/claim/clm_7648F63B044B, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_7648F63B044B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_09D30AF4F61B","sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_D0351F66293B","predicate":"website","value":"https://cvshealth.com/","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health website: https://cvshealth.com/\", undated. Claim clm_D0351F66293B, https://asof.is/claim/clm_D0351F66293B, accessed 2026-11-09. Source: https://www.wikidata.org/wiki/Q624375.","url":"https://asof.is/claim/clm_D0351F66293B","accessed":"2026-11-09"},"confidence":0.45,"status":"unverified","assertable":false,"why_not":"low_confidence","superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q624375","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"own-site","on":"2026-11-08","quote":"Leading Health Solutions Company | CVS Health.","url":"https://www.cvshealth.com/"}},{"id":"clm_02DBC2AC50FC","predicate":"sic_industry","value":"Retail-Drug Stores and Proprietary Stores (5912)","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health sic industry: Retail-Drug Stores and Proprietary Stores (5912)\", undated. Claim clm_02DBC2AC50FC, https://asof.is/claim/clm_02DBC2AC50FC, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_02DBC2AC50FC","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_32E3ADE77CC6","predicate":"state_of_incorporation","value":"DE","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health state of incorporation: DE\", undated. Claim clm_32E3ADE77CC6, https://asof.is/claim/clm_32E3ADE77CC6, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_32E3ADE77CC6","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_51282B82469D","predicate":"headquarters","value":"Woonsocket","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health headquarters: Woonsocket\", undated. Claim clm_51282B82469D, https://asof.is/claim/clm_51282B82469D, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_51282B82469D","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_5CDDEA08A8E2","predicate":"fiscal_year_end","value":"12-31","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health fiscal year end: 12-31\", undated. Claim clm_5CDDEA08A8E2, https://asof.is/claim/clm_5CDDEA08A8E2, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_5CDDEA08A8E2","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_8E541519C12F","predicate":"ticker","value":"CVS","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health ticker: CVS\", undated. Claim clm_8E541519C12F, https://asof.is/claim/clm_8E541519C12F, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_8E541519C12F","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_B554B2E33EF3","predicate":"listed_on","value":"NYSE","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health listed on: NYSE\", undated. Claim clm_B554B2E33EF3, https://asof.is/claim/clm_B554B2E33EF3, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_B554B2E33EF3","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_CE114779DDB5","predicate":"cik","value":"0000064803","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cik: 0000064803\", undated. Claim clm_CE114779DDB5, https://asof.is/claim/clm_CE114779DDB5, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_CE114779DDB5","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}}],"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{"unverified":"Unverified: one source that is not primary, or a primary source below confidence 0.7. Asserted once a primary source or a second independent domain confirms it.","low_confidence":"Confidence below 0.5, the line the record asserts at."},"checked_by":{"sec-filing":"parsed from the SEC filing","page-read":"its source page states the value and the date","own-site":"the entity's own site names it (a website whose page names the entity, a handle its website links to)"}}}